<SEC-DOCUMENT>0000719135-18-000024.txt : 20180504
<SEC-HEADER>0000719135-18-000024.hdr.sgml : 20180504
<ACCEPTANCE-DATETIME>20180504140029
ACCESSION NUMBER:		0000719135-18-000024
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20180504
DATE AS OF CHANGE:		20180504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOVIE MEDICAL Corp
		CENTRAL INDEX KEY:			0000719135
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				112644611
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-224677
		FILM NUMBER:		18807224

	BUSINESS ADDRESS:	
		STREET 1:		4 MANHATTANVILLE ROAD, SUITE 106
		CITY:			PURCHASE
		STATE:			NY
		ZIP:			10577
		BUSINESS PHONE:		800-537-2790

	MAIL ADDRESS:	
		STREET 1:		4 MANHATTANVILLE ROAD, SUITE 106
		CITY:			PURCHASE
		STATE:			NY
		ZIP:			10577

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOVIE MEDICAL CORP
		DATE OF NAME CHANGE:	19990216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AN CON GENETICS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>bvx_s-3x201805.htm
<DESCRIPTION>BVX_2018.05_S-3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="see075f8777624164b429321839a06fd9"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">FORM S-3</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">REGISTRATION STATEMENT</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Under</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">THE SECURITIES ACT OF 1933</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BOVIE MEDICAL CORPORATION</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Exact name of registrant as specified in its charter)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:35%;"></td><td style="width:30%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">11-2644611</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(State or other jurisdiction of</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(I.R.S. Employer</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">5115 Ulmerton Road</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Clearwater, FL 33760 </font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(727) 384-2323 </font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Address, including zip code, and telephone number, including area code, of Registrant&#8217;s principal executive offices)</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Charles D. Goodwin, II</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Chief Executive Officer</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">5115 Ulmerton Road</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Clearwater, Florida 33760</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(727) 384-2323</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Copy to:</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adam P. Silvers, Esq.</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Michael S. Williams, Esq.</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Ruskin Moscou Faltischek, P.C.</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">1425 RXR Plaza</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">East Tower, 15</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">th</sup></font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#32;Floor</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Uniondale, New York 11556-1425</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(516) 663-6519</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Approximate date of commencement of proposed sale to the public:</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">From time to time after the effective date of this registration statement.</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><font style="font-family:inherit;font-size:8pt;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: </font><font style="font-family:Wingdings;font-size:9.5pt;font-weight:bold;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><font style="font-family:inherit;font-size:8pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or intent reinvestments plans, check the following box: </font><font style="font-family:Wingdings;font-size:9.5pt;">&#253;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><font style="font-family:inherit;font-size:8pt;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. </font><font style="font-family:Wingdings;font-size:9.5pt;font-weight:bold;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><font style="font-family:inherit;font-size:8pt;">If this Form is a post effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. </font><font style="font-family:Wingdings;font-size:9.5pt;font-weight:bold;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><font style="font-family:inherit;font-size:8pt;">If this form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. </font><font style="font-family:Wingdings;font-size:9.5pt;font-weight:bold;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><font style="font-family:inherit;font-size:8pt;">If this form is a post-effective amendment to a registration statement filed pursuant General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. </font><font style="font-family:Wingdings;font-size:9.5pt;font-weight:bold;">o</font></div><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Indicate by check mark whether registrant is a large accelerated filer, an accelerated filer, a non accelerated filer, or a smaller reporting company.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:22%;"></td><td style="width:3%;"></td><td style="width:49%;"></td><td style="width:23%;"></td><td style="width:3%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Large accelerated filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Wingdings;font-size:8pt;font-weight:bold;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accelerated filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Wingdings;font-size:8pt;font-weight:bold;">o</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-accelerated filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Wingdings;font-size:8pt;font-weight:bold;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Do not check if a smaller reporting company)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Smaller reporting company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Wingdings;font-size:8pt;">&#253;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Emerging growth company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Wingdings;font-size:8pt;">o</font></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Wingdings;font-size:8pt;">o</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">752522</font></div></div><hr style="page-break-after:always"><div><a name="s935b34ca13a543c6821a1ab091969b3a"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:36%;"></td><td style="width:16%;"></td><td style="width:16%;"></td><td style="width:16%;"></td><td style="width:16%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CALCULATION OF REGISTRATION FEE</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Title of Each Class of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities to be Registered</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount to be Registered</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(1)(2)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Proposed Maximum </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Offering Price Per Security (3)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Proposed Maximum Aggregate Offering Price (4)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Registration Fee (4)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock, par value $.001 per share</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)(2)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred Stock, par value $.001 per share</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)(2)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt Securities</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)(2)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrants</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)(2)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Units (5)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)(2)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)(2)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$25,000,000</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$3,112.50</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There are being registered hereunder such indeterminate number of shares of common stock, such indeterminate number of shares of preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock and/or preferred stock and such indeterminate number of units as may be sold by the Registrant from time to time, which together shall have an aggregate initial offering price not to exceed $25,000,000. If any debt securities are issued at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $25,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or as units with the other securities registered hereunder. The proposed maximum offering price per unit will be determined, from time to time, by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder. The securities registered hereunder also include such indeterminate number of shares of common stock and amount of debt securities as may be issued upon conversion of or exchange for common stock, preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the anti-dilution provisions of any of such securities. In addition, this registration statement also relates to an indeterminate number of shares of common stock that may be issued upon stock splits, stock dividends or similar transactions in accordance with Rule 416 under the Securities Act of 1933.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the restrictions of Section 713 of the NYSE MKT Company Guide, the Registrant may sell no more than 20% of its shares in a primary offering, in any given year if such shares are sold below the greater of book value or market value.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The proposed maximum offering price per class of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder. The principal amount of any debt securities issued with original issue discount will be greater at maturity. If any debt securities are issued with original issue discount, then the offering price of such debt securities shall be in such greater principal amount as shall result in an aggregate initial offering price not to exceed $25,000,000, less the aggregate dollar amount of all securities previously issued hereunder.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) of the Securities Act of 1933.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consisting of some or all of the securities listed above, in any combination, including common stock, preferred stock, debt securities and warrants.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become effective on such date as the Commission, acting pursuant to Section 8(a), may determine.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">752522</font></div></div><hr style="page-break-after:always"><div><a name="scdba40d8456e4d8583e657b75b62e704"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#ff0000;">THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. THESE SECURITIES WILL NOT BE SOLD UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES, AND IT IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUBJECT TO COMPLETION, DATED </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">May&#160;4, 2018</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:center;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;"><img src="a2017bvxlogoa01.jpg" alt="a2017bvxlogoa01.jpg" style="height:84px;width:285px;"></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PROSPECTUS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BOVIE MEDICAL CORPORATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">$</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">25,000,000</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Common Stock</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Preferred Stock</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Debt Securities</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Warrants</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Units</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may offer and sell from time to time in one or more offerings up to $25,000,000 in the aggregate of: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">shares of our common stock;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">shares of our preferred stock, in one or more series;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our debt securities, in one or more series, which may be either senior or subordinated debt securities; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">warrants to purchase shares of our common stock or preferred stock;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">units consisting of shares of common stock, debt securities and/or warrants to purchase shares of common stock and/or debt securities in any combination; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any combination of the foregoing.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each time we offer securities, we will provide the specific terms of the securities offered in one or more supplements to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus. You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents incorporated by reference, before buying any of the securities being offered. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The securities offered by this prospectus may be sold directly by us to investors, through agents designated from time to time or to or through underwriters or dealers. We will set forth the names of any underwriters or agents and any applicable fees, commissions, discounts and over-allotments in an accompanying prospectus supplement. For additional information on the methods of sale, you should refer to the section entitled &#8220;Plan of Distribution&#8221; in this prospectus and in the applicable prospectus supplement. The price to the public of such securities and the net proceeds we expect to receive from such sale will also be set forth in a prospectus supplement.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our common stock is listed on the NYSE MKT under the symbol &#8220;BVX.&#8221; The last reported sale price of our common stock on April 30, 2018 was $3.49 per share. As of April 30, 2018, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $87,621,706. For purposes of this disclosure, shares of common stock held by persons who are known by us to beneficially own more than 5% of the outstanding shares of common stock and shares held by officers and directors of the Registrant have been excluded in that such persons may be deemed to be affiliates. We have not offered any securities pursuant to General Instruction I.B.6 of Form S-3 during the prior 12-calendar month period that ends on, and includes, the date of this prospectus.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INVESTING IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD REVIEW CAREFULLY THE RISKS AND UNCERTAINTIES REFERENCED UNDER THE HEADING &#8220;RISK FACTORS&#8221; ON PAGE 9 OF THIS PROSPECTUS AS WELL AS THOSE CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENT AND ANY RELATED FREE WRITING PROSPECTUS, AND IN THE OTHER DOCUMENTS THAT ARE INCORPORATED BY REFERENCE INTO THIS PROSPECTUS.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">THE DATE OF THIS PROSPECTUS IS </font><font style="font-family:inherit;font-size:10pt;">MAY&#160;4, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><a name="s7dc24b47a16a4989b442cd449a3a238a"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:88%;"></td><td style="width:12%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">TABLE OF CONTENTS</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Page</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sa8809c87ebf14da7b6da4d33759ab72f"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">ABOUT THIS PROSPECTUS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sa8809c87ebf14da7b6da4d33759ab72f">1</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s5e55a1a2758f4743bf1d5aaf20316d4d"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">SUMMARY</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s5e55a1a2758f4743bf1d5aaf20316d4d">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sefd608ec857b412088a96b588463d581"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sefd608ec857b412088a96b588463d581">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sde6b1c98f52b42ab8d4ae2d23d842c3b"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">RISK FACTORS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sde6b1c98f52b42ab8d4ae2d23d842c3b">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#scc978c8ae6b74653b919af9520c31b2c"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">USE OF PROCEEDS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#scc978c8ae6b74653b919af9520c31b2c">10</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s5d486f71ad26459a8657214511ca35f4"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">DESCRIPTION OF CAPITAL STOCK</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s5d486f71ad26459a8657214511ca35f4">10</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sd79fe45d1eb74683914917e97d9f227b"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">DESCRIPTION OF DEBT SECURITIES</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sd79fe45d1eb74683914917e97d9f227b">12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sfb590ed2dee04850b403824cd7ee9d72"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">DESCRIPTION OF WARRANTS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sfb590ed2dee04850b403824cd7ee9d72">18</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s36ce31e6b30d44889db36413869ad1f7"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">DESCRIPTION OF UNITS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s36ce31e6b30d44889db36413869ad1f7">19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s746e1e82b39f49cf9e6be810effcca99"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">PLAN OF DISTRIBUTION</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s746e1e82b39f49cf9e6be810effcca99">19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sf2d4805a8bc44db898fa9fdf346e2963"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">LEGAL MATTERS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#sf2d4805a8bc44db898fa9fdf346e2963">21</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s5e447ddb6a954f71baa3b2521a7c2fd0"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">EXPERTS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s5e447ddb6a954f71baa3b2521a7c2fd0">21</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#se4a4329fea484cda8401f02441792880"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#se4a4329fea484cda8401f02441792880">21</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s8164c20eeafb4697aa7c98caaf89a590"><font style="font-family:inherit;font-size:11pt;text-decoration:none;">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;text-decoration:none;" href="#s8164c20eeafb4697aa7c98caaf89a590">21</a></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You should read this prospectus, including all documents incorporated herein by reference, together with additional information described under &#8220;Where You Can Find More Information.&#8221;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You may obtain the information incorporated by reference without charge by following the instructions under &#8220;Where You Can Find More Information.&#8221;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">752522</font></div></div><hr style="page-break-after:always"><div><a name="sa8809c87ebf14da7b6da4d33759ab72f"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ABOUT THIS PROSPECTUS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;), utilizing a &#8220;shelf&#8221; registration process. Under this shelf registration process, we may offer shares of our common stock and preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or in units, in one or more offerings, up to a total dollar amount of $25,000,000. However, in no event will we sell more than one-third (1/3) of our &#8220;public float&#8221; (the market value of our common stock held by non-affiliates) in any twelve (12) month period. This prospectus provides you with a general description of the securities we may offer. Each time we offer a type or series of securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about the specific terms of the offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. Each such prospectus supplement (and any related free writing prospectus that we may authorize to be provided to you) may also add, update or change information contained in this prospectus or in documents incorporated by reference into this prospectus. We urge you to carefully read this prospectus, any applicable prospectus supplement and any related free writing prospectus, together with the information incorporated herein by reference as described under the headings &#8220;Where You Can Find Additional Information&#8221; and &#8220;Incorporation of Certain Information by Reference&#8221; before buying any of the securities being offered. </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">THIS PROSPECTUS MAY NOT BE USED TO OFFER OR SELL SECURITIES UNLESS IT IS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You should rely only on the information contained or incorporated by reference in this prospectus, any applicable prospectus supplement and any related free writing prospectus. We have not authorized anyone to provide you with different information in addition to or different from that contained in this prospectus, any applicable prospectus supplement and any related free writing prospectus. No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus that we may authorize to be provided to you. You must not rely on any unauthorized information or representation. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should assume that the information in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate only as of the date on the front of the document and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus, any applicable prospectus supplement or any related free writing prospectus, or any sale of a security. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &#8220;Where You Can Find Additional Information.&#8221;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><div><a name="s5e55a1a2758f4743bf1d5aaf20316d4d"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUMMARY</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summary highlights selected information from this prospectus or incorporated by reference in this prospectus. This summary does not contain all the information you should consider before investing in our securities. You should carefully read the entire prospectus, the applicable prospectus supplement and any related free writing prospectus, including the risks of investing in our securities referred to under the heading &#8220;Risk Factors&#8221; in this prospectus and contained in the applicable prospectus supplement and any related free writing prospectus, and in the other documents that are incorporated by reference into this prospectus. You should also carefully read the information incorporated by reference into this prospectus, including our financial statements, and the exhibits to the registration statement of which this prospectus is a part.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Our Company</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bovie Medical Corporation (&#8220;Company&#8221;, &#8220;Bovie Medical&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221;) was incorporated in 1982, under the laws of the State of Delaware and has its principal executive office at&#160;5115 Ulmerton Road, Clearwater, FL 33760.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are an energy-based medical device company specializing in developing, manufacturing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor&#8217;s offices, surgery centers and hospitals worldwide. Our medical devices are marketed through Bovie&#8217;s own well-respected brands (Bovie</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, IDS&#8482; and DERM</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></font><font style="font-family:inherit;font-size:10pt;">) and on a private label basis to distributors throughout the world. The Company also leverages its expertise in the design, development and manufacturing of electrosurgical equipment by producing equipment for large, well-known medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies with the need for our energy based designs.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also the developer of J-Plasma; a patented helium-based plasma surgical product which we believe has the potential to be a transformational product for surgeons.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our objective is to achieve profitable, sustainable growth by increasing our market share in the advanced energy category, including the commercialization of products that have the potential to be transformational with respect to the results they produce for surgeons and patients. In order to achieve this objective, we plan to leverage our long history in the industry, along with the reputation for quality and reliability that the Bovie brand enjoys within the medical community. At the same time, we will expand our product offerings beyond radio frequency devices, move forward with research and developments projects aimed at creating value within our existing product portfolio, build our pipeline of new complementary products, and utilize multiple channels to bring new and existing products to market.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are working to build our position in advanced electrosurgical generators and disposables, which can be used in diversified niche markets with minimally invasive surgical instruments, while furthering our status as a pioneer in plasma technology and its various medical applications.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant Subsidiaries</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aaron Medical Industries, Inc. is a wholly-owned Florida corporation based in Clearwater, Florida. It is principally engaged in the business of marketing our medical products through distributors worldwide under the Bovie name.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bovie Bulgaria, EOOD is a wholly-owned limited liability company incorporated under Bulgarian law, located in Sofia, Bulgaria. It is engaged in the business of engineering and manufacturing our electrosurgical and OEM generators and accessories.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Industry</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Healthcare reform has caused consolidation among providers, with hospitals merging, physician practices joining hospitals and institutions combining to form Accountable Care Organizations, to manage patients on an interdisciplinary basis. Although the medical device industry can be challenging and very competitive, we believe it will continue to have a positive, long-term growth trajectory with the number of surgical procedures performed increasing annually as a result of the aging &#8220;baby boomer&#8221; population and other healthcare trends. Additionally, we also anticipate a continued increase in minimally invasive surgical procedures due to ongoing advancements in technology coupled with continued overall pressure to reduce healthcare costs via a reduction in patient trauma and recovery time. Markets will also continue to provide growth opportunities for the medical device industry.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that Bovie Medical has sustainable, competitive advantages in the medical device market for several reasons. We have a long history in electrosurgery. Our inspiration dates back to the first use of an electrosurgical generator in an operating room in the U.S. in 1926 where Dr. William T.&#160;Bovie was present. Thus, the Bovie name is recognized by surgeons the world over for having pioneered the electrosurgery field and is recognized for its outstanding product quality supported by strong engineering and research and development capabilities. This history equates to very strong recognition of the Bovie brand. We believe that our equipment and devices have and will continue to provide better experiences for patients at a lower cost to the healthcare system.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intellectual Property</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We rely on our intellectual property that we have developed or acquired over the years including patents, trade secrets, technical innovations and various licensing agreements to provide our future growth and build our competitive position. We have been issued&#160;41&#160;patents in the United States and&#160;23&#160;foreign patents. We have&#160;12&#160;pending patent applications in the United States and&#160;9&#160;pending foreign applications. Our intellectual property portfolio for the technology and products related to Advanced Energy products is included in these totals and continues to grow. Specific to Advanced Energy products, we have been issued&#160;21&#160;U.S. and&#160;6&#160;foreign patents and we have&#160;12&#160;U.S. and&#160;9&#160;foreign applications pending. As we continue to expand our intellectual property portfolio we believe it is critical for us to continue to invest in filing patent applications to protect our technology, inventions and improvements. However, we can give no assurance that competitors will not infringe on our patent rights or otherwise create similar or non-infringing competing products that are technically patentable in their own right.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Manufacturing and Suppliers</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are committed to producing the most technically advanced and highest quality products of their kind available on the market. We manufacture the majority of our products on our premises in Clearwater, Florida and at our facility located in Sofia, Bulgaria, which are certified under the ISO international quality standards and are subject to continuing regulation and routine inspections by the FDA to ensure compliance with regulations relating to our quality system, medical device complaint reporting and adherence to FDA restrictions on promotion and advertising. In addition, we are subject to regulations under the Occupational Safety and Health Act, the Environmental Protection Act and other federal, state and local regulations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2015, we acquired all of the outstanding shares of Bovie Bulgaria, EOOD. Bovie Bulgaria operates an&#160;18,745&#160;square foot ISO13485 certified and FDA registered manufacturing facility located in the capital city of Sofia, which houses manufacturing, development and assembly operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We also have collaborative arrangements with three foreign suppliers under which we request the development of certain items and components, which we purchase pursuant to purchase orders. Our purchase order commitments are never more than one year in duration and are supported by our sales forecasts.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Our Three Business Segments</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manage our business through three reportable operating segments: Core, OEM, and Advanced Energy.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the year ended&#160;December&#160;31, 2017, our Core segment contributed&#160;73.7%&#160;of our consolidated total revenue, our OEM segment contributed&#160;6.7%&#160;of our consolidated total revenue and our Advanced Energy segment contributed&#160;19.6%&#160;of our consolidated total revenue.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Segment</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Overview</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Core segment manufactures and markets various medical products, both under private label and the Bovie brands (Bovie, IDS and DERM), to distributors worldwide, which distribute to more than 6,000 hospitals and to doctors and other healthcare facilities. New distributors are contacted through responses to our advertising in international and domestic medical journals and our presence at domestic and international trade shows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Customers</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We sell our Core products through major distributors which include Cardinal Health, Independent Medical Co-Op Inc. (IMCO), McKesson Medical Surgical, Inc., National Distribution and Contracting Inc. (NDC), Henry Schein, Medline, and Owens &amp; Minor and have manufacturing agreements for private label of certain products with these and others.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Products</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Core products consist of electrosurgery generators and accessories, battery-operated cauteries, lighting, nerve locators, eye-bubbles, penlights, and a variety of other products.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Electrosurgery Products</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Electrosurgery is our largest product line and includes desiccators, generators, electrodes, electrosurgical pencils and various ancillary disposable products. These electrosurgical products are used during surgical procedures in gynecology, urology, plastic surgery, dermatology and other surgical markets, including veterinary, for the cutting and coagulation of tissue. It is estimated that electrosurgery is used in 80% of all surgical procedures. Our electrosurgery products fall under two categories, monopolar and bipolar. Monopolar products require the use of a grounding pad attached to the patient for the return of the electrical current, while bipolar products consist of two electrodes; one for the inbound current and one for the return current and therefore do not require the use of a grounding pad.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">DERM 101 and DERM 102</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These effective and economical 10 watt high frequency desiccators provide a low wattage platform for minor in-office skin procedures. We designed these products specifically for family practice physicians, pediatricians and other general practitioners, enabling them to perform simple skin procedures in their offices instead of referring the patient to a specialist saving the patient time and providing additional revenue generating procedures for the physician.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">DERM A942</font><font style="font-family:inherit;font-size:10pt;">&#8482;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, Bantam|Pro A952</font><font style="font-family:inherit;font-size:10pt;">&#8482;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;and Specialist|Pro A1250S</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bovie&#8217;s line of electrosurgical generators has been recently updated with added features and to provide a more modern look for today&#8217;s physician office.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The new Bovie DERM A942 is a low powered 40-watt high frequency desiccator designed primarily for dermatology. These units are used mainly for removing skin lesions and growths as well as for coagulation in office-based procedures.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Bovie Bantam|Pro A952 is a 50-watt high frequency desiccator with the added feature of a cut capacity for outpatient surgical procedures. In effect, the Bovie Bantam|Pro is two independent surgical devices in one small package. The Bantam|Pro replaces the Aaron A950 but with the added feature of Bovie NEM (neutral electrode monitoring), a safety feature that reduces the potential for alternate site burns. This unit is designed mainly for use in doctors&#8217; offices and is used in a broad range of specialties including dermatology, gynecology, family practice, urology, plastic surgery and ophthalmology.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Bovie Specialist|Pro A1250S is a 120-watt multipurpose electrosurgery generator. The unit features monopolar and bipolar functions with pad sensing and is designed to operate like the larger operating room generator in a reduced size. This product is considered to be ideally suited for office-based procedures in the specialties of gynecology, plastic surgery and urology.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Bovie Surgi-Center|Pro A2350 - IDS210 and Bovie OR|Pro A3350 - IDS310</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To address market demand for more powerful electrosurgical generators, Bovie developed 200, 300 and 400-watt multipurpose digital electrosurgery generators designed for the surgi-center market and the hospital outpatient and inpatient markets. This equipment includes digital hardware that enables very high parallel data processing throughout the operation or procedure. All data is sampled and processed digitally. For the first time in electrosurgery, generators are able to measure tissue impedance in real time (5,000 times a second) thanks to the utilization of digital technology. The design of these units is based on a digital feedback system. By using dedicated digital hardware in place of a general purpose controller for processing data, our equipment enables the power to be adjusted as the impedance varies, to deliver a consistent clinical effect.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bovie Surgi-Center|Pro A2350 and IDS210 are 200-watt generators that have the capability to be used in the majority of procedures performed today in surgi-center or outpatient settings. Although 200 watts is adequate to do most procedures in the operating room, 300 watts is considered the standard and believed to be what most hospitals and surgi-centers will require. To meet this requirement, we developed the Bovie OR|Pro A3350 - IDS 310. The Bovie OR|Pro and IDS 310 incorporate the best features of the IDS 300 and upgrade its capabilities by providing additional bipolar options, including the 225-watt Bovie bipolar and an auto bipolar feature. The 300 watt units also offer the capability to utilize two pencils with simultaneous activation in fulguration mode. In addition, these newer models meet new standards required to sell these products in many of the global markets. The Bovie IDS 400 is a 400-watt generator designed primarily for sale in markets outside of the United States. These units feature both monopolar and bipolar functions, have pad and tissue sensing and include nine blended cutting setting.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Electrosurgical Disposables</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Resistick</font><font style="font-family:inherit;font-size:10pt;">&#8482;&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">II</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Resistick II is a trademarked and proprietary coating that is applied to stainless steel that resist eschar (scab or scar tissue caused by burning) during surgery. We have experienced strong demand for this product since its introduction in 2011 and it represents our continued expansion of the Bovie line of electrosurgical disposables.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Disposable Laparoscopic Electrodes</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have introduced a line of disposable laparoscopic electrodes in Resistick coated and stainless steel for use by physicians from a broad group of specialties including gynecology, general surgery and urology. These electrodes are offered in J-hook, L-hook, needle, ball and spatula design and have an adapter included which makes these laparoscopic electrodes usable with a 3/32&#8220; or 4mm plug.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cauteries</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Battery Operated Cauteries</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Battery operated cauteries were originally designed for precise hemostasis (to stop bleeding) in ophthalmology. The current use of cauteries has been substantially expanded to include a broad range of applications. Battery operated cauteries are primarily sterile one-time use products. We have continued to improve our offering and in 2016, had a patent issued covering our snap design cautery. It features a switch mechanism that dramatically reduces the potential for accidental activation. We manufacture one of the broadest lines of cauteries in the world, including but not limited to, a line of replaceable battery and replaceable tip cauteries, which are popular in veterinary and overseas markets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Products</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Battery Operated Medical Lights</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manufacture and market a variety of specialty lighting instruments for use in ophthalmology as well as distribute specialty lighting instruments for general surgery, hip replacement surgery and for the placement of endotracheal tubes in emergency and surgical procedures. We also manufacture and market physicians&#8217; office use penlights.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nerve Locator Stimulator</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manufacture a nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery. This instrument is a sterile, self-contained, battery-operated unit, for one time use.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Competition</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We compete with numerous manufacturers and distributors of medical supplies and devices, many of which are large and well-established. With the exception of endoscopic instrumentation, which are sold directly or through distribution partners to the end-user under our own brand, many of our products are private labeled. The majority of the products in our core business are sold through distributors under the Bovie label. The balance is private labeled for major distributors who sell it under their own name. By having private labeled and branded distribution, we are able&#160;to increase our position in the marketplace and compete with much larger organizations. While our private label customers distribute products through their internal sales force, the majority of our products are sold through distributors which increase our sales potential and help level the playing field relative to our large competitors that sell direct. Domestically, we continue to believe that we have a substantial market share in the field of electrosurgical generator manufacturing through our Bovie branded and OEM units.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our main competitors in electrosurgical and accessory markets are Valleylab (a division of Medtronic), Conmed and Erbe Electromedizine. In the&#160;battery-operated&#160;cautery market, our main competitor is Beaver Visitec and in the endoscopic instrumentation market, it is Ethicon (a division of Johnson and Johnson) and Covidien Surgical Solutions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OEM Segment</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Overview</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company leverages its expertise in the design, development and manufacturing of electrosurgical equipment by producing equipment for large, well-known medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies with the need for our energy based designs. These OEM and private label arrangements and our use of the Bovie brands enable us to gain greater market share for the distribution of our products.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Advanced Energy Segment</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Overview</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Advanced Energy Segment consists primarily of J-Plasma (rebranded as Renuvion</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;Cosmetic Technology for the cosmetic surgery market), a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma/Renuvion system utilizes a helium ionization process to produce a stable, focused beam of plasma that provides surgeons with greater precision, and minimal invasiveness. The new J-Plasma/Renuvion handpieces with Cool-Coag&#8482; technology deliver the precision of helium plasma energy, the power of traditional monopolar coagulation and the efficiency of plasma beam coagulation - enabling thin-layer ablation and dissection and fast coagulation with a single instrument, minimizing instrument exchange and allowing a surgeon to focus on their patient and their procedures. With Cool-Coag technology, the new J-Plasma/Renuvion handpieces can deliver three distinctly different energy modalities - further increasing the utility and versatility of the J-Plasma system. J-Plasma has been the subject of ten white papers and has been cited therein for its clinical utility in various surgical procedures.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our J-Plasma product initially received FDA clearance in 2012 and a CE mark in December, 2014, which enables us to sell the product in the European Union. In 2014, we created and trained a direct sales force dedicated to J-Plasma. In 2015, we continued the commercialization process for J-Plasma with a multi-faceted strategy designed to accelerate adoption of the product. This strategy primarily involved deployment of a dedicated sales force, extending and customizing the J-Plasma product line and expanding the surgical specialties in which J-Plasma can become the &#8220;standard of care&#8220; for certain procedures.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By the end of&#160;2017, we had&#160;17&#160;field-based selling professionals and a network of&#160;14&#160;independent manufacturing representatives, resulting in a total sales force of&#160;31. This is a surgery based selling organization with its focus on the use of J-Plasma for surgical procedures, with the primary focus of cosmetic surgery in the US </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From 2015 through&#160;2017, we launched numerous new J-Plasma products in an effort to target new surgical procedures, users, and markets. As a result of our sales, marketing and product development initiatives, we have significantly increased the number of physicians using J-Plasma by expanding usage to include the surgical oncology market and the cosmetic surgery market.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In&#160;2017&#160;specifically, we launched an updated version of the Bovie Ultimate generator, and a new J-Plasma handpiece for open surgical procedures. The updated version of the Bovie Ultimate generator and the new handpieces allow for the combination of our trademarked Cool-Coag technology and J-Plasma into one, multiple purpose handpiece. Cool-Coag combines standard monopolar coagulation waveforms with helium to provide three distinct modes to stop bleeding including a high fulguration/spray effect. During the second quarter of 2017, we refocused our U.S. sales team into the cosmetic surgery market. Since that time, we have seen a significant increase in the number of physicians using J-Plasma in the cosmetic surgery market.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to assist us in leveraging J-Plasma&#8217;s precision and effectiveness in multiple surgical specialties, we launched a Medical Advisory Board in 2015 which is currently comprised of surgeons who are recognized leaders in GYN, urology, cardiovascular and cardiothoracic surgery, and the cosmetic surgical specialty. In&#160;2018, we added an additional surgeon to this board further enhancing the cosmetic surgical specialty.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, our J-Plasma commercial strategy in the U.S. will be primarily focused on advancing the usage of Renuvion</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;in the cosmetic surgery market. In our international markets, we will also focus on cosmetic surgery and will continue to focus on the surgical oncology market. Our primary international focus will be on advancing the adoption of J-Plasma in the hospital setting. We believe the majority of our targeted procedures in international markets take place in the hospital surgical suite and believe the sales process is shorter in hospitals in international markets as compared to those in the United States. Also, in 2018, we will initiate a clinical and regulatory strategy to support our market focus, once complete, we will launch a corresponding marketing campaign.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are continuing to make substantial investments in the development and marketing of our J-Plasma technology for the long term benefit of the Company and its stakeholders and this may adversely affect our short term profitability and cash flow, particularly over the next 12 to 24 months. While we believe that these investments have the potential to generate additional revenues and profits in the future, there can be no assurance that J-Plasma will be successful or that such future revenues and profitability will be realized.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Customers</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We primarily sell our J-Plasma products through our direct and independent sales force to physicians, surgical centers and hospitals.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Products</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During&#160;2017, Advanced Energy Products consisted of the J-Plasma line of products and the Plazxact arthroscopic bipolar ablator. The J-Plasma system consists of an electrosurgical generator unit (ESU), a handpiece and a supply of helium gas. Radiofrequency (RF) energy is delivered to the handpiece by the ESU and used to energize an electrode. When helium gas passes over the energized electrode, helium plasma is generated which allows for conduction of the RF energy from the electrode to the patient in the form of a precise helium plasma beam. The energy delivered to the patient via the helium plasma beam is very precise and cooler in temperature in comparison to other surgical energy modalities such as standard RF monopolar energy. The Plazxact arthroscopic bipolar ablator is used to ablate damaged, soft tissue in joint procedures to help improve function or reduce pain. The Plazxact system is designed with a very efficient tip design that allows the ablator to be activated with any standard electrosurgical generator. This eases and shortens the sales cycle for the product by removing the need to sell capital equipment to the hospital.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">J-Plasma Generator</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2017, we launched the newest version of the Bovie&#160;Ultimate&#8482; generator. The Bovie&#160;Ultimate 2.0 is a high frequency electrosurgical generator that can be used for delivery of RF energy and/or helium gas plasma to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The generator offers users monopolar, bipolar and J-Plasma features in a single generator. It also powers the Cool-Coag technology that has been incorporated into the new Precise Open and Precise FLEX J-Plasma handpieces that were released in December 2017. These 2017 new product releases continue to expand the procedure base for J-Plasma by providing the surgeons with the tools they need to access additional anatomic locations and perform specific procedures.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">J-Plasma Disposable Portfolio</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We offer different hand pieces for open and laparoscopic procedures. The helium-based plasma generated from these devices have been shown to cause less thermal damage to tissue than CO2 laser, argon plasma and RF energy products currently available on the market. The technology has a general indication and can be used for cutting, coagulating and ablating soft tissue. The two primary specialties that are targeted in phase one of the product launch are surgical oncology and cosmetic surgery. The advantages of helium plasma continue to be studied throughout the medical and scientific communities. We believe that surgical applications are just one area of opportunity for this technology.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Competition</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currently, we are the only company with helium-based plasma and retractable blade products. However, there are RF based competitors, argon plasma competitors, and CO2 laser competitors for our target market. We believe our competitive position did not change in&#160;2017.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Securities We May Offer</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may offer shares of our common stock, preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or in units, with a total value of up to $25,000,000, from time to time under this prospectus at prices and on terms to be determined at the time of any offering. This prospectus provides you with a general description of the securities we may offer. Each time we offer a type or series of securities under this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent applicable: </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">designation or classification; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">aggregate principal amount or aggregate offering price; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">maturity, if applicable; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">original issue discount, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">rates and times of payment of interest or dividends, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">redemption, conversion, exercise, exchange or sinking fund terms, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">preferences over other classes of our securities, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restrictive covenants, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">voting or other rights, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">conversion or exchange prices or rates, if any, and, if applicable, any provisions for changes to or adjustments in the conversion or exchange prices or rates and in the securities or other property receivable upon conversion or exchange; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">important United States federal income tax considerations.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change information contained in this prospectus or in documents we have incorporated by reference. However, no prospectus supplement or free writing prospectus will offer a security that is not registered and described in this prospectus at the time of the effectiveness of the registration statement of which this prospectus is a part. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Common Stock</font><font style="font-family:inherit;font-size:10pt;">. We may issue shares of our common stock from time to time. Holders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the shareholders, and do not have cumulative voting rights. Subject to the preferences that may be applicable to any then outstanding shares of preferred stock, holders of shares of common stock are entitled to share ratably in dividends, if any, as may be declared from time to time by the Board of Directors in its discretion, from funds legally available therefore. In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to shareholders after the payment of all of our debts and other liabilities. Subject to the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock, holders of common stock have no preemptive or other subscription rights, and there are no conversion rights or redemption with respect to such shares.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Preferred Stock</font><font style="font-family:inherit;font-size:10pt;">. We may issue shares of our preferred stock from time to time, in one or more series. The rights, preferences and privileges of the shares of each wholly unissued series, and any qualifications, limitations or restrictions thereon, including dividend rights, conversion rights, preemptive rights, terms of redemption or repurchase, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of any series would be set forth in a Certificate of Designations which would be filed with the Delaware Secretary of State. Convertible preferred stock will be convertible into our common stock or exchangeable for other securities. Conversion may be mandatory or at your option and would be at prescribed conversion rates.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt Securities</font><font style="font-family:inherit;font-size:10pt;">. We may issue debt securities from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. The senior debt securities will rank equally with any other unsecured and unsubordinated debt. The subordinated debt securities will be subordinate and junior in right of payment, to the extent and in the manner described in the instrument governing the debt, to all of our senior indebtedness. Convertible debt securities will be convertible into or exchangeable for our common stock or other securities. Conversion may be mandatory or at your option and would be at prescribed conversion rates. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The debt securities will be issued under one or more documents called indentures, which are contracts between us and a national banking association or other eligible party, as trustee. In this prospectus, we have summarized certain general features of the debt securities. We urge you, however, to read the applicable prospectus supplement (and any free writing prospectus that we may authorize to be provided to you) related to the series of debt securities being offered, as well as the complete indentures that contain the terms of the debt securities. A form of indenture has been filed as an exhibit to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports we file with the SEC.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Warrants</font><font style="font-family:inherit;font-size:10pt;">. We may issue warrants for the purchase of common stock, preferred stock and/or debt securities in one or more series. We may issue warrants independently or together with common stock, preferred stock and/or debt securities, and the warrants may be attached to or separate from these securities. In this prospectus, we have summarized certain general features of the warrants. We urge you, however, to read the applicable prospectus supplement (and any free writing prospectus that we may authorize to be provided to you) related to the particular series of warrants being offered, as well as the complete warrant agreements and/or warrant certificates that contain the terms of the warrants. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Units</font><font style="font-family:inherit;font-size:10pt;">. We may issue, in one or more series, units consisting of common stock, preferred stock, debt securities and/or warrants for the purchase of common stock, preferred stock and/or debt securities in any combination. In this prospectus, we have summarized certain general features of the units. We urge you, however, to read the applicable prospectus supplement (and any free writing prospectus that we may authorize to be provided to you) related to the series of units being offered, as well as the complete unit agreement that contains the terms of the units. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may evidence each series of units by unit certificates that we will issue. Units may be issued under a unit agreement that we enter into with a unit agent. We will indicate the name and address of the unit agent, if applicable, in the prospectus supplement relating to the particular series of units being offered.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sefd608ec857b412088a96b588463d581"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This prospectus contains forward-looking statements within the meaning of Section&#160;27A of the Securities Act regarding our business, financial condition, results of operations and prospects. Words such as expects, anticipates, intends, plans, believes, seeks, estimates, and similar expressions or variations of such words are intended to identify forward-looking statements. However, these are not the exclusive means of identifying forward-looking statements. Although forward-looking statements contained in this prospectus reflect our good faith judgment, such statements can only be based on facts and factors currently known to us. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact us are described or incorporated by reference in &#8220;Risk Factors&#8221; below. You should read that section carefully. You should not place undue reliance on forward-looking statements, which speak only as of the date of this prospectus. We undertake no obligation to update publicly any forward-looking statements in order to reflect any event or circumstance occurring after the date of this prospectus or currently unknown facts or conditions or the occurrence of unanticipated events. In addition, our past results are not necessarily indicative of future results, thus, we cannot guarantee future results, levels of activity, performance or achievements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sde6b1c98f52b42ab8d4ae2d23d842c3b"></a></div><div style="line-height:120%;padding-bottom:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RISK FACTORS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investing in our securities involves significant risks. You should review carefully the risks and uncertainties described under the heading &#8220;Risk Factors&#8221; contained in, or incorporated into, the applicable prospectus supplement and any related free writing prospectus, and under similar headings in the other documents that are incorporated by reference herein or therein. Each of the referenced risks and uncertainties could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment in our securities. Additional risks and uncertainties not known to us or that we believe are immaterial may also adversely affect our business, operating results and financial condition and the value of an investment in our securities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div><a name="scc978c8ae6b74653b919af9520c31b2c"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">USE OF PROCEEDS</font></div><div style="line-height:120%;padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless otherwise indicated in the applicable prospectus supplement, we currently intend to use the net proceeds from the sale of securities offered by this prospectus for working capital and other general corporate purposes, including expanding our sales and marketing, capital expenditures, facilities expansion, acquisitions of complementary products, technologies or businesses and repaying indebtedness we may incur from time to time. The timing and amount of our actual expenditures will be based on many factors, including cash flows from operations and the anticipated growth of our business.&#160;As a result, unless otherwise indicated in the prospectus supplement, our management will have broad discretion to allocate the net proceeds of the offerings.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s5d486f71ad26459a8657214511ca35f4"></a></div><div style="line-height:120%;text-align:center;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF CAPITAL STOCK</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is only a summary of the material terms of our common stock and preferred stock. Because it is only a summary, it does not contain all the information that may be important to you. Accordingly, you should carefully read the more detailed provisions of our certificate of incorporation, as amended, and our by-laws, each of which has been filed with the SEC, as well as applicable provisions of Delaware law.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Authorized Capitalization </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our authorized capital stock consists of 75,000,000 shares of Common Stock, par value $0.001 per share, and 10,000,000 shares of &#8220;blank check&#8221; Preferred Stock, par value $.001 per share. As of April 30, 2018, there were 33,023,049 shares of common stock issued, and 32,879,970 shares outstanding, held by approximately 601 stockholders of record and over 3,500 beneficial owners.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the stockholders, and do not have cumulative voting rights, subject to the preferences that may be applicable to any then outstanding shares of preferred stock. Holders of shares of common stock are entitled to share ratably in dividends, if any, as may be declared from time to time by the Board of Directors in its discretion, from funds legally available therefore. In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to shareholders after the payment of all of our debts and other liabilities. Holders of common stock have no preemptive or other subscription rights, and there are no conversion rights or redemption with respect to such shares.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Preferred Stock</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our certificate of incorporation, as amended, provides that our Board of Directors has the authority, without further action by the stockholders, to issue up to a specified number of shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions of this preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of a series, without further vote or action by the stockholders.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we issue preferred stock, our Board of Directors would fix the rights, preferences, privileges and restrictions of the preferred stock of each series in a Certificate of Designations relating to that series. We will incorporate by reference as an exhibit to the registration statement that includes this prospectus or as an exhibit to a current report on Form&#160;8-K, the form of any Certificate of Designations that describes the terms of the series of preferred stock we are offering before the issuance of the related series of preferred stock. This description will include:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the title and stated value;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the number of shares we are offering;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the liquidation preference per share;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the purchase price;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the dividend rate, period and payment date and method of calculation for dividends;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the procedures for any auction and remarketing, if any;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the provisions for a sinking fund, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase rights;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any listing of the preferred stock on any securities exchange or market;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether the preferred stock will be convertible into our common stock, and, if applicable, the conversion price, or how it will be calculated, and the conversion period;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">voting rights, if any, of the preferred stock;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">preemption rights, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restrictions on transfer, sale or other assignment, if any;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a discussion of any material or special United States federal income tax considerations applicable to the preferred stock;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The issuance of preferred stock, whether pursuant to this offering or otherwise, could adversely affect the voting power, conversion or other rights of holders of our common stock. Preferred stock could be issued quickly with terms designed to delay or prevent a change in control of our company or make removal of management more difficult. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of our common stock. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Transfer Agent and Registrar</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The transfer agent and registrar for our common stock is Manhattan Transfer Registrar Co. Its telephone number is 800-786-0362.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Listing</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our common stock trades on the NYSE MKT Market under the symbol &#8220;BVX.&#8221;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware General Corporation Law Section 203</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a corporation organized under the laws of the State of Delaware, we are subject to Section 203 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;) which restricts certain business combinations between us and an &#8220;interested stockholder&#8221; (in general, a stockholder owning 15% or more of our outstanding voting stock) or its affiliates or associates for a period of three years following the date on which the stockholder becomes an &#8220;interested stockholder.&#8221; The restrictions do not apply if (i) prior to an interested stockholder becoming such, the board of directors approves either the business combination or the transaction in which the stockholder becomes an interested stockholder, (ii) upon consummation of the transaction in which any person becomes an interested stockholder, such interested stockholder owns at least 85% of our voting stock outstanding at the time the transaction commences (excluding shares owned by certain employee stock ownership plans and persons who are both directors and officers of us) or (iii) on or subsequent to the date an interested stockholder becomes such, the business combination is both approved by the board of directors and authorized at an annual or special meeting of our stockholders, not by written consent, by the affirmative vote of at least 66-2/3% of the outstanding voting stock not owned by the interested stockholder.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Limitations of Liability and Disclosure of Commission Position On Indemnification for Securities Act Liabilities</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As permitted under Delaware law, we have adopted provisions in our certificate of incorporation that limit or eliminate the personal liability of our directors for a breach of their fiduciary duty of care as a director. The duty of care generally requires that, when acting on behalf of the corporation, directors exercise an informed business judgment based on all material information reasonably available to them. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director, except for liability for:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any breach of the director&#8217;s duty of loyalty to us or our stockholders;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any act related to unlawful stock repurchases, redemptions or other distributions or payment of dividends under DGCL Section 174; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any transaction from which the director derived an improper personal benefit.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our certificate of incorporation also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the company pursuant to the foregoing provisions, or otherwise, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sd79fe45d1eb74683914917e97d9f227b"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF DEBT SECURITIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may issue debt securities, secured or unsecured, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement. The terms of any debt securities offered under a prospectus supplement may differ from the terms described below. As you read this section, please remember that the specific terms of a debt security as described in the applicable prospectus supplement will supplement and may modify or replace the general terms described in this section. If there are any differences between the applicable prospectus supplement and this prospectus, the applicable prospectus supplement will control. Unless the context requires otherwise, whenever we refer to the indentures, we also are referring to any supplemental indentures that specify the terms of a particular series of debt securities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may issue the debt securities under an indenture that we would enter into with a trustee to be named in the indenture. If we enter into an indenture, the indenture would be qualified under the Trust Indenture Act of 1939, as in effect on the date of the indenture. We use the term &#8220;trustee&#8221; to refer to the trustee under the indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">General</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we issue debt securities, we will describe in the applicable prospectus supplement the terms of the series of debt securities being offered, including:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the title or designation of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether the debt securities will be secured or unsecured, and the terms of any secured debt;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the terms of the subordination of any series of subordinated debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any limit upon the aggregate principal amount of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the date or dates on which the debt securities may be issued and on which we will pay the principal on the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the interest rate, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the date or dates interest will be payable and the record dates for interest payment dates or the method for determining such dates;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the manner in which the amounts of payment of principal of, premium or interest on the debt securities will be determined, if these amounts may be determined by reference to an index based on a currency or currencies other than that in which the debt securities are denominated or designated to be payable or by reference to a commodity, commodity index, stock exchange index or financial index;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the currency of denomination of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if payments of principal of, premium or interest on the debt securities will be made in one or more currencies or currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the place or places where the principal of, premium, and interest on the debt securities will be payable, where debt securities of any series may be presented for registration of transfer, exchange or conversion, and where notices and demands to or upon us in respect of the debt securities may be made;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the form of consideration in which principal of, premium or interest on the debt securities will be paid;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the terms and conditions upon which we may redeem the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund, amortization or analogous provisions or at the option of a holder of debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the dates on which and the price or prices at which we will repurchase the debt securities at the option of the holders of debt securities and other detailed terms and provisions of these repurchase obligations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity date, if other than the principal amount;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether the debt securities are to be issued at any original issuance discount and the amount of discount with which such debt securities may be issued;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether the debt securities will be issued in the form of certificated debt securities or global debt securities and, in such case, the depositary for such global security or securities and the terms and conditions, if any, upon which interests in such global security or securities may be exchanged in whole or in part for the individual securities represented thereby;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">provisions, if any, for the defeasance of the debt securities of a series in whole or in part and any addition or change in the provisions related to satisfaction and discharge;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the form of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the terms and conditions upon which the debt securities will be so convertible or exchangeable into securities or property of another person, if at all, and any additions or changes, if any, to permit or facilitate such conversion or exchange;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether the debt securities will be subject to subordination and the terms of such subordination;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">provisions, if any, granting special rights to holders of the debt securities upon the occurrence of specified events;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any restriction or condition on the transferability of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any addition or change in the provisions related to compensation and reimbursement of the trustee which applies to securities of such series;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any addition to or change in the events of default described in this prospectus or in the indenture with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any addition to or change in the covenants described in this prospectus or in the indenture with respect to the debt securities; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any other terms of the debt securities, which may modify or delete any provision of the indenture.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Conversion or Exchange Rights</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we issue debt securities, we will set forth in the prospectus supplement the terms, if any, on which a series of debt securities may be convertible into or exchangeable for our common stock or our other securities. We will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of our common stock or our other securities that the holders of the series of debt securities receive would be subject to adjustment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidation, Merger or Sale</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the indentures will not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of all or substantially all of our assets. However, any successor to or acquirer of such assets must assume all of our obligations under the indentures or the debt securities, as appropriate. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions that may afford holders of the debt securities additional protection in the event we have a change of control or in the event of a highly leveraged transaction (whether or not such transaction results in a change of control), which could adversely affect holders of debt securities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Events of Default Under the Indenture</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under the indenture with respect to any series of debt securities that we may issue:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if we fail to pay interest when due and payable and our failure continues for more than 30 days and the time for payment has not been extended or deferred;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if we fail to pay the principal, premium, or sinking fund payment, if any, when due and payable and our failure continues for more than 30 days and the time for payment has not been extended or delayed;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if we fail to observe or perform any other covenant relating to such series contained in the debt securities of such series or the indenture, other than a covenant specifically relating to and for the benefit of holders of another series of debt securities, and our failure continues for 60 days after we receive written notice from the trustee or holders of not less than a majority in aggregate principal amount of the outstanding debt securities of the applicable series; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if specified events of bankruptcy, insolvency or reorganization occur as to us; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any other event of default provided in or pursuant to the applicable agreement or indenture, if any, or prospectus supplement with respect to the debt securities of that series.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, no event of default with respect to a particular series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an event of default with respect to any other series of debt securities. The occurrence of an event of default may constitute an event of default under any bank credit agreements we may have in existence from time to time. In addition, the occurrence of certain events of default or an acceleration under the indenture may constitute an event of default under certain of our other indebtedness outstanding from time to time.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an event of default with respect to debt securities of any series at the time outstanding occurs and is continuing, then the trustee or the holders of not less than a majority in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders), declare to be due and payable immediately the principal (or, if the debt securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of that series) of and premium and accrued and unpaid interest, if any, on all debt securities of that series. The holders of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect to the series and its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, unless we have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default or event of default. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We refer you to the prospectus supplement relating to any series of debt securities that are discount securities for the particular provisions relating to acceleration of a portion of the principal amount of such discount securities upon the occurrence of an event of default.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the terms of the indenture, if an event of default under the indenture shall occur and be continuing, the trustee will be under no obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities, unless such holders have offered the trustee reasonable indemnity. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee, with respect to the debt securities of that series, provided that, subject to the terms of the indenture, the trustee need not take any action that it believes, upon the advice of counsel, might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A holder of the debt securities of any series will only have the right to institute a proceeding under the indenture or to appoint a receiver or trustee, or to seek other remedies if:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the holder previously has given written notice to the trustee of a continuing event of default with respect to that series;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the holders of at least a majority in aggregate principal amount of the outstanding debt securities of that series have made written request, and such holders have offered reasonable indemnity to the trustee to institute the proceeding as trustee; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series (or at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series represented at such meeting) other conflicting directions within 60 days after the notice, request and offer.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt securities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will periodically file statements with the applicable trustee regarding our compliance with specified covenants in the applicable indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Modification of Indenture; Waiver</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The trustee and we may, without the consent of any holders, execute a supplemental indenture to change the applicable indenture with respect to specific matters, including, among other things:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to surrender any right or power conferred upon us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to provide, change or eliminate any restrictions on the payment of principal of or premium, if any, on the debt securities; provided that any such action shall not adversely affect the interests of the holders of debt securities of any series in any material respect;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to change or eliminate any of the provisions of the indenture; provided that any such change or elimination shall become effective only when there is no outstanding debt security of any series created prior to the execution of such supplemental indenture that is entitled to the benefit of such provision and as to which such supplemental indenture would apply;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to evidence the succession of another corporation to us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to evidence and provide for the acceptance of appointment by a successor trustee with respect to one or more series of debt securities and to add or change provisions of the indenture to facilitate the administration of the trusts thereunder by more than one trustee;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to cure any ambiguity, mistake, manifest error, omission, defect or inconsistency in the indenture or to conform the text of any provision in the indenture or in any supplemental indenture to any description thereof in the applicable section of a prospectus, prospectus supplement or other offering document that was intended to be a verbatim recitation of a provision of the indenture or of any supplemental indenture;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to add to or change or eliminate any provision of the indenture as shall be necessary or desirable in accordance with any amendments to the Trust Indenture Act of 1939;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to make any change in any series of debt securities that does not adversely affect in any material respect the interests of the holders of such debt securities; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to supplement any of the provisions of the indenture to such extent as shall be necessary to permit or facilitate the defeasance and discharge of any series of debt securities; provided that any such action shall not adversely affect the interests of the holders of debt securities of such series or any other series of debt securities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, under the indenture, the rights of holders of a series of debt securities may be changed by us and the trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the trustee may make the following changes only with the consent of each holder of any outstanding debt securities affected:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">extending the fixed maturity of the series of debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reducing the principal amount, reducing the rate of or extending the time of payment of interest, or reducing any premium payable upon the redemption of any debt securities; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reducing the principal amount of discount securities payable upon acceleration of maturity;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">making the principal of or premium or interest on any debt security payable in currency other than that stated in the debt security;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">impairing the right to institute suit for the enforcement of any payment on or after the fixed maturity date of any series of debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">materially adversely affecting the economic terms of any right to convert or exchange any debt securities; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reducing the percentage of debt securities, the holders of which are required to consent to any amendment, supplement, modification or waiver.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series (or, at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series represented at such meeting) may, on behalf of the holders of all debt securities of that series, waive our compliance with provisions of the indenture. The holders of a majority in principal amount of the outstanding debt securities of any series may, on behalf of the holders of all the debt securities of such series, waive any past default under the indenture with respect to that series and its consequences, other than a default in the payment of the principal of, premium or any interest on any debt security of that series; provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Discharge</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The indenture provides that we can elect to be discharged from our obligations with respect to one or more series of debt securities. In order to exercise our rights to be discharged with respect to a series, we must deposit with the trustee money or government obligations sufficient to pay all the principal of, the premium, if any, and interest on, the debt securities of the series on the dates payments are due.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Form, Exchange and Transfer</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will issue the debt securities of each series only in fully registered form without coupons and, unless we otherwise specify in the applicable prospectus supplement, in denominations of $1,000 and any integral multiple thereof. We may issue debt securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with a depositary named by us and identified in a prospectus supplement with respect to that series.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the option of the holder, subject to the terms of the indenture and the limitations applicable to global securities described in the applicable prospectus supplement, the holder of the debt securities of any series can exchange the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the terms of the indenture and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange or in the indenture, we will make no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will name in the applicable prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each series.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we elect to redeem the debt securities of any series, we will not be required to:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">issue, register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Information Concerning the Trustee</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The trustee, other than during the occurrence and continuance of an event of default under the indenture, undertakes to perform only those duties as are specifically set forth in the indenture. Upon an event of default under the indenture, the trustee must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the trustee is under no obligation to exercise any of the powers given it by the indenture at the request of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Payment and Paying Agents</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless we otherwise indicate in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record date for the interest.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless we otherwise indicate in the applicable prospectus supplement, we will pay principal of and any premium and interest on the debt securities of a particular series at the office of the indenture trustee or, at our option, by wire or check payable to the holder. Unless we otherwise indicate in a prospectus supplement, we will designate the corporate trust office of the trustee our sole paying agent for payments with respect to debt securities of a particular series. We will name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular series. We will maintain a paying agent in each place of payment for the debt securities of a particular series. All money we pay to a paying agent or the trustee for the payment of the principal of or any premium or interest on any debt securities which remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the security thereafter may look only to us for payment thereof.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Governing Law</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless we otherwise indicate in the applicable prospectus supplement, each indenture and the debt securities will be governed and construed in accordance with the laws of the State of Delaware.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><div><a name="sfb590ed2dee04850b403824cd7ee9d72"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF WARRANTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may issue warrants to purchase debt securities, preferred stock or common stock. We may issue warrants independently or together with any other securities we offer under a prospectus supplement. The warrants may be attached to or separate from the securities. We may issue each series of warrants under a separate warrant agreement that we will enter into with a bank or trust company, as warrant agent. The statements made in this section relating to the warrant agreement are summaries only. These summaries are not complete. When we issue warrants, we will provide the specific terms of the warrants and the applicable warrant agreement in a prospectus supplement. To the extent the information contained in the prospectus supplement differs from this summary description, you should rely on the information in the prospectus supplement. For more detail, we refer you to the applicable warrant agreement itself, which we will file as an exhibit to, or incorporate by reference in, the registration statement. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">General</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will describe in the applicable prospectus supplement the terms relating to warrants being offered including:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the offering price and aggregate number of warrants offered;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if applicable, the date on and after which the warrants and the related securities will be separately transferable;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the terms of any rights to redeem or call the warrants;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the dates on which the right to exercise the warrants will commence and expire;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the manner in which the warrant agreements and warrants may be modified;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">federal income tax consequences of holding or exercising the warrants, if material;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the terms of the securities issuable upon exercise of the warrants; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any other specific terms, preferences, rights or limitations of or restrictions on the warrants.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including, in the case of warrants to purchase common stock, the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up of our affairs or to exercise voting rights, if any.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise of Warrants</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the warrants may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement. We intend to set forth in any warrant agreement and in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the warrant agent.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon receipt of the required payment and any warrant certificate or other form required for exercise properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If fewer than all of the warrants represented by the warrant or warrant certificate are exercised, then we will issue a new warrant or warrant certificate for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Governing Law </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless we provide otherwise in the applicable prospectus supplement, the warrants and warrant agreements will be governed by and construed in accordance with the laws of the State of Delaware. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s36ce31e6b30d44889db36413869ad1f7"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF UNITS </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may issue units comprised of one or more debt securities, shares of common stock, preferred stock and/or warrants in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date. The statements made in this section relating to the unit agreement are summaries only. These summaries are not complete. When we issue units, we will provide the specific terms of the units and the applicable unit agreement in a prospectus supplement. To the extent the information contained in the prospectus supplement differs from this summary description, you should rely on the information in the prospectus supplement. For more detail, we refer you to the applicable unit agreement itself, which we will file as an exhibit to, or incorporate by reference in, the registration statement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will describe in the applicable prospectus supplement the terms of the series of units being offered, including:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any provisions of the governing unit agreement that differ from those described below; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provisions described in this section, as well as those described under &#8220;Description of Capital Stock,&#8221; &#8220;Description of Debt Securities&#8221; and &#8220;Description of Warrants&#8221; will apply to each unit and to any common stock, debt security or warrant included in each unit, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may issue units in such amounts and in such numerous distinct series as we determine.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s746e1e82b39f49cf9e6be810effcca99"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PLAN OF DISTRIBUTION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may sell the securities through underwriters or dealers, through agents, or directly to one or more purchasers. We may sell the securities from time to time in one or more transactions at a fixed price or prices, which may be changed from time to time, at market prices prevailing at the times of sale, at prices related to such prevailing market prices, or at negotiated prices. The accompanying prospectus supplement will describe the terms of the offering of the securities, including:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the name or names of any underwriters;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the purchase price of the securities being offered and the proceeds we will receive from the sale;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any over-allotment options pursuant to which underwriters may purchase additional securities from us; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any agency fees or underwriting discounts and other items constituting agents&#8217; or underwriters&#8217; compensation; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any public offering price;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any discounts or concessions allowed or reallowed or paid to dealers; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any securities exchange or market on which the securities may be listed.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If underwriters are used in the sale, they will acquire the securities for their own account and may resell the securities from time to time in one or more transactions at a fixed public offering price or at varying prices determined at the time of the sale. The obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement. We may offer the securities to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Subject to certain conditions, the underwriters will be obligated to purchase all the securities offered by the prospectus supplement. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may change from time to time. We may use underwriters with whom we have a material relationship. We will describe such relationships in the prospectus supplement naming the underwriter and the nature of any such relationship.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may engage in &#8220;at the market&#8221; offerings of our common stock in accordance with Rule 415 under the Securities Act, which are offerings into an existing trading market, at other than a fixed price, on or through the facilities of a national securities exchange or to or through a market maker otherwise than on an exchange.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may sell securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of the securities, and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent will act on a best efforts basis for the period of its appointment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of common shares, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of common shares. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus, will be identified in the applicable prospectus supplement or a post-effective amendment to this registration statement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Some or all of the securities that we offer through this prospectus, other than common stock, may be new issues of securities with no established trading market. Any underwriters to whom we sell our securities for public offerings and sale may make a market for those securities, but they will not be obligated to do so and they may discontinue any market making at any time without notice. Accordingly, we cannot assure you of the liquidity of, or continued trading markets for, any securities that we offer.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All securities we offer, other than common stock, will be new issues of securities for which there is no established trading market. Any underwriters may make a market in these securities, but will not be obligated to do so and may discontinue any market making activities at any time without notice. We cannot guaranty the liquidity of the trading markets for any securities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may provide agents and underwriters with indemnification against civil liabilities related to this offering, including liabilities under the Securities Act, or contribution with respect to payments that the agents or underwriters may make with respect to these liabilities. Agents and underwriters may engage in transactions with, or perform services for, us in the ordinary course of business. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any underwriter may also engage in stabilizing transactions, syndicate covering transactions and penalty bids in accordance with Rule&#160;104 under the Securities Exchange Act of 1934, as amended.&#160;Stabilizing transactions involve bids to purchase the underlying security in the open market for the purpose of pegging, fixing or maintaining the price of the securities.&#160;&#160;Syndicate covering transactions involve purchases of the securities in the open market after the distribution has been completed in order to cover syndicate short positions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Penalty bids permit the underwriters to reclaim a selling concession from a syndicate member when the securities originally sold by the syndicate member are purchased in a syndicate covering transaction to cover syndicate short positions.&#160;&#160;Stabilizing transactions, syndicate covering transactions and penalty bids may cause the price of the securities to be higher than it would be in the absence of the transactions.&#160;The underwriters may, if they commence these transactions, discontinue them at any time.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Similar to other purchase transactions, an underwriter&#8217;s purchases to cover the syndicate short sales or to stabilize the market price of our securities may have the effect of raising or maintaining the market price of our securities or preventing or mitigating a decline in the market price of our securities. As a result, the price of the securities may be higher than the price that might otherwise exist in the open market. The imposition of a penalty bid might also have an effect on the price of shares if it discourages resales of the securities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any underwriters who are qualified market makers on the NYSE MKT Market may engage in passive market making transactions in our common stock on the NYSE MKT Market in accordance with Rule 103 of Regulation M, during the business day prior to the pricing of the offering, before the commencement of offers or sales of common stock. Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered below the passive market maker&#8217;s bid, however, the passive market maker&#8217;s bid must then be lowered when certain purchase limits are exceeded.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Underwriters, broker-dealers or agents who may become involved in the sale of our securities may engage in transactions with and perform other services for us in the ordinary course of their business for which they receive compensation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sf2d4805a8bc44db898fa9fdf346e2963"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LEGAL MATTERS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The validity of the issuance of securities offered hereby will be passed upon for us by Ruskin Moscou Faltischek, P.C., of Uniondale, New York.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s5e447ddb6a954f71baa3b2521a7c2fd0"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXPERTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements incorporated in this prospectus by reference from Bovie Medical Corporation&#8217;s Annual Report on Form l0-K for the year ended December 31, 2017 have been audited by Frazier and Deeter, LLC, independent auditors, as stated in their report, which is incorporated herein by reference, and have been so incorporated in reliance upon the report of such firm given upon their authority as experts in accounting and auditing.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="se4a4329fea484cda8401f02441792880"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WHERE YOU CAN FIND MORE INFORMATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC&#8217;s website at www.sec.gov. You may also read and copy any document we file at the SEC&#8217;s public reference room at 100 F Street, N.E., Washington, D.C. 205409. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registration statement and the documents referred to below under &#8220;Incorporation of Certain Information by Reference&#8221; are also available on our website at http://www.boviemedical.com. We have not incorporated by reference into this prospectus the information on our website, and you should not consider it to be a part of this prospectus.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s8164c20eeafb4697aa7c98caaf89a590"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The SEC allows us to incorporate by reference the information we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this prospectus, and information in documents that we file later with the SEC will automatically update and supersede the information in this prospectus. We incorporate by reference into this prospectus the documents listed below and any future filings we make with the SEC under Section 13(a), 13(c) 14 or 15(d) of the Securities Exchange Act of 1934, as amended, until this offering is completed and all securities are sold or until the sale of securities pursuant to this prospectus is terminated by us:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Annual Report on Form 10-K for the year ended December 31, 2017 filed with the SEC on March 13, 2018.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Current Reports on Form 8-K filed with the SEC on March 14, 2018 and May 3, 2018.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Description of the Registrant&#8217;s Common Stock contained in the Registration Statement on Form 8-A filed with the SEC on November 3, 2003.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This prospectus is part of a registration statement on Form S-3 we have filed with the SEC. This prospectus does not contain all of the information in the registration statement. We have omitted certain parts of the registration statement as permitted under the rules and regulations of the SEC. You may view and inspect the registration statement and exhibits at the SEC&#8217;s Public Reference Room at 100 F Street, N.E., Washington, D.C. 205409 by calling 1-800-SEC-0330 or on the SEC&#8217;s website (see above &#8220;Where You Can Find Additional Information&#8221;).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon request, Bovie will provide, free of charge, to each person to whom a prospectus is delivered, including a beneficial owner, a copy of any or all information that has been incorporated by reference in the prospectus but not delivered with the prospectus. Any such request may be made orally or in writing to Bovie Medical Corporation, 5115 Ulmerton Road, Clearwater, Florida 33760, Attention: Jay D. Ewers, Chief Financial Officer, Tel. No.: (727) 803-8636.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></div><hr style="page-break-after:always"><div><a name="s82d0b840855744259f246eb1a756d767"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;"><img src="a2017bvxlogoa01.jpg" alt="a2017bvxlogoa01.jpg" style="height:84px;width:285px;"></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">$25,000,000</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Common Stock</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Preferred Stock</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Debt Securities</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Warrants</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Units</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">BOVIE MEDICAL CORPORATION</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PROSPECTUS</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">May&#160;4, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></div><hr style="page-break-after:always"><div><a name="se4d2dd5163e045e1b2879e44d27ae7e0"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">II</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INFORMATION NOT REQUIRED IN PROSPECTUS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the estimated costs and expenses of the sales and distribution of the securities being registered, all of which are being borne by us.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:86%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SEC registration fee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,112.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounting fees and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal fees and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Miscellaneous expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">* The amount of securities and number of offerings are indeterminable and expenses cannot be estimated at this time.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 15.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEMNIFICATION OF DIRECTORS AND OFFICERS.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Section 145 of the Delaware General Corporation Law (&#8220;DGCL&#8221;) states:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) A corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action arising by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the person&#8217;s conduct was unlawful.</font></div><div style="line-height:120%;text-align:justify;text-indent:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(b) A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, or other enterprise against expenses (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expense which the Court of Chancery or such other court shall deem proper.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As permitted under the DGCL, we have adopted provisions in our Certificate of Incorporation, as amended, and By-laws that limit or eliminate the personal liability of our directors for a breach of their fiduciary duty of care as a director. The duty of care generally requires that, when acting on behalf of the corporation, directors exercise an informed business judgment based on all material information reasonably available to them. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director, except for liability for:</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:72px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Any breach of the director&#8217;s duty of loyalty to us or our stockholders;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:72px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:72px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Any act related to unlawful stock repurchases, redemptions or other distributions or payment of dividends under DGCL Section 174; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:72px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Any transaction from which the director derived an improper personal benefit.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our Certificate of Incorporation, as amended, also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the company pursuant to the foregoing provisions, or otherwise, we have been informed that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 16. EXHIBITS </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following documents are filed as part of this Registration Statement:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:92%;"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Underwriting Agreement</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/719135/000100944811000015/exhibit31.htm"><font style="font-family:inherit;font-size:10pt;text-decoration:none;">Articles of Incorporation of the Registrant (Incorporated by reference to the Registrant&#8217;s report on Form 10-K/A filed on March 31, 2011)</font></a></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/719135/000100944811000015/exhibit32.htm"><font style="font-family:inherit;font-size:10pt;text-decoration:none;">By laws of the Registrant (Incorporated by reference to the Registrant&#8217;s report on Form 10-K/A filed on March 31, 2011)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/719135/000071913517000064/a2017q3exhibit35.htm"><font style="font-family:inherit;font-size:10pt;text-decoration:none;">Certificate of Amendment of the Certificate of Incorporation of the Registrant (Incorporated by reference to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on November 3, 2017).</font></a></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/719135/000071913518000021/bvx_201805xex31certificate.htm"><font style="font-family:inherit;font-size:10pt;text-decoration:none;">Certificate of Elimination (Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K filed on May 3, 2018)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="bvx_201805xex45formofinden.htm"><font style="font-family:inherit;font-size:10pt;text-decoration:none;">Form of Indenture</font></a></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Common Stock Warrant Agreement and Warrant Certificate</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Preferred Stock Warrant Agreement and Warrant Certificate</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Unit Agreement</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="bvx_201805xex51opinionofrmf.htm"><font style="font-family:inherit;font-size:10pt;text-decoration:none;">Opinion of Ruskin Moscou Faltischek, P.C.</font></a></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consent of Ruskin Moscou Faltischek, P.C. (contained in Exhibit 5.1)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="bovies3consentexecuted.htm"><font style="font-family:inherit;font-size:10pt;text-decoration:none;">Consent of Frazier &amp; Deeter, LLC</font></a></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">*</font><font style="font-family:inherit;font-size:9pt;">&#160;To be filed by amendment or by a report filed under the Securities Exchange Act of 1934, as amended, and incorporated herein by reference, if applicable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 17. UNDERTAKINGS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The undersigned registrant hereby undertakes:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(1)</font><font style="font-family:inherit;font-size:10pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(i)</font><font style="font-family:inherit;font-size:10pt;">To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(ii)</font><font style="font-family:inherit;font-size:10pt;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(iii)</font><font style="font-family:inherit;font-size:10pt;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Provided, however</font><font style="font-family:inherit;font-size:10pt;">, that:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(A) Paragraphs (i), (ii)&#160;and (iii)&#160;above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement; and</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(2)</font><font style="font-family:inherit;font-size:10pt;">That, for the purpose of determining any liability under the&#160;Securities Act&#160;of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. &#160;</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(3)</font><font style="font-family:inherit;font-size:10pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(4)</font><font style="font-family:inherit;font-size:10pt;">For the purpose of determining liability under the Securities Act of 1933 to any purchaser:</font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(i)</font><font style="font-family:inherit;font-size:10pt;">Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(ii)</font><font style="font-family:inherit;font-size:10pt;">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x)&#160;for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(5)</font><font style="font-family:inherit;font-size:10pt;">For the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</font></div><div style="line-height:120%;text-align:justify;padding-left:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(i)</font><font style="font-family:inherit;font-size:10pt;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(i)</font><font style="font-family:inherit;font-size:10pt;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(i)</font><font style="font-family:inherit;font-size:10pt;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:96px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">(i)</font><font style="font-family:inherit;font-size:10pt;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6) For purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">annual report pursuant to Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section&#160;15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7)&#160;&#160;&#160;&#160;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933, and will be governed by the final adjudication of such issue.</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8) That, for purposes of determining any liability under the Securities Act of 1933:</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(i) &#160;&#160;&#160;&#160;The information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4)&#160;or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective; and</font></div><div style="line-height:120%;text-align:justify;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(ii) &#160;&#160;&#160;&#160;Each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9) To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a)&#160;of Section&#160;310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the SEC under Section&#160;305(b)(2) of the Act.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></div><hr style="page-break-after:always"><div><a name="s001fe418e64d412f8da7c4e121f62039"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Clearwater, State of Florida on </font><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:48%;"></td><td style="width:5%;"></td><td style="width:34%;"></td><td style="width:13%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Bovie Medical Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ Charles D. Goodwin II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charles D. Goodwin II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer and Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">POWER OF ATTORNEY</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each person whose signature appears below hereby constitutes and appoints Charles D. Goodwin II as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:32%;"></td><td style="width:1%;"></td><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Title</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Directors:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ CHARLES D. GOODWIN II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer and Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charles D. Goodwin II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ ANDREW MAKRIDES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chairman of the Board</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Andrew Makrides</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ JAY D. EWERS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer), Treasurer and Secretary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jay D. Ewers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ J. ROBERT SARON</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief Sales and Marketing Officer and Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">J. Robert Saron</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ JOHN ANDRES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice Chairman of the Board</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John Andres</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ LAWRENCE J. WALDMAN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lawrence J. Waldman</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ MICHAEL GERAGHTY</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael Geraghty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ CRAIG A. SWANDAL</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Craig A. Swandal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>bvx_201805xex45formofinden.htm
<DESCRIPTION>BVX_2018.05_EXHIBIT 4.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s1d13bd1d33014aa7b1993455a7cdee19"></a></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BOVIE MEDICAL CORPORATION INDENTURE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Dated as of</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">__________, 20___</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="s9e7c3f48e6a94f8aafd8b4176abe523e"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">TABLE OF CONTENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:16%;"></td><td style="width:78%;"></td><td style="width:6%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Page</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">No.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE I DEFINITIONS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sccdf3fa4fc2a496fae78630bda54787e">1</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 1.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Definitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sc585d049cb204b97833dabc2b16ce19f">2</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE II FORMS OF SECURITIES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s7d04b59e6dd04fd3baf9e9c315873d37">8</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 2.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Terms of the Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s69a77a8c5a0842709725df5493a78c2f">8</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 2.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Form of Trustee&#8217;s Certificate of Authentication</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s8d3726a00b864b55a8c7d827ff41a044">8</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 2.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Form of Trustee&#8217;s Certificate of Authentication by an Authenticating Agent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s14fceaa36b014575bb17018ac1e13061">9</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE III THE DEBT SECURITIES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s0cb2a9726ec34e11b1e660dc795159cd">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amount; Issuable in Series</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s0316cb2be08448ee82a6a90526aa6b84">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Denominations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s302752f6cb8a41c7996f50faa4ae72bf">11</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Execution, Authentication, Delivery and Dating</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s101dd8d110544b128fb11161ada9f92b">12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Temporary Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s1a72b3ef5b364828a2b928577e335b19">13</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Registrar</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s899c2c5b31d040dbad2eb76f395f2198">14</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Transfer and Exchange</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s65e4430abd654f69a93bbad9a3b8179e">14</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.07.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Mutilated, Destroyed, Lost and Stolen Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s07414191f76b43ba981f72daf043a446">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.08.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Payment of Interest; Interest Rights Preserved</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s966bcf48f1b94894a2c89677af5eb96c">18</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.09.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cancellation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s4d1db5a35d56468d94741c1e6a2b049a">19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.10.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Computation of Interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s6ef13fa33d1d41a9a2d11bcbeb225d58">19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.11.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Currency of Payments in Respect of Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#seb2068760ef040538ddd4b91986de02f">19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.12.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Judgments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s1cff6ec79a18419c826226a87a23751b">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 3.13.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">CUSIP Numbers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s6e70a19a20f24c43bfa7dacc8b202284">20</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE IV REDEMPTION OF SECURITIES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s3ea64114787a4363a3dc62b9596f07c1">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 4.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicability of Right of Redemption</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s615544b0a2fe4f628e15551ad0c0ebe1">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 4.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Selection of Securities to be Redeemed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s8bc24ec2aa0042a6a22d54b9882a5e47">21</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 4.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Notice of Redemption</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s067f10229fdf435da30164baa9476a6d">21</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 4.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Deposit of Redemption Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s971bafdebd4d48f1a998ca9096228cc2">22</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 4.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Securities Payable on Redemption Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s81969e1005024bb2a04d33451d36f8b8">22</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 4.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Securities Redeemed in Part</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s2d825e721320486c92f815d03922cba9">22</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE V SINKING FUNDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s8daa497a1c994e228f0879fecb9daa45">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 5.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicability of Sinking Fund.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s1280f7a505bd469bb1feb7a783941791">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 5.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Mandatory Sinking Fund Obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s9dc0dfa4e6134dff8acfe46dfff49d58">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 5.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Optional Redemption at Sinking Fund Redemption Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sbe97f759281f461886eacc92e14fdc5b">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 5.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Application of Sinking Fund Payment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s0fee0448ef6d4014a18a32097ccd64ce">24</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE VI PARTICULAR COVENANTS OF THE COMPANY</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s7977184f6ac8494cbb7e966d3186ab8d">25</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 6.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Payments of Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sf962db4e022d44148eeab9d70dabf311">25</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 6.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Paying Agent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s4a47b97f31f947a89489c3a38f2f9e4c">25</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 6.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">To Hold Payment in Trust</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s5b29ae6611014bf886fabd94a700d5ba">25</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 6.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Merger, Consolidation and Sale of Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s50b71d0cd6634e8fa38e1d6041b51c90">26</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 6.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Compliance Certificate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s223b2444cfc540708444ac62493f807f">27</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 6.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Conditional Waiver by Holders of Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sf3b252d28c374194a830b91a11127f82">27</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 6.07.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Statement by Officers as to Default</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#se8994f387e394101b428ffb64be5ad87">28</a></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ii</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:16%;"></td><td style="width:78%;"></td><td style="width:6%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE VII REMEDIES OF TRUSTEE AND SECURITYHOLDERS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s9e899ecacf584e3ea25b30ded88d5c5a">28</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Events of Default</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s4b512e65deb34f79bc3780f60ca75563">28</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Acceleration; Rescission and Annulment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s6e8f22cefcb345a2bc413521e0fd8993">29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other Remedies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s8ea21cbbe6ca4883b0f686da2bcd9883">30</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Trustee as Attorney-in-Fact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s72f2491716e8495380c0fa4eec3c7c4b">31</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Priorities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sfb350211266a46f2979a6f7af7dc23f9">31</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Control by Securityholders; Waiver of Past Defaults</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s89e703813a2d4bf79263a174b3cfcc1b">32</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.07.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Limitation on Suits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#scd68ccf8135d448ba915fd0c48e1934c">32</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.08.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Undertaking for Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s6dbb2be867f7432082caebcae7162683">33</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 7.09.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remedies Cumulative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s50059c65546941e6b8f44d343ab8afe8">33</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE VIII CONCERNING THE SECURITYHOLDERS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#scf60591fa478474896d7752c78f2d5fa">34</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 8.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Evidence of Action of Securityholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sb6ec3bdda2c5430abe643f9487e4dfd8">34</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 8.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Proof of Execution or Holding of Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s79ef2a832b9c4dbbb4084148dde91b68">34</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 8.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Persons Deemed Owners.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s188194827247400abf6c9f460c96d524">35</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 8.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effect of Consents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s5e8b4acf46fc4ea8b8578c05fd83cf12">35</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE IX SECURITYHOLDERS&#8217; MEETINGS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sa55be2a6b1dc4e03a1d99c96da49dd08">35</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 9.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Purposes of Meetings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s702c713718104931ac56c356200fea67">35</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 9.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Call of Meetings by Trustee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s0c15c83e53984010b31f7791cdbebc19">35</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 9.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Call of Meetings by Company or Securityholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s65ae7ccbb7d147b08c96ead46bc0fbea">36</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 9.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Qualifications for Voting</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s2838312f9e9849d98679e6aab14f1656">36</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 9.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Regulation of Meetings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s3931c1f27a674cb2aaaed171d078bc21">36</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 9.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Voting</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s5bfe11dd708a430c8c9c2037ea2c0a0b">37</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 9.07.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">No Delay of Rights by Meeting</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s91107b2c3143451eb49f7a4e800f664e">37</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE X REPORTS BY THE COMPANY AND THE TRUSTEE AND SECURITYHOLDERS&#8217; LISTS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s51f9fcef9ba44eb084bdc1152d48632b">37</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 10.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Reports by Trustee.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sd04d40646354420b8e311bb788de1bd2">37</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 10.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Reports by the Company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sb0c8df16acb54d5eb7d3cdc2d48d061a">38</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 10.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Securityholders&#8217; Lists</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s8a985c571ab64414afea04b4f09a1376">38</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE XI CONCERNING THE TRUSTEE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s7f146478476a47d5b606ea46e507e399">38</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Rights of Trustees; Compensation and Indemnity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s2f51650680a54f9aaf51119bc4dd9e12">38</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Duties of Trustee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s4b8054f35a0540f09f2b742cb841491f">40</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Notice of Defaults</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#scde15a1436b1442793454a9a0e7aa954">41</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Eligibility; Disqualification.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sdbcd9ca127304f7092e95636b92c06f2">42</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Registration and Notice; Removal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sb8ea3cccd1734959b04fcca2b6612715">42</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Successor Trustee by Appointment.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s7ae6949919f745489fcbcd7338f9e704">43</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.07.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Successor Trustee by Merger</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s59eedf72a1ed4b89ae3d1f59a23829e7">44</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.08.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Right to Rely on Officer&#8217;s Certificate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sd22976d8fae64618a2c047091f17748e">44</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.09.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Appointment of Authenticating Agent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sceca71aac39c4e79a7a934c80eb1f9e6">45</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 11.10.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Communications by Securityholders with Other Securityholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s71a6a66d1e4d4e92953354f3c16dd1f0">45</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE XII SATISFACTION AND DISCHARGE; DEFEASANCE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s55c510a8abc5468e98eeff97f90e36bb">46</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 12.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicability of Article</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sec6e24c7e2ed4add8b70997951d9b476">46</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 12.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Satisfaction and Discharge of Indenture</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s6c921200a22a4a21bdd10068ab19656e">46</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 12.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Defeasance upon Deposit of Moneys or U.S Government Obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s31eca71d3f144f819413cda2062323db">47</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 12.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Repayment to Company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sdfc3c58354f04da3ae86d4f1b22bcfb1">47</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 12.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Indemnity for U.S Government Obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s0ffd40a809fa4f3a80b1e71560e69c62">48</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 12.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Application of Trust Money</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s86c77237ba7747e28d7e39e22107c268">48</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 12.07.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Deposits of Non-U.S</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s56a02e9b4cc04ffc9511ef89b3678a94">48</a></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">iii</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:16%;"></td><td style="width:78%;"></td><td style="width:6%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE XIII IMMUNITY OF CERTAIN PERSONS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s56fafd23b55b40f3a933a63e0907ee36">48</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 13.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">No Personal Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s35beca92762447f19cf2ab902577e05a">48</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE XIV SUPPLEMENTAL INDENTURES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s83f0f11f5eaf49ddb5275ffd7599315b">49</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 14.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Without Consent of Securityholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s766834b04cb74c84a2a1f96f45486e50">49</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 14.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">With Consent of Securityholders; Limitations.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s266e039320e241e98034206932f11a9a">50</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 14.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Trustee Protected</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s1d7b67479d454e779028c3e8b65729d6">51</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 14.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effect of Execution of Supplemental Indenture</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s2e1511ac1b984674b3fe8b9971ac1c64">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 14.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Notation on or Exchange of Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s15c77126834a45eaaa5f2a17118fcc60">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 14.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Conformity with TIA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s050be75b99b244b7a1aaf3d3d97c1b72">52</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE XV SUBORDINATION OF SECURITIES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sfb804a7e9fe243a28e4df6871ea54890">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Agreement to Subordinate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s9b5ec22c775444f88d8526fbc97049f4">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Distribution on Dissolution, Liquidation and Reorganization; Subrogation of Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sfce6b0fc7e8d4fc99b7d0a4b97d07624">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">No Payment on Securities in Event of Default on Senior Indebtedness</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s3df8cf03c59e455fa473dea8ac227241">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Payments on Securities Permitted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s216c52307ff548e59f8e45501583c113">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Authorization of Securityholders to Trustee to Effect Subordination</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s2b7502e593374c4fa665d9e5adcd1452">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Notices to Trustee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sfe9e6bd28a41478381a7903e86fa8e9a">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.07.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Trustee as Holder of Senior Indebtedness</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sd9833ddb52614e728e85a77bc13abc0b">55</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.08.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Modifications of Terms of Senior Indebtedness</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sa0236b2afa894a7c8181488e5d1140d5">55</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.09.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Reliance on Judicial Order or Certificate of Liquidating Agent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s9e598d3515f64686883c95767c856a6d">55</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.10.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Satisfaction and Discharge; Defeasance and Covenant Defeasance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s5b17a6ff57f94a83a39b8e76c37ed4f3">55</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 15.11.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Trustee Not Fiduciary for Holders of Senior Indebtedness</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s6aa41d75023b4268ba9f9101b7d3c04d">56</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ARTICLE XVI MISCELLANEOUS PROVISIONS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sa6ac74b3bed64f94933821ce7dacb7c7">56</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.01.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Certificates and Opinions as to Conditions Precedent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s2a39450d0e704c3bb8d77cccb37df31c">56</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.02.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Trust Indenture Act Controls</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sefe67758c3a04ee996627d258cf4c434">57</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.03.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Notices to the Company and Trustee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sa606543b65c94241a5284586166025dd">57</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.04.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Notices to Securityholders; Waiver</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s4adcf57b9ab849b7985d98496f189cb7">57</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.05.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Legal Holiday</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s02898f70ec984ac79b88953bedd5fd9b">58</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.06.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effects of Headings and Table of Contents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sada595b2c1be420e8511ba61d2a33c31">58</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.07.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Successors and Assigns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s1372a6faaa194298bbf7b9b05b8b37ec">58</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.08.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Severability Clause</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s7930f09734064478a2aecc1e0e303aba">58</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.09.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Benefits of Indenture</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sc4d7a01e8dca4798be06e0c2833a76ef">58</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.10.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Counterparts Originals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#s27de0da8b3bf41349b4d21dec42657c1">58</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Section 16.11.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Governing Law; Waiver of Trial by Jury</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><a style="font-family:inherit;font-size:11pt;color:#000000;text-decoration:none;" href="#sa20b4ed3af67452aa9717ed1b5ef9eb0">58</a></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">iv</font></div></div><hr style="page-break-after:always"><div><a name="s4e572d04bb634954a7ebed3b91c1bc33"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">BOVIE MEDICAL CORPORATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">INDENTURE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dated as of</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">__________, 20___</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DEBT SECURITIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trustee</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">INDENTURE dated as of _______________, 20___, among Bovie Medical Corporation, a Delaware corporation (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Company</font><font style="font-family:inherit;font-size:12pt;">&#8221;), and ____________, as trustee (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Trustee</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WITNESSETH:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debentures, notes, bonds or other evidences of indebtedness (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Securities</font><font style="font-family:inherit;font-size:12pt;">&#8221;) in an unlimited aggregate principal amount to be issued from time to time in one or more series as provided in this Indenture; and</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, all things necessary to make this Indenture a valid and legally binding agreement of the Company, in accordance with its terms, have been done.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, THIS INDENTURE WITNESSETH:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">That, in consideration of the premises and the purchase of the Securities by the Holders thereof for the equal and proportionate benefit of all of the present and future Holders of the Securities, each party agrees and covenants as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sccdf3fa4fc2a496fae78630bda54787e"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE I</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">DEFINITIONS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For all purposes of this Indenture, except as otherwise expressly provided or unless the context otherwise requires:</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) the terms defined in this Article have the meanings assigned to them in this Article and include the plural as well as the singular;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) all terms used herein without definition which are defined in the Trust Indenture Act, either directly or by reference therein, have the meanings assigned to them therein; </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) the words &#8220;herein&#8221;, &#8220;hereof&#8221; and &#8220;hereunder&#8221; and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision, and</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) References to &#8220;Article&#8221; or &#8220;Section&#8221; or other subdivision herein are references to an Article, Section or other subdivision of the Indenture, unless the context otherwise requires. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="sc585d049cb204b97833dabc2b16ce19f"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Definitions.</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Unless otherwise defined in this Indenture or the context otherwise requires, all terms used herein shall have the meanings assigned to them in the Trust Indenture Act. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) Unless the context otherwise requires, the terms defined in this Section 1.01(b) shall for all purposes of this Indenture have the meanings hereinafter set forth, the following definitions to be equally applicable to both the singular and the plural forms of any of the terms herein defined: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Affiliate"</font><font style="font-family:inherit;font-size:12pt;">&#32;with respect to any specified Person shall mean any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, &#8220;control&#8221; when used with respect to any specified Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms &#8220;controlling&#8221; and &#8220;controlled&#8221; have meanings correlative to the foregoing. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Authenticating Agent" </font><font style="font-family:inherit;font-size:12pt;">shall have the meaning assigned to it in Section 11.09. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Board of Directors"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean either the board of directors of the Company or the executive or any other committee of that board duly authorized to act in respect hereof. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Board Resolution"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean a copy of a resolution or resolutions certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors (or by a committee of the Board of Directors to the extent that any such other committee has been authorized by the Board of Directors to establish or approve the matters contemplated) and to be in full force and effect on the date of such certification and delivered to the Trustee. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Business Day" </font><font style="font-family:inherit;font-size:12pt;">when used with respect to any Place of Payment or any other particular location referred to in this Indenture or in the Securities, shall mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in that Place of Payment or other location are authorized or obligated by law or executive order to close. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Capital Stock&#8221; </font><font style="font-family:inherit;font-size:12pt;">shall mean: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) in the case of a corporation, corporate stock; </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock; </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) in the case of a partnership or limited liability company, partnership interests (whether general or limited) or membership interests; and </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person, but excluding from all of the foregoing any debt securities convertible into Capital Stock, whether or not such debt securities include any right of participation with Capital Stock. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Code"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean the Internal Revenue Code of 1986 as in effect on the date hereof. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Company"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean the Person named as the &#8220;Company&#8221; in the first paragraph of this Indenture until a successor Person shall have become such pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Company&#8221; shall mean such successor Person. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Company Order"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean a written order signed in the name of the Company by the Chairman, Chief Executive Officer, President, Chief Financial Officer, any Vice President, Treasurer, any Assistant Treasurer, Controller, Assistant Controller, Secretary or any Assistant Secretary of the Company, and delivered to the Trustee. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Corporate Trust Office" </font><font style="font-family:inherit;font-size:12pt;">or other similar term, shall mean the principal office of the Trustee at which at any particular time its corporate trust business shall be administered, which office at the date hereof is located at _________, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust officer of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the Company). </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Currency"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean U.S. Dollars or Foreign Currency. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Default" </font><font style="font-family:inherit;font-size:12pt;">shall have the meaning assigned to it in Section 11.03. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Defaulted Interest"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall have the same meaning assigned to it in Section 3.08(b).</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Depositary"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean, with respect to the Securities of any series issuable in whole or in part in the form of one or more Global Securities, the Person designated as Depositary by the Company pursuant to Section 3.01 until a successor Depositary shall have become such pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Depositary&#8221; shall mean or include each Person who is then a Depositary hereunder, and if at any time there is more than one such Person, &#8220;Depositary&#8221; as used with respect to the Securities of any such series shall mean the Depositary with respect to the Securities of that series. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Designated Currency"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall have the same meaning assigned to it in Section 3.12. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Discharged</font><font style="font-family:inherit;font-size:12pt;">&#8221; shall have the meaning assigned to it in Section 12.03.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Event of Default" </font><font style="font-family:inherit;font-size:12pt;">shall have the meaning specified in Section 7.01. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Exchange Act" </font><font style="font-family:inherit;font-size:12pt;">shall mean the Securities Exchange Act of 1934, as amended. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Exchange Rate"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall have the meaning assigned to it in Section 7.01. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Floating Rate Security" </font><font style="font-family:inherit;font-size:12pt;">shall mean a Security that provides for the payment of interest at a variable rate determined periodically by reference to an interest rate index specified pursuant to Section 3.01. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Foreign Currency":</font><font style="font-family:inherit;font-size:12pt;">&#32;The term &#8220;Foreign Currency&#8221; shall mean a currency issued by the government of any country other than the United States or a composite currency, the value of which is determined by reference to the values of the currencies of any group of countries. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"GAAP" </font><font style="font-family:inherit;font-size:12pt;">shall mean generally accepted accounting principles in the United States as in effect from time to time, including, without limitation, those set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as approved by a significant segment of the accounting profession. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Global Security"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean any Security that evidences all or part of a series of Securities, issued in fully-registered certificated form to the Depositary for such series in accordance with Section 3.03 and bearing the legend prescribed in Section 3.03(g). </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Holder&#8221; or &#8220;Holder of Securities"</font><font style="font-family:inherit;font-size:12pt;">&#32;are defined under &#8220;Security holder&#8221; or &#8220;Holder of Securities&#8221; or &#8220;Holder.&#8221; </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Indebtedness"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean any and all obligations of a Person for money borrowed which, in accordance with GAAP, would be reflected on the balance sheet of such Person as a liability on the date as of which Indebtedness is to be determined. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Indenture"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean this instrument and all indentures supplemental hereto. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Interest" </font><font style="font-family:inherit;font-size:12pt;">shall mean, with respect to an Original Issue Discount Security that by its terms bears interest only after Maturity, interest payable after Maturity. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Interest Payment Date"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean, with respect to any Security, the Stated Maturity of an installment of interest on such Security. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Mandatory Sinking Fund Payment"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall have the meaning assigned to it in Section 5.01. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Maturity"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean the date on which the principal of such Security shall become due and payable as therein and herein provided, whether by declaration, call for redemption or otherwise. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Members"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall have the meaning assigned to it in Section 3.03(i). </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Officer&#8217;s Certificate" </font><font style="font-family:inherit;font-size:12pt;">shall mean a certificate signed by any of the Chairman of the Board of Directors, Chief Executive Officer, President, Chief Financial Officer, any Vice President, Treasurer, any Assistant Treasurer, Controller, Assistant Controller, Secretary or any Assistant Secretary of the Company and delivered to the Trustee. Each such certificate shall include the statements provided for in Section 16.01 if and to the extent required by the provisions of such Section. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Opinion of Counsel" </font><font style="font-family:inherit;font-size:12pt;">shall mean an opinion in writing signed by legal counsel, who may be an employee of or of counsel to the Company, or may be other counsel that meets the requirements provided for in Section 16.01. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Optional Sinking Fund Payment" </font><font style="font-family:inherit;font-size:12pt;">shall have the meaning assigned to it in Section 5.01. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Original Issue Discount Security" </font><font style="font-family:inherit;font-size:12pt;">shall mean any Security that is issued with &#8220;original issue discount&#8221; within the meaning of Section 1273(a) of the Code and the regulations thereunder and any other Security designated by the Company as issued with original issue discount for United States federal income tax purposes. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Outstanding"</font><font style="font-family:inherit;font-size:12pt;">&#32;when used with respect to Securities means, as of the date of determination, all Securities theretofore authenticated and delivered under this Indenture, except: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Securities theretofore canceled by the Trustee or delivered to the Trustee for cancellation; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) Securities or portions thereof for which payment or redemption money in the necessary amount has been theretofore deposited with the Trustee or any Paying Agent (other than the Company) in trust or set aside and segregated in trust by the Company (if the Company shall act as its own Paying Agent) for the Holders of such Securities or Securities as to which the Company&#8217;s obligations have been Discharged; provided, however, that if such Securities or portions thereof are to be redeemed, notice of such redemption has been duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee has been made; and </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Securities that have been paid pursuant to Section 3.07(b) or in exchange for or in lieu of which other Securities have been authenticated and delivered pursuant to this Indenture, other than any such Securities in respect of which there shall have been presented to a Responsible Officer of the Trustee proof satisfactory to it that such Securities are held by a protected purchaser in whose hands such Securities are valid obligations of the Company; provided, however, that in determining whether the Holders of the requisite principal amount of Securities of a series Outstanding have performed any action hereunder, Securities owned by the Company or any other obligor upon the Securities of such series or any Affiliate of the Company or of such other obligor shall be disregarded and deemed not to be Outstanding, except that, in determining whether the Trustee shall be protected in relying upon any such action, only Securities of such series that a Responsible Officer of the Trustee actually knows to be so owned shall be so disregarded. Securities so owned that have been pledged in good faith may be regarded as Outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee&#8217;s right to act with respect to such Securities and that the pledgee is not the Company or any other obligor upon such Securities or any Affiliate of the Company or of such other obligor. In determining whether the Holders of the requisite principal amount of Outstanding Securities of a series have performed any action hereunder, the principal amount of an Original Issue Discount Security that shall be deemed to be Outstanding for such purpose shall be the amount of the principal thereof that would be due and payable as of the date of such determination upon a declaration of acceleration of the Maturity thereof pursuant to Section 7.02 and the principal amount of a Security denominated in a Foreign Currency that shall be deemed to be Outstanding for such purpose shall be the amount calculated pursuant to Section 3.11(b). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Paying Agent"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall have the meaning assigned to it in Section 6.02(a). </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Person" </font><font style="font-family:inherit;font-size:12pt;">shall mean an individual, a corporation, a limited liability company, a partnership, an association, a joint stock company, a trust, an unincorporated organization or a government or an agency or political subdivision thereof. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Place of Payment"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean, when used with respect to the Securities of any series, the place or places where the principal of and premium, if any, and interest on the Securities of that series are payable as specified pursuant to Section 3.01. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Predecessor Security" </font><font style="font-family:inherit;font-size:12pt;">shall mean, with respect to any Security, every previous Security evidencing all or a portion of the same debt as that evidenced by such particular Security, and, for the purposes of this definition, any Security authenticated and delivered under Section 3.07 in lieu of a lost, destroyed or stolen Security shall be deemed to evidence the same debt as the lost, destroyed or stolen Security. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Record Date"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean, with respect to any interest payable on any Security on any Interest Payment Date, the close of business on any date specified in such Security for the payment of interest pursuant to Section 3.01. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Redemption Date"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean, when used with respect to any Security to be redeemed, in whole or in part, the date fixed for such redemption by or pursuant to this Indenture and the terms of such Security, which, in the case of a Floating Rate Security, unless otherwise specified pursuant to Section 3.01, shall be an Interest Payment Date only. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Redemption Price" </font><font style="font-family:inherit;font-size:12pt;">when used with respect to any Security to be redeemed, in whole or in part, shall mean the price at which it is to be redeemed pursuant to the terms of the Security and this Indenture. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Register"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall have the meaning assigned to it in Section 3.05(a). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Registrar" </font><font style="font-family:inherit;font-size:12pt;">shall have the meaning assigned to it in Section 3.05(a). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Responsible Officers" </font><font style="font-family:inherit;font-size:12pt;">when used with respect to the Trustee hereunder shall mean any Vice President, any Assistant Vice President, any Trust Officer, any Assistant Trust Officer or any other officer associated with the corporate trust department of the Trustee customarily performing functions similar to those performed by any of the above designated officers, and also means, with respect to a particular corporate trust matter, any other officer of the Trustee to whom such matter is referred because of such person&#8217;s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of this Indenture. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"SEC" </font><font style="font-family:inherit;font-size:12pt;">shall mean the U.S. Securities and Exchange Commission, as constituted from time to time. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Securities Act" </font><font style="font-family:inherit;font-size:12pt;">shall mean the Securities Act of 1933, as amended. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Security" or &#8220;Securities&#8221; </font><font style="font-family:inherit;font-size:12pt;">shall have the meaning stated in the recitals and shall more particularly mean one or more of the Securities duly authenticated by the Trustee and delivered pursuant to the provisions of this Indenture. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">&#8220;Security Custodian&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean the custodian with respect to any Global Security appointed by the Depositary, or any successor Person thereto, and shall initially be the Paying Agent. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Securityholder&#8221; or &#8220;Holder of Securities&#8221; or &#8220;Holder"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean the Person in whose name Securities shall be registered in the Register kept for that purpose hereunder. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Senior Indebtedness" </font><font style="font-family:inherit;font-size:12pt;">means the principal of (and premium, if any) and unpaid interest on (x) Indebtedness of the Company, whether outstanding on the date hereof or thereafter created, incurred, assumed or guaranteed, for money borrowed other than (a) any Indebtedness of the Company which when incurred, and without respect to any election under Section 1111(b) of the Federal Bankruptcy Code, was without recourse to the Company, (b) any Indebtedness of the Company to any of its Subsidiaries, (c) Indebtedness to any employee of the Company, (d) any liability for taxes, (e) Trade Payables and (f) any Indebtedness of the Company which is expressly subordinate in right of payment to any other Indebtedness of the Company, and (y) renewals, extensions, modifications and refundings of any such Indebtedness. For purposes of the foregoing and the definition of &#8220;Senior Indebtedness,&#8221; the phrase &#8220;subordinated in right of payment&#8221; means debt subordination only and not lien subordination, and accordingly, (i) unsecured indebtedness shall not be deemed to be subordinated in right of payment to secured indebtedness merely by virtue of the fact that it is unsecured, and (ii) junior liens, second liens and other contractual arrangements that provide for priorities among Holders of the same or different issues of indebtedness with respect to any collateral or the proceeds of collateral shall not constitute subordination in right of payment. This definition may be modified or superseded by a supplemental indenture. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Special Record Date" </font><font style="font-family:inherit;font-size:12pt;">shall have the meaning assigned to it in Section 3.08(b)(i). </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Stated Maturity" </font><font style="font-family:inherit;font-size:12pt;">when used with respect to any Security or any installment of interest thereon, shall mean the date specified in such Security as the fixed date on which the principal (or any portion thereof) of or premium, if any, on such Security or such installment of interest is due and payable. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Subsidiary" </font><font style="font-family:inherit;font-size:12pt;">&#32;when used with respect to any Person, shall mean: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:12pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">any corporation, limited liability company, association or other business entity of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency and after giving effect to any voting agreement or stockholders&#8217; agreement that effectively transfers voting power) to vote in the election of directors, managers or trustees of the corporation, association or other business entity is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person (or a combination thereof); and </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:12pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">any partnership (i) the sole general partner or the managing general partner of which is such Person or a Subsidiary of such Person or (ii) the only general partners of which are that Person or one or more Subsidiaries of that Person (or any combination thereof). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Successor Company" </font><font style="font-family:inherit;font-size:12pt;">shall have the meaning assigned to it in Section 3.06(i). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Trade Payables"</font><font style="font-family:inherit;font-size:12pt;">&#32;means accounts payable or any other Indebtedness or monetary obligations to trade creditors created or assumed by the Company or any Subsidiary of the Company in the ordinary course of business (including guarantees thereof or instruments evidencing such liabilities). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Trust Indenture Act&#8221; or &#8220;TIA"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean the Trust Indenture Act of 1939, as amended. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">"Trustee"</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean the Person named as the &#8220;Trustee&#8221; in the first paragraph of this Indenture until a successor Trustee shall have become such with respect to one or more series of Securities pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Trustee&#8221; shall mean or include each Person who is then a Trustee hereunder, and if at any time there is more than one such Person, &#8220;Trustee&#8221; as used with respect to the Securities of any series shall mean the Trustee with respect to Securities of that series. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">&#8220;U.S. Dollars&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean such currency of the United States as at the time of payment shall be legal tender for the payment of public and private debts. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">U.S. Government Obligations</font><font style="font-family:inherit;font-size:12pt;">&#8221; means securities that are (i) direct obligations of the United States for the payment of which its full faith and credit is pledged or (ii) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States the timely of payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States, that, in either case under clauses (i) or (ii) are not callable or redeemable at the action of the issuer thereof, and shall also include a depositary receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or a specific payment of interest on or principal of any such U.S. Government Obligation held by such custodian for the account of the holder of a depositary receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the U.S. Government Obligation or the specific payment of interest on or principal of the U.S. Government Obligation evidenced by such depositary receipt. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">&#8220;United States&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#32;shall mean the United States of America (including the States and the District of Columbia), its territories and its possessions and other areas subject to its jurisdiction. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7</font></div></div><hr style="page-break-after:always"><div><a name="s7d04b59e6dd04fd3baf9e9c315873d37"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE II</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">FORMS OF SECURITIES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s69a77a8c5a0842709725df5493a78c2f"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Terms of the Securities.</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Securities of each series shall be substantially in the form set forth in a Board Resolution or Company Order or in one or more indentures supplemental hereto, and shall have such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture, and may have such letters, numbers or other marks of identification or designation and such legends or endorsements placed thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange on which any series of the Securities may be listed or of any automated quotation system on which any such series may be quoted, or to conform to usage, all as determined by the officers executing such Securities as conclusively evidenced by their execution of such Securities. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The terms and provisions of the Securities shall constitute, and are hereby expressly made, a part of this Indenture, and, to the extent applicable, the Company and the Trustee, by their execution and delivery of this Indenture expressly agree to such terms and provisions and to be bound thereby. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s8d3726a00b864b55a8c7d827ff41a044"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Form of Trustee&#8217;s Certificate of Authentication.</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Only such of the Securities as shall bear thereon a certificate substantially in the form of the Trustee&#8217;s certificate of authentication hereinafter recited, executed by the Trustee by manual signature, shall be valid or become obligatory for any purpose or entitle the Holder thereof to any right or benefit under this Indenture. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) Each Security shall be dated the date of its authentication, except that any Global Security shall be dated as of the date specified as contemplated in Section 3.01. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) The form of the Trustee&#8217;s certificate of authentication to be borne by the Securities shall be substantially as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Date of Authentication: ____________________________ ____________________, as Trustee</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:46%;"></td><td style="width:5%;"></td><td style="width:49%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Authorized Signatory</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">8</font></div></div><hr style="page-break-after:always"><div><a name="s14fceaa36b014575bb17018ac1e13061"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Form of Trustee&#8217;s Certificate of Authentication by an Authenticating Agent</font><font style="font-family:inherit;font-size:12pt;">. If at any time there shall be an Authenticating Agent appointed with respect to any series of Securities, then the Trustee&#8217;s Certificate of Authentication by such Authenticating Agent to be borne by Securities of each such series shall be substantially as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This is one of the Securities of the Series designated herein referred to in the within-mentioned Indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Date of Authentication: ____________________________ ____________________, as Trustee</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:46%;"></td><td style="width:5%;"></td><td style="width:49%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Authorized Agent</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Authorized Signatory</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s0cb2a9726ec34e11b1e660dc795159cd"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE III</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">THE DEBT SECURITIES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s0316cb2be08448ee82a6a90526aa6b84"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amount; Issuable in Series</font><font style="font-family:inherit;font-size:12pt;">. The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more series. There shall be set forth in a Company Order or Board Resolution in one or more indentures supplemental hereto, prior to the issuance of Securities of any series:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) the title of the Securities of the series (which shall distinguish the Securities of such series from the Securities of all other series, except to the extent that additional Securities of an existing series are being issued);</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) whether the Securities will be secured or unsecured, and the terms of any secured debt;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) the terms of the subordination of any series of subordinated Securities;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) any limit upon the aggregate principal amount of the Securities of the series that may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon transfer of, or in exchange for, or in lieu of, other Securities of such series pursuant to Section 3.04, 3.06, 3.07, 4.06, or 14.05);</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) the dates on which or periods during which the Securities of the series may be issued, and the dates on, or the range of dates within, which the principal of and premium, if any, on the Securities of such series are or may be payable or the method by which such date or dates shall be determined or extended;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">9</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f) the rate or rates at which the Securities of the series shall bear interest, if any, or the method by which such rate or rates shall be determined, the date or dates from which such interest shall accrue, or the method by which such date or dates shall be determined, the Interest Payment Dates on which any such interest shall be payable, and the Record Dates for the determination of Holders to whom interest is payable on such Interest Payment Dates or the method by which such date or dates shall be determined, the right, if any, to extend or defer interest payments and the duration of such extension or deferral;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g) if other than U.S. Dollars, the Currency in which Securities of the series shall be denominated or in which payment of the principal of, premium, if any, or interest on the Securities of the series shall be payable and any other terms concerning such payment;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h) if the amount of payment of principal of, premium, if any, or interest on the Securities of the series may be determined with reference to an index, formula or other method including, but not limited to, an index based on a Currency or Currencies other than that in which the Securities are stated to be payable, the manner in which such amounts shall be determined;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) if the principal of, premium, if any, or interest on Securities of the series are to be payable, at the election of the Company or a Holder thereof, in a Currency other than that in which the Securities are denominated or stated to be payable without such election, the period or periods within which, and the terms and conditions upon which, such election may be made and the time and the manner of determining the exchange rate between the Currency in which the Securities are denominated or payable without such election and the Currency in which the Securities are to be paid if such election is made;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j) the place or places, if any, in addition to or instead of the Corporate Trust Office of the Trustee where the principal of, premium, if any, and interest on Securities of the series shall be payable, and where Securities of any series may be presented for registration of transfer, exchange or conversion, and the place or places where notices and demands to or upon the Company in respect of the Securities of such series may be made;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(k) the form of consideration in which principal of, premium or interest on the Securities will be paid;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(l) the price or prices at which, the period or periods within which or the date or dates on which, and the terms and conditions upon which Securities of the series may be redeemed, in whole or in part, at the option of the Company, if the Company is to have that option;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(m) the obligation or right, if any, of the Company to redeem, purchase or repay Securities of the series pursuant to any sinking fund, amortization or analogous provisions or at the option of a Holder thereof and the price or prices at which, the period or periods within which or the date or dates on which, the Currency or Currencies in which and the terms and conditions upon which Securities of the series shall be redeemed, purchased or repaid, in whole or in part, pursuant to such obligation;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(n) if other than denominations of $1,000 or any integral multiple thereof, the denominations in which Securities of the series shall be issuable;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(o) if other than the principal amount thereof, the portion of the principal amount of the Securities of the series which shall be payable upon declaration of acceleration of the Maturity thereof pursuant to Section 7.02; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(p) whether the Securities of the series are to be issued as Original Issue Discount Securities and the amount of discount with which such Securities may be issued;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">10</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(q) provisions, if any, for the defeasance of Securities of the series in whole or in part and any addition or change in the provisions related to satisfaction and discharge;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(r) whether the Securities of the series are to be issued in whole or in part in the form of one or more Global Securities and, in such case, the Depositary for such Global Security or Securities and the terms and conditions, if any, upon which interests in such Global Security or Securities may be exchanged in whole or in part for the individual Securities represented thereby;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(s) the date as of which any Global Security of the series shall be dated if other than the original issuance of the first Security of the series to be issued;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(t) the form of the Securities of the series;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(u) if the Securities of the series are to be convertible into or exchangeable for any securities or property of any Person (including the Company), the terms and conditions upon which such Securities will be so convertible or exchangeable, and any additions or changes, if any, to permit or facilitate such conversion or exchange;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v) whether the Securities of such series are subject to subordination and the terms of such subordination;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(w) any restriction or condition on the transferability of the Securities of such series;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(x) any addition or change in the provisions related to compensation and reimbursement of the Trustee which applies to Securities of such series;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(y) any addition or change in the provisions related to supplemental indentures set forth in Sections 14.04 and 14.02 which applies to Securities of such series;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(z) provisions, if any, granting special rights to Holders upon the occurrence of specified events;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(aa) any addition to or change in the Events of Default which applies to any Securities of the series and any change in the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 7.02 and any addition or change in the provisions set forth in Article VII which applies to Securities of the series;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(bb) any addition to or change in the covenants set forth in Article VI which applies to Securities of the series; and</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(cc) any other terms of the Securities of such series (which terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 14.01).</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">All Securities of any one series shall be substantially identical, except as to denomination and except as may otherwise be provided herein or set forth in a Company Order or in one or more indentures supplemental hereto.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s302752f6cb8a41c7996f50faa4ae72bf"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Denominations</font><font style="font-family:inherit;font-size:12pt;">. In the absence of any specification pursuant to Section 3.01 with respect to Securities of any series, the Securities of such series shall be issuable only as Securities in denominations of any integral multiple of $1,000, and shall be payable only in U.S. Dollars.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">11</font></div></div><hr style="page-break-after:always"><div><a name="s101dd8d110544b128fb11161ada9f92b"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Execution, Authentication, Delivery and Dating</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Securities shall be executed in the name and on behalf of the Company by the manual or facsimile signature of its Chairman of the Board of Directors, Chief Executive Officer, President, Chief Operating Officer, Chief Financial Officer, one of its Vice Presidents or Treasurer. If the Person whose signature is on a Security no longer holds that office at the time the Security is authenticated and delivered, the Security shall nevertheless be valid.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a Company Order for the authentication and delivery of such Securities and, if required pursuant to Section 3.01, a supplemental indenture or Company Order setting forth the terms of the Securities of a series. The Trustee shall thereupon authenticate and deliver such Securities without any further action by the Company. The Company Order shall specify the amount of Securities to be authenticated and the date on which the original issue of Securities is to be authenticated.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) In authenticating the first Securities of any series and accepting the additional responsibilities under this Indenture in relation to such Securities the Trustee shall receive, and (subject to Section 11.02) shall be fully protected in relying upon an Officer&#8217;s Certificate and an Opinion of Counsel, each prepared in accordance with Section 16.01 stating that the conditions precedent, if any, provided for in the Indenture have been complied with.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) The Trustee shall have the right to decline to authenticate and deliver the Securities under this Section 3.03 if the issue of the Securities pursuant to this Indenture will affect the Trustee&#8217;s own rights, duties or immunities under the Securities and this Indenture or otherwise in a manner which is not reasonably acceptable to the Trustee.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) Each Security shall be dated the date of its authentication, except as otherwise provided pursuant to Section 3.01 with respect to the Securities of such series.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f) Notwithstanding the provisions of Section 3.01 and of this Section 3.03, if all of the Securities of any series are not to be originally issued at the same time, then the documents required to be delivered pursuant to this Section 3.03 must be delivered only once prior to the authentication and delivery of the first Security of such series;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g) If the Company shall establish pursuant to Section 3.01 that the Securities of a series are to be issued in whole or in part in the form of one or more Global Securities, then the Company shall execute and the Trustee shall authenticate and deliver one or more Global Securities that (i) shall represent an aggregate amount equal to the aggregate principal amount of the Outstanding Securities of such series to be represented by such Global Securities, (ii) shall be registered, if in registered form, in the name of the Depositary for such Global Security or Securities or the nominee of such Depositary, (iii) shall be delivered by the Trustee to such Depositary or pursuant to such Depositary&#8217;s instruction and (iv) shall bear a legend substantially to the following effect:</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;Unless and until it is exchanged in whole or in part for the individual Securities represented hereby, this Global Security may not be transferred except as a whole by the Depositary to a nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary.&#8221;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">12</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The aggregate principal amount of each Global Security may from time to time be increased or decreased by adjustments made on the records of the Security Custodian, as provided in this Indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h) Each Depositary designated pursuant to Section 3.01 for a Global Security in registered form must, at the time of its designation and at all times while it serves as such Depositary, be a clearing agency registered under the Exchange Act and any other applicable statute or regulation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) Members of, or participants in, the Depositary (&#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Members</font><font style="font-family:inherit;font-size:12pt;">&#8221;) shall have no rights under this Indenture with respect to any Global Security held on their behalf by the Depositary or by the Security Custodian under such Global Security, and the Depositary may be treated by the Company, the Trustee, the Paying Agent and the Registrar and any of their agents as the absolute owner of such Global Security for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee, the Paying Agent or the Registrar or any of their agents from giving effect to any written certification, proxy or other authorization furnished by the Depositary or impair, as between the Depositary and its Members, the operation of customary practices of the Depositary governing the exercise of the rights of an owner a beneficial interest in any Global Security. The Holder of a Global Security may grant proxies and otherwise authorize any Person, including Members and Persons that may hold interests through Members, to take any action that a Holder is entitled to take under this Indenture or the Securities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j) No Security shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in one of the forms provided for herein duly executed by the Trustee or by an Authenticating Agent by manual or facsimile signature of an authorized signatory of the Trustee, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder and is entitled to the benefits of this Indenture.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s1a72b3ef5b364828a2b928577e335b19"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Temporary Securities</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Pending the preparation of definitive Securities of any series, the Company may execute, and upon Company Order the Trustee shall authenticate and deliver, temporary Securities that are printed, lithographed, typewritten, mimeographed or otherwise reproduced, in any authorized denomination, substantially of the tenor of the definitive Securities in lieu of which they are issued, in registered form and with such appropriate insertions, omissions, substitutions and other variations as the officers executing such Securities may determine, as conclusively evidenced by their execution of such Securities. Any such temporary Security may be in global form, representing all or a portion of the Outstanding Securities of such series. Every such temporary Security shall be executed by the Company and shall be authenticated and delivered by the Trustee upon the same conditions and in substantially the same manner, and with the same effect, as the definitive Security or Securities in lieu of which it is issued.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) If temporary Securities of any series are issued, the Company will cause definitive Securities of such series to be prepared without unreasonable delay. After the preparation of definitive Securities of such series, the temporary Securities of such series shall be exchangeable for definitive Securities of such series upon surrender of such temporary Securities at the office or agency of the Company in a Place of Payment for such series, without charge to the Holder. Upon surrender for cancellation of any one or more temporary Securities of any series, the Company shall execute and the Trustee shall authenticate and deliver in exchange therefor a like principal amount of definitive Securities of the same series of authorized denominations and of like tenor. Until so exchanged, the temporary Securities of any series shall in all respects be entitled to the same benefits under this Indenture as definitive Securities of such series.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">13</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Upon any exchange of a portion of a temporary Global Security for a definitive Global Security or for the individual Securities represented thereby pursuant to this Section 3.04 or Section 3.06, the temporary Global Security shall be endorsed by the Trustee to reflect the reduction of the principal amount evidenced thereby, whereupon the principal amount of such temporary Global Security shall be reduced for all purposes by the amount so exchanged and endorsed.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s899c2c5b31d040dbad2eb76f395f2198"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Registrar</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Company will keep, at an office or agency to be maintained by it in a Place of Payment where Securities may be presented for registration or presented and surrendered for registration of transfer or of exchange, and where Securities of any series that are convertible or exchangeable may be surrendered for conversion or exchange, as applicable (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Registrar</font><font style="font-family:inherit;font-size:12pt;">&#8221;), a security register for the registration and the registration of transfer or of exchange of the Securities (the registers maintained in such office and in any other office or agency of the Company in a Place of Payment being herein sometimes collectively referred to as the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Register</font><font style="font-family:inherit;font-size:12pt;">&#8221;), as in this Indenture provided, which Register shall at all reasonable times be open for inspection by the Trustee. Such Register shall be in written form or in any other form capable of being converted into written form within a reasonable time. The Company may have one or more co-Registrars; the term &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Registrar</font><font style="font-family:inherit;font-size:12pt;">&#8221; includes any co-registrar. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The Company shall enter into an appropriate agency agreement with any Registrar or co-Registrar not a party to this Indenture. The agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall notify the Trustee of the name and address of each such agent. If the Company fails to maintain a Registrar for any series, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 11.01. The Company or any Affiliate thereof may act as Registrar, co-Registrar or transfer agent.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) The Company hereby appoints the Trustee at its Corporate Trust Office as Registrar in connection with the Securities and this Indenture, until such time as another Person is appointed as such.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s65e4430abd654f69a93bbad9a3b8179e"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Transfer and Exchange</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Transfer.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) Upon surrender for registration of transfer of any Security of any series at the Registrar the Company shall execute, and the Trustee or any Authenticating Agent shall authenticate and deliver, in the name of the designated transferee, one or more new Securities of the same series for like aggregate principal amount of any authorized denomination or denominations. The transfer of any Security shall not be valid as against the Company or the Trustee unless registered at the Registrar at the request of the Holder, or at the request of his, her or its attorney duly authorized in writing.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) Notwithstanding any other provision of this Section, unless and until it is exchanged in whole or in part for the individual Securities represented thereby, a Global Security representing all or a portion of the Securities of a series may not be transferred except as a whole by the Depositary for such series to a nominee of such Depositary or by a nominee of such Depositary to such Depositary or another nominee of such Depositary or by such Depositary or any such nominee to a successor Depositary for such series or a nominee of such successor Depositary. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">14</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) Exchange.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) At the option of the Holder, Securities of any series (other than a Global Security, except as set forth below) may be exchanged for other Securities of the same series for like aggregate principal amount of any authorized denomination or denominations, upon surrender of the Securities to be exchanged at the Registrar.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) Whenever any Securities are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Securities that the Holder making the exchange is entitled to receive.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Exchange of Global Securities for Individual Securities. Except as provided below, owners of beneficial interests in Global Securities will not be entitled to receive individual Securities.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) Individual Securities shall be issued to all owners of beneficial interests in a Global Security in exchange for such interests if: (A) at any time the Depositary for the Securities of a series notifies the Company that it is unwilling or unable to continue as Depositary for the Securities of such series or if at any time the Depositary for the Securities of such series shall no longer be eligible under Section 3.03(h) and, in each case, a successor Depositary is not appointed by the Company within 90 days of such notice, or (B) the Company executes and delivers to the Trustee and the Registrar an Officer&#8217;s Certificate stating that such Global Security shall be so exchangeable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In connection with the exchange of an entire Global Security for individual Securities pursuant to this subsection (c), such Global Security shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall execute, and the Trustee, upon receipt of a Company Order for the authentication and delivery of individual Securities of such series, will authenticate and deliver to each beneficial owner identified by the Depositary in exchange for its beneficial interest in such Global Security, an equal aggregate principal amount of individual Securities of authorized denominations.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) The owner of a beneficial interest in a Global Security will be entitled to receive an individual Security in exchange for such interest if an Event of Default has occurred and is continuing. Upon receipt by the Security Custodian and Registrar of instructions from the Holder of a Global Security directing the Security Custodian and Registrar to (x) issue one or more individual Securities in the amounts specified to the owner of a beneficial interest in such Global Security and (y) debit or cause to be debited an equivalent amount of beneficial interest in such Global Security, subject to the rules and regulations of the Depositary:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(A) the Security Custodian and Registrar shall notify the Company and the Trustee of such instructions, identifying the owner and amount of such beneficial interest in such Global Security;</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(B) the Company shall promptly execute and the Trustee, upon receipt of a Company Order for the authentication and delivery of individual Securities of such series, shall authenticate and deliver to such beneficial owner individual Securities in an equivalent amount to such beneficial interest in such Global Security; and </font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">15</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(C) the Security Custodian and Registrar shall decrease such Global Security by such amount in accordance with the foregoing. In the event that the individual Securities are not issued to each such beneficial owner promptly after the Registrar has received a request from the Holder of a Global Security to issue such individual Securities, the Company expressly acknowledges, with respect to the right of any Holder to pursue a remedy pursuant to Section 7.07 hereof, the right of any beneficial Holder of Securities to pursue such remedy with respect to the portion of the Global Security that represents such beneficial Holder&#8217;s Securities as if such individual Securities had been issued.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii) If specified by the Company pursuant to Section 3.01 with respect to a series of Securities, the Depositary for such series of Securities may surrender a Global Security for such series of Securities in exchange in whole or in part for individual Securities of such series on such terms as are acceptable to the Company and such Depositary. Thereupon, the Company shall execute, and the Trustee shall authenticate and deliver, without service charge,</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(A) to each Person specified by such Depositary a new individual Security or Securities of the same series, of any authorized denomination as requested by such Person in aggregate principal amount equal to and in exchange for such Person&#8217;s beneficial interest in the Global Security; and</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(B) to such Depositary a new Global Security in a denomination equal to the difference, if any, between the principal amount of the surrendered Global Security and the aggregate principal amount of individual Securities delivered to Holders thereof.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv) In any exchange provided for in clauses (i) through (iii), the Company will execute and the Trustee will authenticate and deliver individual Securities in registered form in authorized denominations.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v) Upon the exchange in full of a Global Security for individual Securities, such Global Security shall be canceled by the Trustee. Individual Securities issued in exchange for a Global Security pursuant to this Section shall be registered in such names and in such authorized denominations as the Depositary for such Global Security, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee. The Trustee shall deliver such Securities to the Persons in whose names such Securities are so registered.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) All Securities issued upon any registration of transfer or exchange of Securities shall be valid obligations of the Company evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered for such registration of transfer or exchange.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) Every Security presented or surrendered for registration of transfer, or for exchange or payment shall (if so required by the Company, the Trustee or the Registrar) be duly endorsed, or be accompanied by a written instrument or instruments of transfer in form satisfactory to the Company, the Trustee and the Registrar, duly executed by the Holder thereof or by his, her or its attorney duly authorized in writing.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f) No service charge will be made for any registration of transfer or exchange of Securities. The Company may require payment of a sum sufficient to cover any tax, assessment or other governmental charge that may be imposed in connection with any registration of transfer or exchange of Securities, other than those expressly provided in this Indenture to be made at the Company&#8217;s own expense or without expense or charge to the Holders.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">16</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g) The Company shall not be required to (i) register, transfer or exchange Securities of any series during a period beginning at the opening of business 15 days before the day of the transmission of a notice of redemption of Securities of such series selected for redemption under Section 4.03 and ending at the close of business on the day of such transmission, or (ii) register, transfer or exchange any Security so selected for redemption in whole or in part, except the unredeemed portion of any Security being redeemed in part.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h) Prior to the due presentation for registration of transfer or exchange of any Security, the Company, the Trustee, the Paying Agent, the Registrar, any co-Registrar or any of their agents may deem and treat the Person in whose name a Security is registered as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notation of ownership or other writing thereon) for all purposes whatsoever, and none of the Company, the Trustee, the Paying Agent, the Registrar, any co-Registrar or any of their agents shall be affected by any notice to the contrary.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) In case a successor Company (&#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Successor Company</font><font style="font-family:inherit;font-size:12pt;">&#8221;) has executed an indenture supplemental hereto with the Trustee pursuant to Article XIV, any of the Securities authenticated or delivered pursuant to such transaction may, from time to time, at the request of the Successor Company, be exchanged for other Securities executed in the name of the Successor Company with such changes in phraseology and form as may be appropriate, but otherwise identical to the Securities surrendered for such exchange and of like principal amount; and the Trustee, upon Company Order of the Successor Company, shall authenticate and deliver Securities as specified in such order for the purpose of such exchange. If Securities shall at any time be authenticated and delivered in any new name of a Successor Company pursuant to this Section 3.06 in exchange or substitution for or upon registration of transfer of any Securities, such Successor Company, at the option of the Holders but without expense to them, shall provide for the exchange of all Securities at the time Outstanding for Securities authenticated and delivered in such new name. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j) Each Holder of a Security agrees to indemnify the Company and the Trustee against any liability that may result from the transfer, exchange or assignment of such Holder&#8217;s Security in violation of any provision of this Indenture and/or applicable United States federal or state securities laws. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(k) The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Security other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(l) Neither the Trustee nor any agent of the Trustee shall have any responsibility for any actions taken or not taken by the Depositary.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s07414191f76b43ba981f72daf043a446"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.07. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Mutilated, Destroyed, Lost and Stolen Securities</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) If (i) any mutilated Security is surrendered to the Trustee at its Corporate Trust Office or (ii) the Company and the Trustee receive evidence to their satisfaction of the destruction, loss or theft of any Security, and there is delivered to the Company and the Trustee security or indemnity bond satisfactory to them to save each of them and any Paying Agent harmless, and neither the Company nor the Trustee receives notice that such Security has been acquired by a protected purchaser, then the Company shall execute and upon Company Order the Trustee shall authenticate and deliver, in exchange for or in lieu of any such mutilated, destroyed, lost or stolen Security, a new Security of the same series and of like tenor, form, terms and principal amount, bearing a number not contemporaneously outstanding, that neither gain nor loss in interest shall result from such exchange or substitution. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">17</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) In case any such mutilated, destroyed, lost or stolen Security has become or is about to become due and payable, the Company in its discretion may, instead of issuing a new Security, pay the amount due on such Security in accordance with its terms. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Upon the issuance of any new Security under this Section, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in respect thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) Every new Security of any series issued pursuant to this Section shall constitute an original additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of that series duly issued hereunder. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s966bcf48f1b94894a2c89677af5eb96c"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.08. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Payment of Interest; Interest Rights Preserved</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Interest on any Security that is payable and is punctually paid or duly provided for on any Interest Payment Date shall be paid to the Person in whose name such Security (or one or more Predecessor Securities) is registered at the close of business on the Record Date for such interest notwithstanding the cancellation of such Security upon any transfer or exchange subsequent to the Record Date. Payment of interest on Securities shall be made at the Corporate Trust Office (except as otherwise specified pursuant to Section 3.01) or, at the option of the Company, by check mailed to the address of the Person entitled thereto as such address shall appear in the Register or, in accordance with arrangements satisfactory to the Trustee, by wire transfer to an account designated by the Holder. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) Any interest on any Security that is payable but is not punctually paid or duly provided for on any Interest Payment Date (herein called &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Defaulted Interest</font><font style="font-family:inherit;font-size:12pt;">&#8221;) shall forthwith cease to be payable to the Holder on the relevant Record Date by virtue of his, her or its having been such a Holder, and such Defaulted Interest may be paid by the Company, at its election in each case, as provided in clause (i) or (ii) below: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) The Company may elect to make payment of any Defaulted Interest to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered at the close of business on a special record date for the payment of such Defaulted Interest (a &#8220;Special Record Date&#8221;), which shall be fixed in the following manner. The Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided. Thereupon the Trustee shall fix a Special Record Date for the payment of such Defaulted Interest which shall be not more than 15 calendar days and not less than 10 calendar days prior to the date of the proposed payment and not less than 10 calendar days after the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of such Special Record Date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and the Special Record Date therefor to be mailed, first-class postage prepaid, to the Holders of such Securities at their addresses as they appear in the Register, not less than 10 calendar days prior to such Special Record Date. Notice of the proposed </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">18</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">payment of such Defaulted Interest and the Special Record Date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered at the close of business on such Special Record Date and shall no longer be payable pursuant to the following clause (ii). </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) The Company may make payment of any Defaulted Interest on Securities in any other lawful manner not inconsistent with the requirements of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall deemed practicable by the Trustee. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Subject to the provisions set forth herein relating to Record Dates, each Security delivered pursuant to any provision of this Indenture in exchange or substitution for, or upon registration of transfer of, any other Security shall carry all the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4d1db5a35d56468d94741c1e6a2b049a"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.09. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Cancellation</font><font style="font-family:inherit;font-size:12pt;">. Unless otherwise specified pursuant to Section 3.01 for Securities of any series, all Securities surrendered for payment, redemption, registration of transfer or exchange or credit against any sinking fund or otherwise shall, if surrendered to any Person other than the Trustee, be delivered to the Trustee for cancellation and shall be promptly canceled by it and, if surrendered to the Trustee, shall be promptly canceled by it. The Company may at any time deliver to the Trustee for cancellation any Securities previously authenticated and delivered hereunder that the Company may have acquired in any manner whatsoever, and all Securities so delivered shall be promptly canceled by the Trustee. No Securities shall be authenticated in lieu of or in exchange for any Securities canceled as provided in this Section, except as expressly permitted by this Indenture. The Trustee shall dispose of all canceled Securities held by it in accordance with its then customary procedures and deliver a certificate of such disposal to the Company upon its request therefor. The acquisition of any Securities by the Company shall not operate as a redemption or satisfaction of the Indebtedness represented thereby unless and until such Securities are surrendered to the Trustee for cancellation. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s6ef13fa33d1d41a9a2d11bcbeb225d58"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.10. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Computation of Interest</font><font style="font-family:inherit;font-size:12pt;">. Except as otherwise specified pursuant to Section 3.01 for Securities of any series, interest on the Securities of each series shall be computed on the basis of a 360-day year of twelve 30-day months. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="seb2068760ef040538ddd4b91986de02f"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.11. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Currency of Payments in Respect of Securities</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Except as otherwise specified pursuant to Section 3.01 for Securities of any series, payment of the principal of and premium, if any, and interest on Securities of such series will be made in U.S. Dollars. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) For purposes of any provision of the Indenture in which the Holders of Outstanding Securities may perform an action that requires that a specified percentage of the Outstanding Securities of all series perform such action and for purposes of any decision or determination by the Trustee of amounts due and unpaid for the principal of and premium, if any, and interest on the Securities of all series in respect of which moneys are to be disbursed ratably, the principal of and premium, if any, and interest on the Outstanding Securities denominated in a Foreign Currency will be the amount in U.S. Dollars based upon exchange rates, determined as specified pursuant to Section 3.01 for Securities of such series, as of the date for determining whether the Holders entitled to perform such action have performed it or as of the date of such decision or determination by the Trustee, as the case may be. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">19</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Any decision or determination to be made regarding exchange rates shall be made by an agent appointed by the Company; provided, that such agent shall accept such appointment in writing and the terms of such appointment shall, in the opinion of the Company at the time of such appointment, require such agent to make such determination by a method consistent with the method provided pursuant to Section 3.01 for the making of such decision or determination. All decisions and determinations of such agent regarding exchange rates shall, in the absence of manifest error, be conclusive for all purposes and irrevocably binding upon the Company, the Trustee and all Holders of the Securities.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s1cff6ec79a18419c826226a87a23751b"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.12. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Judgments</font><font style="font-family:inherit;font-size:12pt;">. The Company may provide pursuant to Section 3.01 for Securities of any series that (a) the obligation, if any, of the Company to pay the principal of, premium, if any, and interest on the Securities of any series in a Foreign Currency or U.S. Dollars (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Designated Currency</font><font style="font-family:inherit;font-size:12pt;">&#8221;) as may be specified pursuant to Section 3.01 is of the essence and agrees that, to the fullest extent possible under applicable law, judgments in respect of such Securities shall be given in the Designated Currency; (b) the obligation of the Company to make payments in the Designated Currency of the principal of and premium, if any, and interest on such Securities shall, notwithstanding any payment in any other Currency (whether pursuant to a judgment or otherwise), be discharged only to the extent of the amount in the Designated Currency that the Holder receiving such payment may, in accordance with normal banking procedures, purchase with the sum paid in such other Currency (after any premium and cost of exchange) on the business day in the country of issue of the Designated Currency or in the international banking community (in the case of a composite currency) immediately following the day on which such Holder receives such payment; (c) if the amount in the Designated Currency that may be so purchased for any reason falls short of the amount originally due, the Company shall pay such additional amounts as may be necessary to compensate for such shortfall; and (d) any obligation of the Company not discharged by such payment shall be due as a separate and independent obligation and, until discharged as provided herein, shall continue in full force and effect. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s6e70a19a20f24c43bfa7dacc8b202284"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.13. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CUSIP Numbers</font><font style="font-family:inherit;font-size:12pt;">. The Company in issuing any Securities may use CUSIP, ISIN or other similar numbers, if then generally in use, and thereafter with respect to such series, the Trustee may use such numbers in any notice of redemption or exchange with respect to such series provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee in writing of any change in the CUSIP, ISIN or other similar numbers. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s3ea64114787a4363a3dc62b9596f07c1"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE IV</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">REDEMPTION OF SECURITIES</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s615544b0a2fe4f628e15551ad0c0ebe1"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Applicability of Right of Redemption</font><font style="font-family:inherit;font-size:12pt;">. Redemption of Securities (other than pursuant to a sinking fund, amortization or analogous provision) permitted by the terms of any series of Securities shall be made (except as otherwise specified pursuant to Section 3.01 for Securities of any series) in accordance with this Article; provided, however, that if any such terms of a series of Securities shall conflict with any provision of this Article, the terms of such series shall govern. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">20</font></div></div><hr style="page-break-after:always"><div><a name="s8bc24ec2aa0042a6a22d54b9882a5e47"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Selection of Securities to be Redeemed</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) If the Company shall at any time elect to redeem all or any portion of the Securities of a series then Outstanding, it shall at least 30 days prior to the Redemption Date fixed by the Company (unless a shorter period shall be satisfactory to the Trustee) notify the Trustee of such Redemption Date and of the principal amount of Securities to be redeemed, and thereupon the Trustee shall select, by lot or in such other manner as the Trustee shall deem appropriate and which may provide for the selection for redemption of a portion of the principal amount of any Security of such series; provided that the unredeemed portion of the principal amount of any Security shall be in an authorized denomination (which shall not be less than the minimum authorized denomination) for such Security. In any case where more than one Security of such series is registered in the same name, the Trustee may treat the aggregate principal amount so registered as if it were represented by one Security of such series. The Trustee shall, as soon as practicable, notify the Company in writing of the Securities and portions of Securities so selected. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) For all purposes of this Indenture, unless the context otherwise requires, all provisions relating to the redemption of Securities shall relate, in the case of any Security redeemed or to be redeemed only in part, to the portion of the principal amount of such Security that has been or is to be redeemed. If the Company shall so direct, Securities registered in the name of the Company, any Affiliate or any Subsidiary thereof shall not be included in the Securities selected for redemption. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s067f10229fdf435da30164baa9476a6d"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notice of Redemption</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Notice of redemption shall be given by the Company or, at the Company&#8217;s request, by the Trustee in the name and at the expense of the Company; provided, however, that the Company makes such request at least 3 days prior to the date by which such notice of redemption must be given to Holders in accordance with this Section 4.03; provided further that, the text of such notice shall be prepared by the Company. Any such notice shall be delivered in the manner provided in Section 16.04 not less than 30 days before the Redemption Date unless the Trustee consents to a shorter period, to the Holders of Securities of any series to be redeemed in whole or in part pursuant to this Article. Any notice so given shall be conclusively presumed to have been duly given, whether or not the Holder receives such notice. Failure to give such notice, or any defect in such notice to the Holder of any Security of a series designated for redemption, in whole or in part, shall not affect the sufficiency of any notice of redemption with respect to the Holder of any other Security of such series. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) All notices of redemption shall identify the Securities to be redeemed (including CUSIP, ISIN or other similar numbers, if available) and shall state: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) such election by the Company to redeem Securities of such series pursuant to provisions contained in this Indenture or the terms of the Securities of such series or a supplemental indenture establishing such series, if such be the case; </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) the Redemption Date; </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii) the Redemption Price; </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv) if less than all Outstanding Securities of any series are to be redeemed, the identification (and, in the case of partial redemption, the principal amounts) of the Securities of such series to be redeemed;</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">21</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v) that on the Redemption Date the Redemption Price will become due and payable upon each such Security to be redeemed, and that, if applicable, interest thereon shall cease to accrue on and after said date; </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi) the Place or Places of Payment where such Securities are to be surrendered for payment of the Redemption Price; </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii) that the redemption is for a sinking fund, if such is the case; and </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(viii) that the Securities must be surrendered to the Paying Agent for payment of the Redemption Price. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s971bafdebd4d48f1a998ca9096228cc2"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Deposit of Redemption Price</font><font style="font-family:inherit;font-size:12pt;">. On or prior to 11:00 a.m., Eastern Standard time, on the Redemption Date for any Securities, the Company shall deposit with the Trustee or with a Paying Agent (or, if the Company is acting as its own Paying Agent, segregate and hold in trust as provided in Section 6.03) an amount of money in the Currency in which such Securities are denominated (except as provided pursuant to Section 3.01) sufficient to pay the Redemption Price of such Securities or any portions thereof that are to be redeemed on that date. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s81969e1005024bb2a04d33451d36f8b8"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Payable on Redemption Date</font><font style="font-family:inherit;font-size:12pt;">. Notice of redemption having been given as aforesaid, any Securities so to be redeemed shall, on the Redemption Date, become due and payable at the Redemption Price and from and after such date (unless the Company shall Default in the payment of the Redemption Price) such Securities shall cease to bear interest. Upon surrender of any such Security for redemption in accordance with said notice, such Security shall be paid by the Company at the Redemption Price; provided, however, that (unless otherwise provided pursuant to Section 3.01) installments of interest that have a Stated Maturity on or prior to the Redemption Date for such Securities shall be payable according to the terms of such Securities and the provisions of Section 3.08. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If any Security called for redemption shall not be so paid upon surrender thereof for redemption, the principal thereof and premium, if any, thereon shall, until paid, bear interest from the Redemption Date at the rate prescribed therefor in the Security. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s2d825e721320486c92f815d03922cba9"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Redeemed in Part</font><font style="font-family:inherit;font-size:12pt;">. Any Security that is to be redeemed only in part shall be surrendered at the Corporate Trust Office or such other office or agency of the Company as is specified pursuant to Section 3.01 with, if the Company, the Registrar or the Trustee so requires, due endorsement by, or a written instrument of transfer in form satisfactory to the Company, the Registrar and the Trustee duly executed by the Holder thereof or his, her or its attorney duly authorized in writing, and the Company shall execute, and the Trustee shall authenticate and deliver to the Holder of such Security without service charge, a new Security or Securities of the same series, of like tenor and form, of any authorized denomination as requested by such Holder in aggregate principal amount equal to and in exchange for the unredeemed portion of the principal of the Security so surrendered; except that if a Global Security is so surrendered, the Company shall execute, and the Trustee shall authenticate and deliver to the Depositary for such Global Security, without service charge, a new Global Security in a denomination equal to and in exchange for the unredeemed portion of the principal of the Global Security so surrendered. In the case of a Security providing appropriate space for such notation, at the option of the Holder thereof, the Trustee, in lieu of delivering a new Security or Securities as aforesaid, may make a notation on such Security of the payment of the redeemed portion thereof. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">22</font></div></div><hr style="page-break-after:always"><div><a name="s8daa497a1c994e228f0879fecb9daa45"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE V</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SINKING FUNDS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s1280f7a505bd469bb1feb7a783941791"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Applicability of Sinking Fund</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Redemption of Securities permitted or required pursuant to a sinking fund for the retirement of Securities of a series by the terms of such series of Securities shall be made in accordance with such terms of such series of Securities and this Article, except as otherwise specified pursuant to Section 3.01 for Securities of such series, provided, however, that if any such terms of a series of Securities shall conflict with any provision of this Article, the terms of such series shall govern. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Mandatory Sinking Fund Payment</font><font style="font-family:inherit;font-size:12pt;">,&#8221; and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Optional Sinking Fund Payment</font><font style="font-family:inherit;font-size:12pt;">.&#8221; If provided for by the terms of Securities of any series, the cash amount of any Mandatory Sinking Fund Payment may be subject to reduction as provided in Section 5.02. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s9dc0dfa4e6134dff8acfe46dfff49d58"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Mandatory Sinking Fund Obligation</font><font style="font-family:inherit;font-size:12pt;">. The Company may, at its option, satisfy any Mandatory Sinking Fund Payment obligation, in whole or in part, with respect to a particular series of Securities by (a) delivering to the Trustee Securities of such series in transferable form theretofore purchased or otherwise acquired by the Company or redeemed at the election of the Company pursuant to Section 4.03 or (b) receiving credit for Securities of such series (not previously so credited) acquired by the Company and theretofore delivered to the Trustee. The Trustee shall credit such Mandatory Sinking Fund Payment obligation with an amount equal to the Redemption Price specified in such Securities for redemption through operation of the sinking fund and the amount of such Mandatory Sinking Fund Payment shall be reduced accordingly. If the Company shall elect to so satisfy any Mandatory Sinking Fund Payment obligation, it shall deliver to the Trustee not less than 45 days prior to the relevant sinking fund payment date a written notice signed on behalf of the Company by its Chairman of the Board of Directors, Chief Executive Officer, President, Chief Operating Officer, Chief Financial Officer, one of its Vice Presidents, its Treasurer or one of its Assistant Treasurers, which shall designate the Securities (and portions thereof, if any) so delivered or credited and which shall be accompanied by such Securities (to the extent not theretofore delivered) in transferable form. In case of the failure of the Company, at or before the time so required, to give such notice and deliver such Securities the Mandatory Sinking Fund Payment obligation shall be paid entirely in moneys. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sbe97f759281f461886eacc92e14fdc5b"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Optional Redemption at Sinking Fund Redemption Price</font><font style="font-family:inherit;font-size:12pt;">. In addition to the sinking fund requirements of Section 5.02, to the extent, if any, provided for by the terms of a particular series of Securities, the Company may, at its option, make an Optional Sinking Fund Payment with respect to such Securities. Unless otherwise provided by such terms, (a) to the extent that the right of the Company to make such Optional Sinking Fund Payment shall not be exercised in any year, it shall not be cumulative or carried forward to any subsequent year, and (b) such optional payment shall operate to reduce the amount of any Mandatory Sinking Fund Payment obligation as to Securities of the same series. If the Company intends to exercise its right to make such optional payment in any year it shall deliver to the Trustee not less than 45 days prior to the relevant sinking fund payment date a certificate signed by its Chairman of the Board of Directors, Chief Executive Officer, President, Chief Operating Officer, Chief Financial Officer, one of its Vice Presidents, Treasurer or one of its Assistant Treasurers stating that the Company will exercise such optional right, and specifying the amount which the Company will pay on or before the next succeeding sinking fund payment date. Such certificate shall also state that no Event of Default has occurred and is continuing. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">23</font></div></div><hr style="page-break-after:always"><div><a name="s0fee0448ef6d4014a18a32097ccd64ce"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Application of Sinking Fund Payment</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) If the sinking fund payment or payments made in funds pursuant to either Section 5.02 or 5.03 with respect to a particular series of Securities plus any unused balance of any preceding sinking fund payments made in funds with respect to such series shall exceed $50,000 (or a lesser sum if the Company shall so request, or such equivalent sum for Securities denominated other than in U.S. Dollars), it shall be applied by the Trustee on the sinking fund payment date next following the date of such payment, unless the date of such payment shall be a sinking fund payment date, in which case such payment shall be applied on such sinking fund payment date, to the redemption of Securities of such series at the redemption price specified pursuant to Section 4.03(b). The Trustee shall select, in the manner provided in Section 4.02, for redemption on such sinking fund payment date, a sufficient principal amount of Securities of such series to absorb said funds, as nearly as may be, and shall, at the expense and in the name of the Company, thereupon cause notice of redemption of the Securities to be given in substantially the manner provided in Section 4.03(a) for the redemption of Securities in part at the option of the Company, except that the notice of redemption shall also state that the Securities are being redeemed for the sinking fund. Any sinking fund moneys not so applied by the Trustee to the redemption of Securities of such series shall be added to the next sinking fund payment received in funds by the Trustee and, together with such payment, shall be applied in accordance with the provisions of this Section 5.04. Any and all sinking fund moneys held by the Trustee on the last sinking fund payment date with respect to Securities of such series, and not held for the payment or redemption of particular Securities of such series, shall be applied by the Trustee to the payment of the principal of the Securities of such series at Maturity. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) On or prior to each sinking fund payment date, the Company shall pay to the Trustee a sum equal to all interest accrued to but not including the date fixed for redemption on Securities to be redeemed on such sinking fund payment date pursuant to this Section 5.04. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) The Trustee shall not redeem any Securities of a series with sinking fund moneys or mail any notice of redemption of Securities of such series by operation of the sinking fund during the continuance of a Default in payment of interest on any Securities of such series or of any Event of Default (other than an Event of Default occurring as a consequence of this paragraph) of which the Trustee has actual knowledge, except that if the notice of redemption of any Securities of such series shall theretofore have been mailed in accordance with the provisions hereof, the Trustee shall redeem such Securities if funds sufficient for that purpose shall be deposited with the Trustee in accordance with the terms of this Article. Except as aforesaid, any moneys in the sinking fund at the time any such Default or Event of Default shall occur and any moneys thereafter paid into the sinking fund shall, during the continuance of such Default or Event of Default, be held as security for the payment of all the Securities of such series; provided, however, that in case such Default or Event of Default shall have been cured or waived as provided herein, such moneys shall thereafter be applied on the next sinking fund payment date on which such moneys are required to be applied pursuant to the provisions of this Section 5.04. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">24</font></div></div><hr style="page-break-after:always"><div><a name="s7977184f6ac8494cbb7e966d3186ab8d"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE VI</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">PARTICULAR COVENANTS OF THE COMPANY</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company hereby covenants and agrees as follows: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sf962db4e022d44148eeab9d70dabf311"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Payments of Securities</font><font style="font-family:inherit;font-size:12pt;">. The Company will duly and punctually pay the principal of and premium, if any, on each series of Securities, and the interest which shall have accrued thereon, at the dates and place and in the manner provided in the Securities and in this Indenture. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4a47b97f31f947a89489c3a38f2f9e4c"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Paying Agent</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Company will maintain in each Place of Payment for any series of Securities, if any, an office or agency where Securities may be presented or surrendered for payment, where Securities of such series may be surrendered for registration of transfer or exchange and where notices and demands to or upon the Company in respect of the Securities and this Indenture may be served (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Paying Agent</font><font style="font-family:inherit;font-size:12pt;">&#8221;). The Company will give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as Paying Agent to receive all presentations, surrenders, notices and demands. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The Company may also from time to time designate different or additional offices or agencies where the Securities of any series may be presented or surrendered for any or all such purposes (in or outside of such Place of Payment), and may from time to time rescind any such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligations described in the preceding paragraph. The Company will give prompt written notice to the Trustee of any such additional designation or rescission of designation and of any change in the location of any such different or additional office or agency. The Company shall enter into an appropriate agency agreement with any Paying Agent not a party to this Indenture. The agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall notify the Trustee of the name and address of each such agent. The Company or any Affiliate thereof may act as Paying Agent. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s5b29ae6611014bf886fabd94a700d5ba"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">To Hold Payment in Trust</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) If the Company or an Affiliate thereof shall at any time act as Paying Agent with respect to any series of Securities, then, on or before the date on which the principal of and premium, if any, or interest on any of the Securities of that series by their terms or as a result of the calling thereof for redemption shall become payable, the Company or such Affiliate will segregate and hold in trust for the benefit of the Holders of such Securities or the Trustee a sum sufficient to pay such principal and premium, if any, or interest which shall have so become payable until such sums shall be paid to such Holders or otherwise disposed of as herein provided, and will notify the Trustee of its action or failure to act in that regard. Upon any proceeding under any federal bankruptcy laws with respect to the Company or any Affiliate thereof, if the Company or such Affiliate is then acting as Paying Agent, the Trustee shall replace the Company or such Affiliate as Paying Agent. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">25</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) If the Company shall appoint, and at the time have, a Paying Agent for the payment of the principal of and premium, if any, or interest on any series of Securities, then prior to 11:00 a.m., Eastern Standard Time, on the date on which the principal of and premium, if any, or interest on any of the Securities of that series shall become payable as aforesaid, whether by their terms or as a result of the calling thereof for redemption, the Company will deposit with such Paying Agent a sum sufficient to pay such principal and premium, if any, or interest, such sum to be held in trust for the benefit of the Holders of such Securities or the Trustee, and (unless such Paying Agent is the Trustee), the Company or any other obligor of such Securities will promptly notify the Trustee of its payment or failure to make such payment. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) If the Paying Agent shall be other than the Trustee, the Company will cause such Paying Agent to execute and deliver to the Trustee an instrument in which such Paying Agent shall agree with the Trustee, subject to the provisions of this Section 6.03, that such Paying Agent shall: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) hold all moneys held by it for the payment of the principal of and premium, if any, or interest on the Securities of that series in trust for the benefit of the Holders of such Securities until such sums shall be paid to such Holders or otherwise disposed of as herein provided; </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) give to the Trustee notice of any Default by the Company or any other obligor upon the Securities of that series in the making of any payment of the principal of and premium, if any, or interest on the Securities of that series; and </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii) at any time during the continuance of any such Default, upon the written request of the Trustee, pay to the Trustee all sums so held in trust by such Paying Agent. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) Anything in this Section 6.03 to the contrary notwithstanding, the Company may at any time, for the purpose of obtaining a release, satisfaction or discharge of this Indenture or for any other reason, pay or cause to be paid to the Trustee all sums held in trust by the Company or by any Paying Agent other than the Trustee as required by this Section 6.03, such sums to be held by the Trustee upon the same trusts as those upon which such sums were held by the Company or such Paying Agent. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) Subject to any applicable abandoned property law, any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal of and premium, if any, or interest on any Security of any series and remaining unclaimed for two years after such principal and premium, if any, or interest has become due and payable shall be paid to the Company upon Company Order or (if then held by the Company) shall be discharged from such trust, and the Holder of such Security shall thereafter, as an unsecured general creditor, look only to the Company for payment of such amounts without interest thereon, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent before being required to make any such repayment, may at the expense of the Company cause to be published once, in a newspaper published in the English language, customarily published on each Business Day and of general circulation in the County of Pinellas, State of Florida, notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such publication, any unclaimed balance of such money then remaining will be repaid to the Company. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s50b71d0cd6634e8fa38e1d6041b51c90"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Merger, Consolidation and Sale of Assets</font><font style="font-family:inherit;font-size:12pt;">. Except as otherwise provided as contemplated by Section 3.01 with respect to any series of Securities: </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Company will not consolidate with any other entity or accept a merger of any other entity into the Company or permit the Company to be merged into any other entity, or sell other than for cash or lease all or substantially all its assets to another entity, or purchase all or substantially all the assets of another </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">26</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">entity, unless (i) either the Company shall be the continuing entity, or (ii) the successor, transferee or lessee entity (if other than the Company) shall expressly assume, by indenture supplemental hereto, executed and delivered by such entity prior to or simultaneously with such consolidation, merger, sale or lease, the due and punctual payment of the principal of and interest and premium, if any, on all the Securities, according to their tenor, and the due and punctual performance and observance of all other obligations to the Holders and the Trustee under this Indenture or under the Securities to be performed or observed by the Company. A purchase by a Subsidiary of all or substantially all of the assets of another entity shall not be deemed to be a purchase of such assets by the Company. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) Upon any consolidation with or merger into any other entity, or any sale other than for cash, or any conveyance or lease of all or substantially all of the assets of the Company in accordance with this Section 6.04, the successor entity formed by such consolidation or into or with which the Company is merged or to which the Company is sold or to which such conveyance, transfer or lease is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor entity had been named as the Company herein, and thereafter, except in the case of a lease, the predecessor Company shall be relieved of all obligations and covenants under this Indenture and the Securities, and from time to time such entity may exercise each and every right and power of the Company under this Indenture, in the name of the Company, or in its own name; and any act or proceeding by any provision of this Indenture required or permitted to be done by the Board of Directors or any officer of the Company may be done with like force and effect by the like board or officer of any entity that shall at the time be the successor of the Company hereunder. In the event of any such sale or conveyance, but not any such lease, the Company (or any successor entity which shall theretofore have become such in the manner described in this Section 6.04) shall be discharged from all obligations and covenants under this Indenture and the Securities and may thereupon be dissolved and liquidated. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s223b2444cfc540708444ac62493f807f"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Compliance Certificate</font><font style="font-family:inherit;font-size:12pt;">. Except as otherwise provided as contemplated by Section 3.01 with respect to any series of Securities, the Company shall furnish to the Trustee annually, within 120 days after the end of each fiscal year, a brief certificate from the Chief Executive Officer, President, Chief Operating Officer, Principal Financial Officer, Principal Accounting Officer, any Vice President or Treasurer as to his or her knowledge of the Company&#8217;s compliance with all conditions and covenants under this Indenture (which compliance shall be determined without regard to any period of grace or requirement of notice provided under this Indenture) and, in the event of any Default, specifying each such Default and the nature and status thereof of which such person may have knowledge. Such certificates need not comply with Section 16.01 of this Indenture. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sf3b252d28c374194a830b91a11127f82"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Conditional Waiver by Holders of Securities</font><font style="font-family:inherit;font-size:12pt;">. Anything in this Indenture to the contrary notwithstanding, the Company may fail or omit in any particular instance to comply with a covenant or condition set forth herein with respect to any series of Securities if the Company shall have obtained and filed with the Trustee, prior to the time of such failure or omission, evidence (as provided in Article VIII) of the consent of the Holders of a majority in aggregate principal amount of the Securities of such series at the time Outstanding, either waiving such compliance in such instance or generally waiving compliance with such covenant or condition, but no such waiver shall extend to or affect such covenant or condition except to the extent so expressly waived, or impair any right consequent thereon and, until such waiver shall have become effective, the obligations of the Company and the duties of the Trustee in respect of any such covenant or condition shall remain in full force and effect. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">27</font></div></div><hr style="page-break-after:always"><div><a name="se8994f387e394101b428ffb64be5ad87"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.07. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Statement by Officers as to Default</font><font style="font-family:inherit;font-size:12pt;">. The Company shall deliver to the Trustee as soon as possible and in any event within 30 days after the Company becomes aware of the occurrence of any Event of Default or an event which, with the giving of notice or the lapse of time or both, would constitute an Event of Default, an Officer&#8217;s Certificate setting forth the details of such Event of Default or Default and the action which the Company proposes to take with respect thereto. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s9e899ecacf584e3ea25b30ded88d5c5a"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE VII</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">REMEDIES OF TRUSTEE AND SECURITYHOLDERS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4b512e65deb34f79bc3780f60ca75563"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Events of Default</font><font style="font-family:inherit;font-size:12pt;">. Except where otherwise indicated by the context or where the term is otherwise defined for a specific purpose, the term &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Event of Default</font><font style="font-family:inherit;font-size:12pt;">&#8221; as used in this Indenture with respect to Securities of any series shall mean one of the following described events unless it is either inapplicable to a particular series or it is specifically deleted or modified in the manner contemplated in Section 3.01: </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) the failure of the Company to pay any installment of interest on any Security of such series when and as the same shall become payable, which failure shall have continued unremedied for a period of 30 days; provided, however, that a valid extension of an interest payment period by the Company in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment of interest for this purpose; </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) the failure of the Company to pay the principal of (and premium, if any, on) any Security of such series, when and as the same shall become payable, whether at Maturity as therein expressed, by call for redemption (otherwise than pursuant to a sinking fund), by declaration as authorized by this Indenture or otherwise, which failure shall have continued unremedied for a period of 30 days; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) the failure of the Company to pay a sinking fund installment, if any, when and as the same shall become payable by the terms of a Security of such series, which failure shall have continued unremedied for a period of 30 days; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) the failure of the Company, subject to the provisions of Section 6.06, to perform any covenants or agreements contained in this Indenture (including any indenture supplemental hereto pursuant to which the Securities of such series were issued as contemplated by Section 3.01) (other than a covenant or agreement which has been expressly included in this Indenture solely for the benefit of a series of Securities other than that series and other than a covenant or agreement a default in the performance of which is elsewhere in this Section 7.01 specifically addressed), which failure shall not have been remedied, or without provision deemed to be adequate for the remedying thereof having been made, for a period of 60 days after written notice shall have been given to the Company by the Trustee or shall have been given to the Company and the Trustee by Holders of not less than a majority in aggregate principal amount of the Securities of such series then Outstanding, specifying such failure, requiring the Company to remedy the same and stating that such notice is a &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Notice of Default</font><font style="font-family:inherit;font-size:12pt;">&#8221; hereunder; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) the entry by a court having jurisdiction in the premises of a decree or order for relief in respect of the Company in an involuntary case under the federal bankruptcy laws, as now or hereafter constituted, or any other applicable federal or state bankruptcy, insolvency or other similar law now or hereafter in effect, or appointing a receiver, liquidator, assignee, custodian, trustee or sequestrator (or similar official) of the Company or of substantially all the property of the Company or ordering the winding-up or liquidation of its affairs and such decree or order shall remain unstayed and in effect for a period of 90 consecutive days; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">28</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f) the commencement by the Company of a voluntary case under the federal bankruptcy laws, as now or hereafter constituted, or any other applicable federal or state bankruptcy, insolvency or other similar law now or hereafter in effect, or the consent by the Company to the entry of an order for relief in an involuntary case under any such law, or the consent by the Company to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian or sequestrator (or similar official) of the Company or of substantially all the property of the Company or the making by it of an assignment for the benefit of creditors or the admission by it in writing of its inability to pay its debts generally as they become due, or the taking of corporate action by the Company in furtherance of any action; or </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g) the occurrence of any other Event of Default with respect to Securities of such series as provided in Section 3.01; provided, however, that no event described in clause (d) or (other than with respect to a payment default) (g) above shall constitute an Event of Default hereunder until a Responsible Officer assigned to and working in the Trustee&#8217;s corporate trust department has actual knowledge thereof or until a written notice of any such event is received by the Trustee at the Corporate Trust Office, and such notice refers to the facts underlying such event, the Securities generally, the Company and the Indenture. Notwithstanding the foregoing provisions of this Section 7.01, if the principal or any premium or interest on any Security is payable in a Currency other than the Currency of the United States and such Currency is not available to the Company for making payment thereof due to the imposition of exchange controls or other circumstances beyond the control of the Company, the Company will be entitled to satisfy its obligations to Holders of the Securities by making such payment in the Currency of the United States in an amount equal to the Currency of the United States equivalent of the amount payable in such other Currency, as determined by the Company by reference to the noon buying rate in for cable transfers for such Currency (&#8220;Exchange Rate&#8221;), as such Exchange Rate is reported or otherwise made available by the Federal Reserve Bank of New York on the date of such payment, or, if such rate is not then available, on the basis of the most recently available Exchange Rate. Notwithstanding the foregoing provisions of this Section 7.01, any payment made under such circumstances in the Currency of the United States where the required payment is in a Currency other than the Currency of the United States will not constitute an Event of Default under this Indenture. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s6e8f22cefcb345a2bc413521e0fd8993"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Acceleration; Rescission and Annulment</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Except as otherwise provided as contemplated by Section 3.01 with respect to any series of Securities, if any one or more of the above-described Events of Default (other than an Event of Default specified in Section 7.01(e) or 7.01(f)) shall happen with respect to Securities of any series at the time Outstanding, then, and in each and every such case, during the continuance of any such Event of Default, the Trustee or the Holders of not less than a majority in principal amount of the Securities of such series then Outstanding may declare the principal (or, if the Securities of that series are Original Issue Discount Securities, such portion of the principal amount as may be specified in the terms of that series) of and all accrued but unpaid interest on all the Securities of such series then Outstanding to be due and payable immediately by a notice in writing to the Company (and to the Trustee if given by Holders), and upon any such declaration such principal amount (or specified amount) shall become immediately due and payable. If an Event of Default specified in Section 7.01(e) or 7.01(f) occurs and is continuing, then in every such case, the principal amount of all of the Securities of that series then Outstanding shall automatically, and without any declaration or any other action on the part of the Trustee or any Holder, become due and payable immediately. Upon payment of such amounts in the Currency in which such Securities are denominated (subject to Section 7.01 and except as otherwise provided pursuant to Section 3.01), all obligations of the Company in respect of the payment of principal of and interest on the Securities of such series shall terminate. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">29</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The provisions of Section 7.02(a), however, are subject to the condition that, at any time after the principal of all the Securities of such series, to which any one or more of the above-described Events of Default is applicable, shall have been so declared to be due and payable, and before a judgment or decree for payment of the money due has been obtained by the Trustee as hereinafter provided in this Article, the Event of Default giving rise to such declaration of acceleration shall, without further act, be deemed to have been waived, and such declaration and its consequences shall, without further act, be deemed to have been rescinded and annulled, if:</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) the Company has paid or deposited with the Trustee or Paying Agent a sum in the Currency in which such Securities are denominated (subject to Section 7.01 and except as otherwise provided pursuant to Section 3.01) sufficient to pay </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(A) all amounts owing the Trustee and any predecessor trustee hereunder under Section 11.01(a) (provided, however, that all sums payable under this clause shall be paid in U.S. Dollars);</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(B) all arrears of interest, if any, upon all the Securities of such series (with interest, to the extent that interest thereon shall be legally enforceable, on any overdue installment of interest at the rate borne by such Securities at the rate or rates prescribed therefor in such Securities);</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(C) the principal of and premium, if any, on any Securities of such series that have become due otherwise than by such declaration of acceleration and interest thereon; and</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) every other Default and Event of Default with respect to Securities of that series, other than the non-payment of the principal of Securities of that series which have become due solely by such declaration of acceleration, has been cured or waived as provided in Section 7.06. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) No such rescission shall affect any subsequent default or impair any right consequent thereon. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) For all purposes under this Indenture, if a portion of the principal of any Original Issue Discount Securities shall have been accelerated and declared due and payable pursuant to the provisions hereof, then, from and after such declaration, unless such declaration has been rescinded and annulled, the principal amount of such Original Issue Discount Securities shall be deemed, for all purposes hereunder, to be such portion of the principal thereof as shall be due and payable as a result of such acceleration, and payment of such portion of the principal thereof as shall be due and payable as a result of such acceleration, together with interest, if any, thereon and all other amounts owing thereunder, shall constitute payment in full of such Original Issue Discount Securities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s8ea21cbbe6ca4883b0f686da2bcd9883"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Other Remedies</font><font style="font-family:inherit;font-size:12pt;">. If the Company shall fail for a period of 30 days to pay any installment of interest on the Securities of any series or shall fail to pay the principal of and premium, if any, on any of the Securities of such series when and as the same shall become due and payable, whether at Maturity, or by call for redemption (other than pursuant to the sinking fund), by declaration as authorized by this Indenture, or otherwise, or shall fail for a period of 30 days to make any required sinking fund payment as to a series of Securities, then, upon demand of the Trustee, the Company will pay to the Paying Agent for the benefit of the Holders of Securities of such series then Outstanding the whole amount which then shall have become due and payable on all the Securities of such series, with interest on the overdue principal and premium, if any, and (so far as the same may be legally enforceable) on the overdue installments of interest at the rate borne by the Securities of such series, and all amounts owing the Trustee and any predecessor trustee hereunder under Section 11.01(a). </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">30</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In case the Company shall fail forthwith to pay such amounts upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and empowered to institute any action or proceeding at law or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such judgment or final decree against the Company or any other obligor upon the Securities of such series, and collect the moneys adjudged or decreed to be payable out of the property of the Company or any other obligor upon the Securities of such series, wherever situated, in the manner provided by law. Every recovery of judgment in any such action or other proceeding, subject to the payment to the Trustee of all amounts owing the Trustee and any predecessor trustee hereunder under Section 11.01(a), shall be for the ratable benefit of the Holders of such series of Securities which shall be the subject of such action or proceeding. All rights of action upon or under any of the Securities or this Indenture may be enforced by the Trustee without the possession of any of the Securities and without the production of any thereof at any trial or any proceeding relative thereto. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s72f2491716e8495380c0fa4eec3c7c4b"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Trustee as Attorney-in-Fact</font><font style="font-family:inherit;font-size:12pt;">. The Trustee is hereby appointed, and each and every Holder of the Securities, by receiving and holding the same, shall be conclusively deemed to have appointed the Trustee, the true and lawful attorney-in-fact of such Holder, with authority to make or file (whether or not the Company shall be in Default in respect of the payment of the principal of, or interest on, any of the Securities), in its own name and as trustee of an express trust or otherwise as it shall deem advisable, in any receivership, insolvency, liquidation, bankruptcy, reorganization or other judicial proceeding relative to the Company or any other obligor upon the Securities or to their respective creditors or property, any and all claims, proofs of claim, proofs of debt, petitions, consents, other papers and documents and amendments of any thereof, as may be necessary or advisable in order to have the claims of the Trustee and any predecessor trustee hereunder and of the Holders of the Securities allowed in any such proceeding and to collect and receive any moneys or other property payable or deliverable on any such claim, and to execute and deliver any and all other papers and documents and to do and perform any and all other acts and things, as it may deem necessary or advisable in order to enforce in any such proceeding any of the claims of the Trustee and any predecessor trustee hereunder and of any of such Holders in respect of any of the Securities; and any receiver, assignee, trustee, custodian or debtor in any such proceeding is hereby authorized, and each and every taker or Holder of the Securities, by receiving and holding the same, shall be conclusively deemed to have authorized any such receiver, assignee, trustee, custodian or debtor, to make any such payment or delivery only to or on the order of the Trustee, and to pay to the Trustee any amount due it and any predecessor trustee hereunder under Section 11.01(a); provided, however, that nothing herein contained shall be deemed to authorize or empower the Trustee to consent to or accept or adopt, on behalf of any Holder of Securities, any plan of reorganization or readjustment affecting the Securities or the rights of any Holder thereof, or to authorize or empower the Trustee to vote in respect of the claim of any Holder of any Securities in any such proceeding. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sfb350211266a46f2979a6f7af7dc23f9"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Priorities</font><font style="font-family:inherit;font-size:12pt;">. Any moneys or properties collected by the Trustee with respect to a series of Securities under this Article VII shall be applied in the order following, at the date or dates fixed by the Trustee for the distribution of such moneys or properties and, in the case of the distribution of such moneys or properties on account of the Securities of any series, upon presentation of the Securities of such series, and stamping thereon the payment, if only partially paid, and upon surrender thereof, if fully paid: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">First: To the payment of all amounts due to the Trustee and any predecessor trustee hereunder under Section 11.01(a). </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">31</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Second: In case the principal of the Outstanding Securities of such series shall not have become due and be unpaid, to the payment of interest on the Securities of such series, in the chronological order of the Maturity of the installments of such interest, with interest (to the extent that such interest has been collected by the Trustee) upon the overdue installments of interest at the rate borne by such Securities, such payments to be made ratably to the Persons entitled thereto. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Third: In case the principal of the Outstanding Securities of such series shall have become due, by declaration or otherwise, to the payment of the whole amount then owing and unpaid upon the Securities of such series for principal and premium, if any, and interest, with interest on the overdue principal and premium, if any, and (to the extent that such interest has been collected by the Trustee) upon overdue installments of interest at the rate borne by the Securities of such series, and in case such moneys shall be insufficient to pay in full the whole amounts so due and unpaid upon the Securities of such series, then to the payment of such principal and premium, if any, and interest without preference or priority of principal and premium, if any, over interest, or of interest over principal and premium, if any, or of any installment of interest any other Security of such series, ratably to the aggregate of such principal and premium, if any, and accrued and unpaid interest. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any surplus then remaining shall be paid to the Company or as directed by a court of competent jurisdiction. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s89e703813a2d4bf79263a174b3cfcc1b"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Control by Securityholders; Waiver of Past Defaults</font><font style="font-family:inherit;font-size:12pt;">. The Holders of a majority in principal amount of the Securities of any series at the time outstanding may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee hereunder, or of exercising any trust or power hereby conferred upon the Trustee with respect to the Securities of such series, provided, however, that, subject to the provisions of Sections 11.01 and 11.02, the Trustee shall have the right to decline to follow any such direction if the Trustee being advised by counsel determines in good faith that the action so directed may not lawfully be taken or would be unduly prejudicial to Holders not joining in such direction or would involve the Trustee in personal liability. Prior to any declaration accelerating the Maturity of the Securities of any series, the Holders of a majority in aggregate principal amount of such series of Securities at the time Outstanding may on behalf of the Holders of all of the Securities of such series waive any past Default or Event of Default hereunder and its consequences except a Default in the payment of interest or any premium on or the principal of the Securities of such series. Upon any such waiver the Company, the Trustee and the Holders of the Securities of such series shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon. Whenever any Default or Event of Default hereunder shall have been waived as permitted by this Section 7.06, said Default or Event of Default shall for all purposes of the Securities of such series and this Indenture be deemed to have been cured and to be not continuing. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="scd68ccf8135d448ba915fd0c48e1934c"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.07. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Limitation on Suits</font><font style="font-family:inherit;font-size:12pt;">. No Holder of any Security of any series shall have any right to institute any action, suit or proceeding at law or in equity for the execution of any trust hereunder or for the appointment of a receiver or for any other remedy hereunder, in each case with respect to an Event of Default with respect to such series of Securities, unless such Holder previously shall have given to the Trustee written notice of one or more of the Events of Default herein specified with respect to such series of Securities, and unless also the Holders of not less than a majority in principal amount of the Securities of such series then Outstanding shall have requested the Trustee in writing to take action in respect of the matter complained of, and unless also there shall have been offered to the Trustee security and indemnity satisfactory to it against the costs, expenses and liabilities to be incurred therein or thereby, and the Trustee, for 60 days after receipt of such notification, request and offer of indemnity, shall have neglected or refused to institute any such action, suit or proceeding; and such notification, request and offer of indemnity are hereby declared in every such case to be conditions precedent to any such action, suit or proceeding by any Holder of any Security of </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">32</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">such series; it being understood and intended that no one or more of the Holders of Securities of such series shall have any right in any manner whatsoever by his, her, its or their action to enforce any right hereunder, except in the manner herein provided, and that every action, suit or proceeding at law or in equity shall be instituted, had and maintained in the manner herein provided and for the equal benefit of all Holders of the Outstanding Securities of such series; provided, however, that nothing in this Indenture or in the Securities of such series shall affect or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, premium, if any, and interest on the Securities of such series to the respective Holders of such Securities at the respective due dates in such Securities stated, or affect or impair the right, which is also absolute and unconditional, of such Holders to institute suit to enforce the payment thereof. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s6dbb2be867f7432082caebcae7162683"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.08. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Undertaking for Costs</font><font style="font-family:inherit;font-size:12pt;">. All parties to this Indenture and each Holder of any Security, by such Holder&#8217;s acceptance thereof, shall be deemed to have agreed that any court may in its discretion require, in any action, suit or proceeding for the enforcement of any right or remedy under this Indenture, or in any action, suit or proceeding against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such action, suit or proceeding of an undertaking to pay the costs of such action, suit or proceeding, and that such court may in its discretion assess reasonable costs, including reasonable attorneys&#8217; fees and expenses, against any party litigant in such action, suit or proceeding, having due regard to the merits and good faith of the claims or defenses made by such party litigant; provided, however, that the provisions of this Section 7.08 shall not apply to any action, suit or proceeding instituted by the Trustee, to any action, suit or proceeding instituted by any one or more Holders of Securities holding in the aggregate more than 10% in principal amount of the Securities of any series Outstanding, or to any action, suit or proceeding instituted by any Holder of Securities of any series for the enforcement of the payment of the principal of or premium, if any, or the interest on, any of the Securities of such series, on or after the respective due dates expressed in such Securities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s50059c65546941e6b8f44d343ab8afe8"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.09. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Remedies Cumulative</font><font style="font-family:inherit;font-size:12pt;">. No remedy herein conferred upon or reserved to the Trustee or to the Holders of Securities of any series is intended to be exclusive of any other remedy or remedies, and each and every remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity or by statute. No delay or omission of the Trustee or of any Holder of the Securities of any series to exercise any right or power accruing upon any Default or Event of Default shall impair any such right or power or shall be construed to be a waiver of any such Default or Event of Default or an acquiescence therein; and every power and remedy given by this Article VII to the Trustee and to the Holders of Securities of any series, respectively, may be exercised from time to time and as often as may be deemed expedient by the Trustee or by the Holders of Securities of such series, as the case may be. In case the Trustee or any Holder of Securities of any series shall have proceeded to enforce any right under this Indenture and the proceedings for the enforcement thereof shall have been discontinued or abandoned because of waiver or for any other reason or shall have been adjudicated adversely to the Trustee or to such Holder of Securities, then and in every such case the Company, the Trustee and the Holders of the Securities of such series shall severally and respectively be restored to their former positions and rights hereunder, and thereafter all rights, remedies and powers of the Trustee and the Holders of the Securities of such series shall continue as though no such proceedings had been taken, except as to any matters so waived or adjudicated. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">33</font></div></div><hr style="page-break-after:always"><div><a name="scf60591fa478474896d7752c78f2d5fa"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE VIII</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">CONCERNING THE SECURITYHOLDERS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sb6ec3bdda2c5430abe643f9487e4dfd8"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Evidence of Action of Securityholders</font><font style="font-family:inherit;font-size:12pt;">. Whenever in this Indenture it is provided that the Holders of a specified percentage or a majority in aggregate principal amount of the Securities or of any series of Securities may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action the Holders of such specified percentage or majority have joined therein may be evidenced by (a) any instrument or any number of instruments of similar tenor executed by Securityholders in person, an agent or by a proxy appointed in writing, including through an electronic system for tabulating consents operated by the Depositary for such series or otherwise (such action becoming effective, except as herein otherwise expressly provided, when such instruments or evidence of electronic consents are delivered to the Trustee and, where it is hereby expressly required, to the Company), or by the record of the Holders of Securities voting in favor thereof at any meeting of Securityholders duly called and held in accordance with the provisions of Article IX, or (c) by a combination of such instrument or instruments and any such record of such a meeting of Securityholders.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s79ef2a832b9c4dbbb4084148dde91b68"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Proof of Execution or Holding of Securities</font><font style="font-family:inherit;font-size:12pt;">. Proof of the execution of any instrument by a Securityholder or his, her or its agent or proxy and proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The fact and date of the execution by any Person of any such instrument may be proved (i) by the certificate of any notary public or other officer in any jurisdiction who, by the laws thereof, has power to take acknowledgments or proof of deeds to be recorded within such jurisdiction, that the Person who signed such instrument did acknowledge before such notary public or other officer the execution thereof, (ii) by the affidavit of a witness of such execution sworn to before any such notary or other officer or (iii) in such other reasonable manner acceptable to the Trustee. Where such execution is by a Person acting in other than his or her individual capacity, such certificate or affidavit shall also constitute sufficient proof of his or her authority.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The ownership of Securities of any series shall be proved by the Register of such Securities or by a certificate of the Registrar for such series. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) The record of any Holders&#8217; meeting shall be proved in the manner provided in Section 9.06.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) The Trustee may require such additional proof of any matter referred to in this Section 8.02 as it shall deem appropriate or necessary, so long as the request is a reasonable one.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) If the Company shall solicit from the Holders of Securities of any series any action, the Company may, at its option fix in advance a record date for the determination of Holders of Securities entitled to take such action, but the Company shall have no obligation to do so. Any such record date shall be fixed at the Company&#8217;s discretion. If such a record date is fixed, such action may be sought or given before or after the record date, but only the Holders of Securities of record at the close of business on such record date shall be deemed to be Holders of Securities for the purpose of determining whether Holders of the requisite proportion of Outstanding Securities of such series have authorized or agreed or consented to such action, and for that purpose the Outstanding Securities of such series shall be computed as of such record date.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">34</font></div></div><hr style="page-break-after:always"><div><a name="s188194827247400abf6c9f460c96d524"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Persons Deemed Owners.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name any Security is registered as the owner of such Security for the purpose of receiving payment of principal of and premium, if any, and (subject to Section 3.08) interest, if any, on, such Security and for all other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary. All payments made to any Holder, or upon his, her or its order, shall be valid, and, to the extent of the sum or sums paid, effectual to satisfy and discharge the liability for moneys payable upon such Security.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) None of the Company, the Trustee, any Paying Agent or the Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests in a Global Security or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s5e8b4acf46fc4ea8b8578c05fd83cf12"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Effect of Consents</font><font style="font-family:inherit;font-size:12pt;">. After an amendment, supplement, waiver or other action becomes effective as to any series of Securities, a consent to it by a Holder of such series of Securities is a continuing consent conclusive and binding upon such Holder and every subsequent Holder of the same Securities or portion thereof, and of any Security issued upon the transfer thereof or in exchange therefor or in place thereof, even if notation of the consent is not made on any such Security. An amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sa55be2a6b1dc4e03a1d99c96da49dd08"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE IX</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SECURITYHOLDERS&#8217; MEETINGS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s702c713718104931ac56c356200fea67"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purposes of Meetings</font><font style="font-family:inherit;font-size:12pt;">. A meeting of Securityholders of any or all series may be called at any time and from time to time pursuant to the provisions of this Article IX for any of the following purposes:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) to give any notice to the Company or to the Trustee, or to give any directions to the Trustee, or to consent to the waiving of any Default or Event of Default hereunder and its consequences, or to take any other action authorized to be taken by Securityholders pursuant to any of the provisions of Article VIII;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) to remove the Trustee and nominate a successor trustee pursuant to the provisions of Article XI;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) to consent to the execution of an Indenture or of indentures supplemental hereto pursuant to the provisions of Section 14.02; or</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) to take any other action authorized to be taken by or on behalf of the Holders of any specified aggregate principal amount of the Securities of any one or more or all series, as the case may be, under any other provision of this Indenture or under applicable law.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s0c15c83e53984010b31f7791cdbebc19"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Call of Meetings by Trustee</font><font style="font-family:inherit;font-size:12pt;">. The Trustee may at any time call a meeting of all Securityholders of all series that may be affected by the action proposed to be taken, to take any action specified in Section 9.01, to be held at such time and at such place in the County of Pinellas in the State of Florida. Notice of every meeting of the Securityholders of a series, setting forth the time and the place of such meeting and in general terms the action proposed to be taken at such meeting, shall be mailed to Holders of Securities of such series at their addresses as they shall appear on the Register of the Company. Such notice shall be mailed not less than 20 nor more than 180 days prior to the date fixed for the meeting.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">35</font></div></div><hr style="page-break-after:always"><div><a name="s65ae7ccbb7d147b08c96ead46bc0fbea"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Call of Meetings by Company or Securityholders</font><font style="font-family:inherit;font-size:12pt;">. In case at any time the Company or the Holders of at least 10% in aggregate principal amount of the Securities of a series (or of all series, as the case may be) then Outstanding that may be affected by the action proposed to be taken, shall have requested the Trustee to call a meeting of Securityholders of such series (or of all series), by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have mailed the notice of such meeting within 20 days after receipt of such request, then the Company or such Securityholders may determine the time and the place for such meeting and may call such meeting to take any action authorized in Section 9.01, by mailing notice thereof as provided in Section 9.02.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s2838312f9e9849d98679e6aab14f1656"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Qualifications for Voting</font><font style="font-family:inherit;font-size:12pt;">. To be entitled to vote at any meeting of Securityholders, a Person shall (a) be a Holder of one or more Securities affected by the action proposed to be taken at the meeting or (b) be a Person appointed by an instrument in writing as proxy by a Holder of one or more such Securities. The only Persons who shall be entitled to be present or to speak at any meeting of Securityholders shall be the Persons entitled to vote at such meeting and their counsel and any representatives of the Trustee and its counsel and any representatives of the Company and its counsel.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s3931c1f27a674cb2aaaed171d078bc21"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Regulation of Meetings.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Notwithstanding any other provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any meeting of Securityholders, in regard to proof of the holding of Securities and of the appointment of proxies, and in regard to the appointment and duties of inspectors of votes, the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall deem fit.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The Trustee shall, by an instrument in writing, appoint a temporary chairman of the meeting, unless the meeting shall have been called by the Company or by Securityholders as provided in Section 9.03, in which case the Company or the Securityholders calling the meeting, as the case may be, shall in like manner appoint a temporary chair. A permanent chairman and a permanent secretary of the meeting shall be elected by majority vote of the meeting.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) At any meeting of Securityholders of a series, each Securityholder of such series of such Securityholder&#8217;s proxy shall be entitled to one vote for each $1,000 principal amount of Securities of such series Outstanding held or represented by him; provided, however, that no vote shall be cast or counted at any meeting in respect of any Security challenged as not Outstanding and ruled by the chairman of the meeting to be not Outstanding. The chairman of the meeting shall have no right to vote other than by virtue of Securities of such series held by him or her or instruments in writing as aforesaid duly designating him or her as the Person to vote on behalf of other Securityholders. At any meeting of the Securityholders duly called pursuant to the provisions of Section 9.02 or 9.03 the presence of Persons holding or representing Securities in an aggregate principal amount sufficient to take action upon the business for the transaction of which such meeting was called shall be necessary to constitute a quorum, and any such meeting may be adjourned from time to time by a majority of those present, whether or not constituting a quorum, and the meeting may be held as so adjourned without further notice. In the absence of a quorum within 30 minutes of the time appointed for any such meeting, the meeting shall, if convened at the request of holders of Securities of such series, be dissolved. In any other case, the meeting may be adjourned for a period determined by the chairman of the meeting prior to the adjournment of such meeting. In the absence of a quorum at any such adjourned meeting, such adjourned meeting may be further adjourned for a period determined by the chairman of the meeting prior to the adjournment of such adjourned meeting. Notice of the reconvening of any adjourned meeting shall be given as provided in Section 9.02 hereof, except that such notice need be given only once and not less than five days prior to the date on which the meeting is scheduled to be reconvened.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">36</font></div></div><hr style="page-break-after:always"><div><a name="s5bfe11dd708a430c8c9c2037ea2c0a0b"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Voting</font><font style="font-family:inherit;font-size:12pt;">. The vote upon any resolution submitted to any meeting of Securityholders of a series shall be by written ballots on which shall be subscribed the signatures of the Holders of Securities of such series or of their representatives by proxy and the principal amounts of the Securities of such series held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record in duplicate of the proceedings of each meeting of Securityholders shall be prepared by the secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that said notice was mailed as provided in Section 9.02. The record shall show the principal amounts of the Securities voting in favor of or against any resolution. The record shall be signed and verified by the affidavits of the permanent chairman and secretary of the meeting and one of the duplicates shall be delivered to the Company and the other to the Trustee to be preserved by the Trustee.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any record so signed and verified shall be conclusive evidence of the matters therein stated.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s91107b2c3143451eb49f7a4e800f664e"></a></div><div style="line-height:120%;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.07. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Delay of Rights by Meeting</font><font style="font-family:inherit;font-size:12pt;">. Nothing contained in this Article IX shall be deemed or construed to authorize or permit, by reason of any call of a meeting of Securityholders of any series or any rights expressly or impliedly conferred hereunder to make such call, any hindrance or delay in the exercise of any right or rights conferred upon or reserved to the Trustee or to the Securityholders of such series under any of the provisions of this Indenture or of the Securities of such series</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s51f9fcef9ba44eb084bdc1152d48632b"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE X</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">REPORTS BY THE COMPANY AND THE TRUSTEE</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">AND SECURITYHOLDERS&#8217; LISTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sd04d40646354420b8e311bb788de1bd2"></a></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reports by Trustee.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) So long as any Securities are outstanding, the Trustee shall transmit to Holders such reports concerning the Trustee and its actions under this Indenture as may be required pursuant to the Trust Indenture Act at the times and in the manner provided therein.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The Trustee shall, at the time of the transmission to the Holders of Securities of any report pursuant to the provisions of this Section 10.01, file a copy of such report with each stock exchange upon which the Securities are listed, if any, and also with the SEC in respect of a Security listed and registered on a national securities exchange, if any. The Company agrees to notify the Trustee when, as and if the Securities become listed on any stock exchange.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company will reimburse the Trustee for all expenses incurred in the preparation and transmission of any report pursuant to the provisions of this Section 10.01 and of Section 10.02.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">37</font></div></div><hr style="page-break-after:always"><div><a name="sb0c8df16acb54d5eb7d3cdc2d48d061a"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reports by the Company</font><font style="font-family:inherit;font-size:12pt;">. The Company shall file with the Trustee and the SEC, and transmit to Holders, such information, documents and other reports, and such summaries thereof, as may be required pursuant to the Trust Indenture Act at the times and in the manner provided in the Trust Indenture Act; provided that, unless available on EDGAR, any such information, documents or reports required to be filed with the SEC pursuant to Section 13 or 15(d) of the Exchange Act shall be filed with the Trustee within 30 days after the same is filed with the SEC; and provided further, that the filing of the reports specified in Section 13 or 15(d) of the Exchange Act by an entity that is the direct or indirect parent of the Company will satisfy the requirements of this Section 10.02 so long as such entity is an obligor or guarantor on the Securities; and provided further that the reports of such entity will not be required to include condensed consolidating financial information for the Company in a footnote to the financial statements of such entity. Notwithstanding the foregoing, the Company shall not be required to deliver to the Trustee any information or documents for which the Company has requested and received confidential treatment by the SEC.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s8a985c571ab64414afea04b4f09a1376"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securityholders&#8217; Lists</font><font style="font-family:inherit;font-size:12pt;">. The Company covenants and agrees that it will furnish or cause to be furnished to the Trustee:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) semi-annually, within 15 days after each Record Date, but in any event not less frequently than semi-annually, a list in such form as the Trustee may reasonably require of the names and addresses of the Holders of Securities to which such Record Date applies, as of such Record Date, and</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) at such other times as the Trustee may request in writing, within 30 days after receipt by the Company of any such request, a list of similar form and content as of a date not more than 15 days prior to the time such list is furnished; provided, however, that so long as the Trustee shall be the Registrar, such lists shall not be required to be furnished.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s7f146478476a47d5b606ea46e507e399"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE XI</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">CONCERNING THE TRUSTEE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s2f51650680a54f9aaf51119bc4dd9e12"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Rights of Trustees; Compensation and Indemnity</font><font style="font-family:inherit;font-size:12pt;">. The Trustee accepts the trusts created by this Indenture upon the terms and conditions hereof, including the following, to all of which the parties hereto and the Holders from time to time of the Securities agree:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Trustee shall be entitled to such compensation as the Company and the Trustee shall from time to time agree in writing for all services rendered by it hereunder (including in any agent capacity in which it acts). The compensation of the Trustee shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust. The Company shall reimburse the Trustee promptly upon its request for all reasonable out-of-pocket expenses, disbursements and advances incurred or made by the Trustee (including the reasonable expenses and disbursements of its agents and counsel), except any such expense, disbursement or advance as may be attributable to its negligence, bad faith or willful misconduct.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company also agrees to indemnify each of the Trustee and any predecessor Trustee hereunder for, and to hold it harmless against, any and all loss, liability, damage, claim, or expense incurred without its own negligence, bad faith or willful misconduct, arising out of or in connection with the acceptance or administration of the trust or trusts hereunder and the performance of its duties (including in any agent capacity in which it acts), as well as the costs and expenses of defending itself against any claim or liability in connection with the exercise or performance of any of its powers or duties hereunder, except those attributable to its negligence, willful misconduct or bad faith. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. The Company shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have one separate counsel and the Company shall pay the reasonable </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">38</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As security for the performance of the obligations of the Company under this Section 11.01(a), the Trustee shall have a lien upon all property and funds held or collected by the Trustee as such, except funds held in trust by the Trustee to pay principal of and interest on any Securities. Notwithstanding any provisions of this Indenture to the contrary, the obligations of the Company to compensate and indemnify the Trustee under this Section 11.01(a) shall survive the resignation or removal of the Trustee and any satisfaction and discharge under Article XII. When the Trustee incurs expenses or renders services after an Event of Default specified in clause (e) or (f) of Section 7.01 occurs, the expenses and compensation for the services are intended to constitute expenses of administration under any applicable federal or state bankruptcy, insolvency or similar laws.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The Trustee may execute any of the trusts or powers hereof and perform any duty hereunder either directly or by its agents and attorneys and shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) The Trustee shall not be responsible in any manner whatsoever for the correctness of the recitals herein or in the Securities (except its certificates of authentication thereon) contained, all of which are made solely by the Company; and the Trustee shall not be responsible or accountable in any manner whatsoever for or with respect to the validity or execution or sufficiency of this Indenture or of the Securities (except its certificates of authentication thereon), and the Trustee makes no representation with respect thereto, except that the Trustee represents that it is duly authorized to execute and deliver this Indenture, authenticate the Securities and perform its obligations hereunder and that the statements made by it in a Statement of Eligibility on Form T-1 supplied to the Company are true and accurate, subject to the qualifications set forth therein. The Trustee shall not be accountable for the use or application by the Company of any Securities, or the proceeds of any Securities, authenticated and delivered by the Trustee in conformity with the provisions of this Indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) The Trustee may consult with counsel of its selection, and, to the extent permitted by Section 11.02, any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken or suffered by the Trustee hereunder in good faith and in accordance with such Opinion of Counsel.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) The Trustee, to the extent permitted by Section 11.02, may rely upon the certificate of the Secretary or one of the Assistant Secretaries of the Company as to the adoption of any Board Resolution or resolution of the stockholders of the Company, and any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by, and whenever in the administration of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee may rely upon, an Officer&#8217;s Certificate of the Company (unless other evidence in respect thereof be herein specifically prescribed).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f) Subject to Section 11.04, the Trustee or any agent of the Trustee, in its individual or any other capacity, may become the owner or pledgee of Securities and, subject to Sections 310(b) and 311 of the Trust Indenture Act, may otherwise deal with the Company with the same rights it would have had if it were not the Trustee or such agent.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g) Money held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by law. The Trustee shall be under no liability for interest on any money received by it hereunder except as otherwise agreed in writing with the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">39</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h) Any action taken by the Trustee pursuant to any provision hereof at the request or with the consent of any Person who at the time is the Holder of any Security shall be conclusive and binding in respect of such Security upon all future Holders thereof or of any Security or Securities which may be issued for or in lieu thereof in whole or in part, whether or not such Security shall have noted thereon the fact that such request or consent had been made or given.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) Subject to the provisions of Section 11.02, the Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, approval, bond, debenture or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or parties.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j) Subject to the provisions of Section 11.02, the Trustee shall not be under any obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the Holders of the Securities, pursuant to any provision of this Indenture, unless one or more of the Holders of the Securities shall have offered to the Trustee security or indemnity satisfactory to it against the costs, expenses and liabilities which may be incurred by it therein or thereby.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(k) Subject to the provisions of Section 11.02, the Trustee shall not be liable for any action taken or omitted by it in good faith and believed by it to be authorized or within its discretion or within the rights or powers conferred upon it by this Indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(l) Subject to the provisions of Section 11.02, the Trustee shall not be deemed to have knowledge or notice of any Default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless the Holders of not less than 25% of the Outstanding Securities notify the Trustee thereof.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(m) Subject to the provisions of the first paragraph of Section 11.02, the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of Indebtedness or other paper or document, but the Trustee, may, but shall not be required to, make further inquiry or investigation into such facts or matters as it may see fit.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(n) The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4b8054f35a0540f09f2b742cb841491f"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Duties of Trustee.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) If one or more of the Events of Default specified in Section 7.01 with respect to the Securities of any series shall have happened, then, during the continuance thereof, the Trustee shall, with respect to such Securities, exercise such of the rights and powers vested in it by this Indenture, and shall use the same degree of care and skill in their exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person&#8217;s own affairs.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) None of the provisions of this Indenture shall be construed as relieving the Trustee from liability for its own negligent action, negligent failure to act, or its own willful misconduct, except that, anything in this Indenture contained to the contrary notwithstanding, </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) unless and until an Event of Default specified in Section 7.01 with respect to the Securities of any series shall have happened which at the time is continuing,</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">40</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(A) the Trustee undertakes to perform such duties and only such duties with respect to the Securities of that series as are specifically set out in this Indenture, and no implied covenants or obligations shall be read into this Indenture against the Trustee, whose duties and obligations shall be determined solely by the express provisions of this Indenture; and</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(B) the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, in the absence of bad faith on the part of the Trustee, upon certificates and opinions furnished to it pursuant to the express provisions of this </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Indenture; but in the case of any such certificates or opinions which, by the provisions of this Indenture, are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts, statements, opinions or conclusions stated therein);</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) the Trustee shall not be liable to any Holder of Securities or to any other Person for any error of judgment made in good faith by a Responsible Officer or Officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts; and</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii) the Trustee shall not be liable to any Holder of Securities or to any other Person with respect to any action taken or omitted to be taken by it in good faith, in accordance with the direction of Securityholders given as provided in Section 7.06, relating to the time, method and place of conducting any proceeding for any remedy available to it or exercising any trust or power conferred upon it by this Indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) None of the provisions of this Indenture shall require the Trustee to expend or risk its own funds or otherwise to incur any financial liability in the performance of any of its duties hereunder, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) Whether or not therein expressly so provided, every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section 11.02.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="scde15a1436b1442793454a9a0e7aa954"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notice of Defaults</font><font style="font-family:inherit;font-size:12pt;">. Within 90 days after the occurrence thereof, and if known to the Trustee, the Trustee shall give to the Holders of the Securities of a series notice of each Default or Event of Default with respect to the Securities of such series known to the Trustee, by transmitting such notice to Holders at their addresses as the same shall then appear on the Register of the Company, unless such Default shall have been cured or waived before the giving of such notice (the term &#8220;Default&#8221; being hereby defined to be the events specified in Section 7.01, which are, or after notice or lapse of time or both would become, Events of Default as defined in said Section). Except in the case of a Default or Event of Default in payment of the principal of, premium, if any, or interest on any of the Securities of such series when and as the same shall become payable, or to make any sinking fund payment as to Securities of the same series, the Trustee shall be protected in withholding such notice, if and so long as a Responsible Officer or Responsible Officers of the Trustee in good faith determines that the withholding of such notice is in the interests of the Holders of the Securities of such series. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">41</font></div></div><hr style="page-break-after:always"><div><a name="sdbcd9ca127304f7092e95636b92c06f2"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Eligibility; Disqualification.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Trustee shall at all times satisfy the requirements of TIA Section 310(a). The Trustee shall have a combined capital and surplus of at least $50 million as set forth in its most recent published annual report of condition, and shall have a Corporate Trust Office. If at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section 11.04, it shall resign immediately in the manner and with the effect hereinafter specified in this Article.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) The Trustee shall comply with TIA Section 310(b); provided, however, that there shall be excluded from the operation of TIA Section 310(b)(i) any indenture or indentures under which other securities or certificates of interest or participation in other securities of the Company are outstanding if the requirements for such exclusion set forth in TIA Section 310(b)(i) are met. If the Trustee has or shall acquire a conflicting interest within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee shall either eliminate such interest or resign, to the extent and in the manner provided by, and subject to the provisions of, the Trust Indenture Act and this Indenture. If Section 310(b) of the Trust Indenture Act is amended any time after the date of this Indenture to change the circumstances under which a Trustee shall be deemed to have a conflicting interest with respect to the Securities of any series or to change any of the definitions in connection therewith, this Section 11.04 shall be automatically amended to incorporate such changes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sb8ea3cccd1734959b04fcca2b6612715"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Registration and Notice; Removal</font><font style="font-family:inherit;font-size:12pt;">. The Trustee, or any successor to it hereafter appointed, may at any time resign and be discharged of the trusts hereby created with respect to any one or more or all series of Securities by giving to the Company notice in writing. Such resignation shall take effect upon the appointment of a successor Trustee and the acceptance of such appointment by such successor Trustee. Any Trustee hereunder may be removed with respect to any series of Securities at any time by the filing with such Trustee and the delivery to the Company of an instrument or instruments in writing signed by the Holders of a majority in principal amount of the Securities of such series then Outstanding, specifying such removal and the date when it shall become effective. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If at any time:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(1) the Trustee shall fail to comply with the provisions of TIA Section 310(b) after written request therefor by the Company or by any Holder who has been a bona fide Holder of a Security for at least six months, or</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(2) the Trustee shall cease to be eligible under Section 11.04 and shall fail to resign after written request therefor by the Company or by any Holder who has been a bona fide Holder of a Security for at least six months, or</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(3) the Trustee shall become incapable of acting or shall be adjudged a bankrupt or insolvent or a receiver of the Trustee or of its property shall be appointed or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation, then, in any such case, (i) the Company by written notice to the Trustee may remove the Trustee and appoint a successor Trustee with respect to all Securities, or (ii) subject to TIA Section 315(e), any Securityholder who has been a bona fide Holder of a Security for at least six months may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee with respect to all Securities and the appointment of a successor Trustee or Trustees.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">42</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Upon its resignation or removal, any Trustee shall be entitled to the payment of reasonable compensation for the services rendered hereunder by such Trustee and to the payment of all reasonable expenses incurred hereunder and all moneys then due to it hereunder. The Trustee&#8217;s rights to indemnification provided in Section 11.01(a) shall survive its resignation or removal.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s7ae6949919f745489fcbcd7338f9e704"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Successor Trustee by Appointment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) In case at any time the Trustee shall resign, or shall be removed (unless the Trustee shall be removed as provided in Section 11.04(b), in which event the vacancy shall be filled as provided in said subdivision), or shall become incapable of acting, or shall be adjudged bankrupt or insolvent, or if a receiver of the Trustee or of its property shall be appointed, or if any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation with respect to the Securities of one or more series, a successor Trustee with respect to the Securities of that or those series (it being understood that any such successor Trustee may be appointed with respect to the Securities of one or more or all of such series and that at any time there shall be only one Trustee with respect to the Securities of any series) may be appointed by the Holders of a majority in principal amount of the Securities of that or those series then Outstanding, by an instrument or instruments in writing signed in duplicate by such Holders and filed, one original thereof with the Company and the other with the successor Trustee; but, until a successor Trustee shall have been so appointed by the Holders of Securities of that or those series as herein authorized, the Company, or, in case all or substantially all the assets of the Company shall be in the possession of one or more custodians or receivers lawfully appointed, or of trustees in bankruptcy or reorganization proceedings (including a trustee or trustees appointed under the provisions of the federal bankruptcy laws, as now or hereafter constituted), or of assignees for the benefit of creditors, such receivers, custodians, trustees or assignees, as the case may be, by an instrument in writing, shall appoint a successor Trustee with respect to the Securities of such series. Subject to the provisions of Sections 11.04 and 11.05, upon the appointment as aforesaid of a successor Trustee with respect to the Securities of any series, the Trustee with respect to the Securities of such series shall cease to be Trustee hereunder. After any such appointment other than by the Holders of Securities of that or those series, the Person making such appointment shall forthwith cause notice thereof to be mailed to the Holders of Securities of such series at their addresses as the same shall then appear on the Register of the Company but any successor Trustee with respect to the Securities of such series so appointed shall, immediately and without further act, be superseded by a successor Trustee appointed by the Holders of Securities of such series in the manner above prescribed, if such appointment be made prior to the expiration of one year from the date of the mailing of such notice by the Company, or by such receivers, trustees or assignees.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) If any Trustee with respect to the Securities of one or more series shall resign or be removed and a successor Trustee shall not have been appointed by the Company or by the Holders of the Securities of such series or, if any successor Trustee so appointed shall not have accepted its appointment within 30 days after such appointment shall have been made, the resigning Trustee at the expense of the Company may apply to any court of competent jurisdiction for the appointment of a successor Trustee. If in any other case a successor Trustee shall not be appointed pursuant to the foregoing provisions of this Section 11.06 within three months after such appointment might have been made hereunder, the Holder of any Security of the applicable series or any retiring Trustee at the expense of the Company may apply to any court of competent jurisdiction to appoint a successor Trustee. Such court may thereupon, in any such case, after such notice, if any, as such court may deem proper and prescribe, appoint a successor Trustee.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">43</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Any successor Trustee appointed hereunder with respect to the Securities of one or more series shall execute, acknowledge and deliver to its predecessor Trustee and to the Company, or to the receivers, trustees, assignees or court appointing it, as the case may be, an instrument accepting such appointment hereunder, and thereupon such successor Trustee, without any further act, deed or conveyance, shall become vested with all the authority, rights, powers, trusts, immunities, duties and obligations with respect to such series of such predecessor Trustee with like effect as if originally named as Trustee hereunder, and such predecessor Trustee, upon payment of its charges and disbursements then unpaid, shall thereupon become obligated to pay over, and such successor Trustee shall be entitled to receive, all moneys and properties held by such predecessor Trustee as Trustee hereunder, subject nevertheless to its lien provided for in Section 11.01(a). Nevertheless, on the written request of the Company or of the successor Trustee or of the Holders of at least 10% in principal amount of the Securities of such series then Outstanding, such predecessor Trustee, upon payment of its said charges and disbursements, shall execute and deliver an instrument transferring to such successor Trustee upon the trusts herein expressed all the rights, powers and trusts of such predecessor Trustee and shall assign, transfer and deliver to the successor Trustee all moneys and properties held by such predecessor Trustee, subject nevertheless to its lien provided for in Section 11.01(a); and, upon request of any such successor Trustee and the Company shall make, execute, acknowledge and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Trustee all such authority, rights, powers, trusts, immunities, duties and obligations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s59eedf72a1ed4b89ae3d1f59a23829e7"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.07. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Successor Trustee by Merger</font><font style="font-family:inherit;font-size:12pt;">. Any Person into which the Trustee or any successor to it in the trusts created by this Indenture shall be merged or converted, or any Person with which it or any successor to it shall be consolidated, or any Person resulting from any merger, conversion or consolidation to which the Trustee or any such successor to it shall be a party, or any Person to which the Trustee or any successor to it shall sell or otherwise transfer all or substantially all of the corporate trust business of the Trustee, shall be the successor Trustee under this Indenture without the execution or filing of any paper or any further act on the part of any of the parties hereto; provided that such Person shall be otherwise qualified and eligible under this Article. In case at the time such successor to the Trustee shall succeed to the trusts created by this Indenture with respect to one or more series of Securities, any of such Securities shall have been authenticated but not delivered by the Trustee then in office, any successor to such Trustee may adopt the certificate of authentication of any predecessor Trustee, and deliver such Securities so authenticated; and in case at that time any of the Securities shall not have been authenticated, any successor to the Trustee may authenticate such Securities either in the name of any predecessor hereunder or in the name of the successor Trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Securities or in this Indenture provided that the certificate of the Trustee shall have; provided, however, that the right to adopt the certificate of authentication of any predecessor Trustee or authenticate Securities in the name of any predecessor Trustee shall apply only to its successor or successors by merger, conversion or consolidation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sd22976d8fae64618a2c047091f17748e"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.08. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Right to Rely on Officer&#8217;s Certificate</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 11.02, and subject to the provisions of Section 16.01 with respect to the certificates required thereby, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or suffering any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence, bad faith or willful misconduct on the part of the Trustee, be deemed to be conclusively proved and established by an Officer&#8217;s Certificate with respect thereto delivered to the Trustee, and such Officer&#8217;s Certificate, in the absence of negligence, bad faith or willful misconduct on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted by it under the provisions of this Indenture upon the faith thereof.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">44</font></div></div><hr style="page-break-after:always"><div><a name="sceca71aac39c4e79a7a934c80eb1f9e6"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.09. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Appointment of Authenticating Agent</font><font style="font-family:inherit;font-size:12pt;">. The Trustee may appoint an agent (the &#8220;Authenticating Agent&#8221;) reasonably acceptable to the Company to authenticate the Securities, and the Trustee shall give written notice of such appointment to all Holders of Securities of the series with respect to which such Authenticating Agent will serve. Unless limited by the terms of such appointment, any such Authenticating Agent may authenticate Securities whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by the Authenticating Agent. Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Each Authenticating Agent shall at all times be a corporation organized and doing business and in good standing under the laws of the United States, any State thereof or the District of Columbia, authorized under such laws to act as Authenticating Agent, having a combined capital and surplus of not less than $50,000,000 and subject to supervision or examination by Federal or State authority. If such corporation publishes reports of condition at least annually, pursuant to law or to the requirements of said supervising or examining authority, then for the purposes of this Article XI, the combined capital and surplus of such corporation shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. If at any time an Authenticating Agent shall cease to be eligible in accordance with the provisions of this Article XI, it shall resign immediately in the manner and with the effect specified in this Article XI. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any corporation into which an Authenticating Agent may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which such Authenticating Agent shall be a party, or any corporation succeeding to the corporate agency or corporate trust business of an Authenticating Agent, shall continue to be an Authenticating Agent, provided such corporation shall be otherwise eligible under this Article XI, without the execution or filing of any paper or any further act on the part of the Trustee or the Authenticating Agent. An Authenticating Agent may resign at any time by giving written notice thereof to the Trustee and to the Company. The Trustee may at any time terminate the agency of an Authenticating Agent by giving written notice thereof to such Authenticating Agent and to the Company. Upon receiving such a notice of resignation or upon such a termination, or in case at any time such Authenticating Agent shall cease to be eligible in accordance with the provisions of this Section 11.09, the Trustee may appoint a successor Authenticating Agent which shall be acceptable to the Company and shall give written notice of such appointment to all Holders of Securities of the series with respect to which such Authenticating Agent will serve. Any successor Authenticating Agent upon acceptance of its appointment hereunder shall become vested with all the rights, powers and duties of its predecessor hereunder, with like effect as if originally named as an Authenticating Agent. No successor Authenticating Agent shall be appointed unless eligible under the provisions of this Section 11.09.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Trustee agrees to pay to each Authenticating Agent from time to time reasonable compensation for its services under this Section 11.09, and the Trustee shall be entitled to be reimbursed for such payments, subject to the provisions of Section 11.01.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s71a6a66d1e4d4e92953354f3c16dd1f0"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.10. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Communications by Securityholders with Other Securityholders</font><font style="font-family:inherit;font-size:12pt;">. Holders of Securities may communicate pursuant to Section 312(b) of the Trust Indenture Act with other Holders with respect to their rights under this Indenture or the Securities. The Company, the Trustee, the Registrar and anyone else shall have the protection of Section 312(c) of the Trust Indenture Act with respect to such communications.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">45</font></div></div><hr style="page-break-after:always"><div><a name="s55c510a8abc5468e98eeff97f90e36bb"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE XII</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SATISFACTION AND DISCHARGE; DEFEASANCE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sec6e24c7e2ed4add8b70997951d9b476"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Applicability of Article</font><font style="font-family:inherit;font-size:12pt;">. If, pursuant to Section 3.01, provision is made for the defeasance of Securities of a series and if the Securities of such series are denominated and payable only in U.S. Dollars (except as provided pursuant to Section 3.01), then the provisions of this Article shall be applicable except as otherwise specified pursuant to Section 3.01 for Securities of such series. Defeasance provisions, if any, for Securities denominated in a Foreign Currency may be specified pursuant to Section 3.01. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s6c921200a22a4a21bdd10068ab19656e"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Satisfaction and Discharge of Indenture</font><font style="font-family:inherit;font-size:12pt;">. This Indenture, with respect to the Securities of any series (if all series issued under this Indenture are not to be affected), shall, upon Company Order, cease to be of further effect (except as to any surviving rights of registration of transfer or exchange of such Securities herein expressly provided for and rights to receive payments of principal of and premium, if any, and interest on such Securities) and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture, when, </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) either: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) all Securities of such series theretofore authenticated and delivered (other than (A) Securities that have been destroyed, lost or stolen and that have been replaced or paid as provided in Section 3.07 and (B) Securities for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company or discharged from such trust, as provided in Section 6.03) have been delivered to the Trustee for cancellation; or </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) all Securities of such series not theretofore delivered to the Trustee for cancellation, </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(A) have become due and payable, or </font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(B) will become due and payable at their Stated Maturity within one year, or </font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(C) are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice by the Trustee in the name, and at the expense, of the Company, and the Company,</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">and in the case of (A), (B) or (C) above, has deposited or caused to be deposited with the Trustee or Paying Agent as trust funds in trust for the purpose an amount in the Currency in which such Securities are denominated (except as otherwise provided pursuant to Section 3.01) sufficient to pay and discharge the entire Indebtedness on such Securities for principal and premium, if any, and interest to the date of such deposit (in the case of Securities that have become due and payable) or to the Stated Maturity or Redemption Date, as the case may be; provided, however, in the event a petition for relief under federal bankruptcy laws, as now or hereafter constituted, or any other applicable federal or state bankruptcy, insolvency or other similar law, is filed with respect to the Company within 91 days after the deposit and the Trustee is required to return the moneys then on deposit with the Trustee to the Company, the obligations of the Company under this Indenture with respect to such Securities shall not be deemed terminated or discharged; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) the Company has paid or caused to be paid all other sums payable hereunder by the Company; and </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">46</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) the Company has delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel each stating that all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture with respect to such series have been complied with. Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee under Section 11.01 and, if money shall have been deposited with the Trustee pursuant to subclause (B) of clause (a)(i) of this Section, the obligations of the Trustee under Section 12.06 and the last paragraph of Section 6.03(e) shall survive. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s31eca71d3f144f819413cda2062323db"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Defeasance upon Deposit of Moneys or U.S Government Obligations</font><font style="font-family:inherit;font-size:12pt;">. At the Company&#8217;s option, either (a) the Company shall be deemed to have been Discharged (as defined below) from its obligations with respect to Securities of any series on the first day after the applicable conditions set forth below have been satisfied or (b) the Company shall cease to be under any obligation to comply with any term, provision or condition set forth in Section 6.04 with respect to Securities of any series (and, if so specified pursuant to Section 3.01, any other restrictive covenant added for the benefit of such series pursuant to Section 3.01) at any time after the applicable conditions set forth below have been satisfied: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) The Company shall have deposited or caused to be deposited irrevocably with the Trustee as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Securities of such series money in an amount, or (ii) U.S. Government Obligations (as defined below) that through the payment of interest and principal in respect thereof in accordance with their terms will provide, not later than one day before the due date of any payment, money in an amount, or (iii) a combination of (i) and (ii), sufficient to pay and discharge each installment of principal (including any mandatory sinking fund payments) of and premium, if any, and interest on, the Outstanding Securities of such series on the dates such installments of interest or principal and premium are due; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) No Default with respect to the Securities of such series shall have occurred and be continuing on the date of such deposit (other than a Default resulting from the borrowing of funds and the grant of any related liens to be applied to such deposit); and </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) The Company shall have delivered to the Trustee an Opinion of Counsel to the effect that Holders of the Securities of such series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the Company&#8217;s exercise of its option under this Section and will be subject to federal income tax on the same amounts and in the same manner and at the same times as would have been the case if such action had not been exercised and, in the case of the Securities of such series being Discharged accompanied by a ruling to that effect received from or published by the Internal Revenue Service. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;Discharged&#8221; </font><font style="font-family:inherit;font-size:12pt;">means that the Company shall be deemed to have paid and discharged the entire Indebtedness represented by, and obligations under, the Securities of such series and to have satisfied all the obligations under this Indenture relating to the Securities of such series (and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging the same), except the rights of Holders of Securities of such series to receive, from the trust fund described in clause (a) above, payment of the principal of and premium, if any, and interest on such Securities when such payments are due, the Company&#8217;s obligations with respect to Securities of such series under Sections 3.04, 3.06, 3.07, 6.03 and 12.06 and the rights, powers, trusts, duties and immunities of the Trustee hereunder.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sdfc3c58354f04da3ae86d4f1b22bcfb1"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Repayment to Company</font><font style="font-family:inherit;font-size:12pt;">. The Trustee and any Paying Agent shall promptly pay to the Company (or to its designee) upon Company Order any excess moneys or U.S. Government Obligations held by them at any time. The provisions of the last paragraph of Section 6.03 shall apply to any money held by the Trustee or any Paying Agent under this Article that remains unclaimed for two years after the Maturity of any series of Securities for which money or U.S. Government Obligations have been deposited pursuant to Section 12.03.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">47</font></div></div><hr style="page-break-after:always"><div><a name="s0ffd40a809fa4f3a80b1e71560e69c62"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.05.</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Indemnity for U.S Government Obligations</font><font style="font-family:inherit;font-size:12pt;">. The Company shall pay and shall indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the deposited U.S. Government Obligations or the principal or interest received on such U.S. Government Obligations. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s86c77237ba7747e28d7e39e22107c268"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Application of Trust Money</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Subject to any applicable abandoned property law, neither the Trustee nor any other paying agent shall be required to pay interest on any moneys deposited pursuant to the provisions of this Indenture, except such as it shall agree with the Company in writing to pay thereon. Any moneys so deposited for the payment of the principal of, or premium, if any, or interest on the Securities of any series and remaining unclaimed for two years after the date of the maturity of the Securities of such series or the date fixed for the redemption of all the Securities of such series at the time outstanding, as the case may be, shall be repaid by the Trustee or such other paying agent to the Company upon its written request and thereafter, anything in this Indenture to the contrary notwithstanding, any rights of the Holders of Securities of such series in respect of which such moneys shall have been deposited shall be enforceable only against the Company, and all liability of the Trustee or such other paying agent with respect to such moneys shall thereafter cease. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) Subject to the provisions of the foregoing paragraph, any moneys which at any time shall be deposited by the Company or on its behalf with the Trustee or any other paying agent for the purpose of paying the principal of, premium, if any, and interest on any of the Securities shall be and are hereby assigned, transferred and set over to the Trustee or such other paying agent in trust for the respective Holders of the Securities for the purpose for which such moneys shall have been deposited; but such moneys need not be segregated from other funds except to the extent required by law. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s56a02e9b4cc04ffc9511ef89b3678a94"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.07. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Deposits of Non-U.S. Currencies</font><font style="font-family:inherit;font-size:12pt;">. Notwithstanding the foregoing provisions of this Article, if the Securities of any series are payable in a Currency other than U.S. Dollars, the Currency or the nature of the government obligations to be deposited with the Trustee or paying agent under the foregoing provisions of this Article shall be as set forth in the Officer&#8217;s Certificate or established in the supplemental indenture under which the Securities of such series are issued. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s56fafd23b55b40f3a933a63e0907ee36"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE XIII</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">IMMUNITY OF CERTAIN PERSONS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s35beca92762447f19cf2ab902577e05a"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 13.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Personal Liability</font><font style="font-family:inherit;font-size:12pt;">. No recourse shall be had for the payment of the principal of, or the premium, if any, or interest on, any Security or for any claim based thereon or otherwise in respect thereof or of the Indebtedness represented thereby, or upon any obligation, covenant or agreement of this Indenture, against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation, whether by virtue of any constitutional provision, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly agreed and understood that this Indenture and the Securities are solely corporate obligations, and that no personal liability whatsoever shall attach to, or be incurred by, any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation, because of the incurring of the Indebtedness hereby authorized or under or by reason of any of the obligations, covenants, promises or agreements contained in this Indenture or in any of the Securities, or to be implied herefrom or therefrom, and that all liability, if any, of that character against every such incorporator, stockholder, officer and director is, by the acceptance of the Securities and as a condition of, and as part of the consideration for, the execution of this Indenture and the issue of the Securities, expressly waived and released. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">48</font></div></div><hr style="page-break-after:always"><div><a name="s83f0f11f5eaf49ddb5275ffd7599315b"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE XIV</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SUPPLEMENTAL INDENTURES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s766834b04cb74c84a2a1f96f45486e50"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Without Consent of Securityholders</font><font style="font-family:inherit;font-size:12pt;">. Except as otherwise provided as contemplated by Section 3.01 with respect to any series of Securities, the Company and the Trustee, at any time and from time to time, may enter into one or more indentures supplemental hereto, in form satisfactory to the Trustee, for any one or more of or all the following purposes: </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) to add to the covenants and agreements of the Company, to be observed thereafter and during the period, if any, in such supplemental indenture or indentures expressed, and to add Events of Default, in each case for the protection or benefit of the Holders of all or any series of the Securities (and if such covenants, agreements and Events of Default are to be for the benefit of fewer than all series of Securities, stating that such covenants, agreements and Events of Default are expressly being included for the benefit of such series as shall be identified therein), or to surrender any right or power herein conferred upon the Company; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) to delete or modify any Events of Default with respect to all or any series of the Securities, the form and terms of which are being established pursuant to such supplemental indenture as permitted in Section 3.01 (and, if any such Event of Default is applicable to fewer than all such series of the Securities, specifying the series to which such Event of Default is applicable), and to specify the rights and remedies of the Trustee and the Holders of such Securities in connection therewith; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) to add to or change any of the provisions of this Indenture to provide, change or eliminate any restrictions on the payment of principal of or premium, if any, on Securities; provided that any such action shall not adversely affect the interests of the Holders of Securities of any series in any material respect; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) to change or eliminate any of the provisions of this Indenture; provided that any such change or elimination shall become effective only when there is no Outstanding Security of any series created prior to the execution of such supplemental indenture that is entitled to the benefit of such provision and as to which such supplemental indenture would apply; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) to evidence the succession of another corporation to the Company, or successive successions, and the assumption by such successor of the covenants and obligations of the Company contained in the Securities of one or more series and in this Indenture or any supplemental indenture; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to one or more series of Securities and to add to or change any of the provisions of this Indenture as shall be necessary for or facilitate the administration of the trusts hereunder by more than one Trustee, pursuant to the requirements of Section 11.06(c); </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g) to secure any series of Securities; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h) to evidence any changes to this Indenture pursuant to Sections 11.05, 11.06 or 11.07 hereof as permitted by the terms thereof; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) to cure or reform any ambiguity mistake, manifest error, omission, defect or inconsistency, or to conform the text of any provision herein or in any indenture supplemental hereto to any description thereof in the applicable section of a prospectus, prospectus supplement or other offering document that was intended to be a verbatim recitation of a provision of this Indenture of any indenture supplemental hereto; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j) to add to or change or eliminate any provision of this Indenture as shall be necessary or desirable in accordance with any amendments to the Trust Indenture Act; </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">49</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(k) to add guarantors or co-obligors with respect to any series of Securities; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(l) to make any change in any series of Securities that does not adversely affect in any material respect the interests of the Holders of such Securities; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(m) to provide for uncertificated securities in addition to certificated securities; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(n) to supplement any of the provisions of this Indenture to such extent as shall be necessary to permit or facilitate the defeasance and discharge of any series of Securities; provided that any such action shall not adversely affect the interests of the Holders of Securities of such series or any other series of Securities; </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(o) to prohibit the authentication and delivery of additional series of Securities; or </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(p) to establish the form and terms of Securities of any series as permitted in Section 3.01, or to authorize the issuance of additional Securities of a series previously authorized or to add to the conditions, limitations or restrictions on the authorized amount, terms or purposes of issue, authentication or delivery of the Securities of any series, as herein set forth, or other conditions, limitations or restrictions thereafter to be observed. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Subject to the provisions of Section 14.03, the Trustee is authorized to join with the Company in the execution of any such supplemental indenture, to make the further agreements and stipulations which may be therein contained and to accept the conveyance, transfer, assignment, mortgage or pledge of any property or assets thereunder. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any supplemental indenture authorized by the provisions of this Section 14.01 may be executed by the Company and the Trustee without the consent of the Holders of any of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 14.02. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s266e039320e241e98034206932f11a9a"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">With Consent of Securityholders; Limitations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) With the consent of the Holders (evidenced as provided in Article VIII) of at least a majority in aggregate principal amount of the Outstanding Securities of each series affected by such supplemental indenture voting separately, the Company and the Trustee may, from time to time and at any time, enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any manner or eliminating any provisions of this Indenture or of modifying in any manner the rights of the Holders of the Securities of such series to be affected; provided, however, that no such supplemental indenture shall, without the consent of the Holder of each Outstanding Security of each such series affected thereby,</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) extend the Stated Maturity of the principal of, or any installment of interest on, any Security, or reduce the principal amount thereof or the interest thereon or any premium payable upon redemption thereof, or extend the Stated Maturity of, or change the Currency in which the principal of and premium, if any, or interest on such Security is denominated or payable, or reduce the amount of the principal of an Original Issue Discount Security that would be due and payable upon a declaration of acceleration of the Maturity thereof pursuant to Section 7.02, or impair the right to institute suit for the enforcement of any payment on or after the Stated Maturity thereof (or, in the case of redemption, on or after the Redemption Date), or materially adversely affect the economic terms of any right to convert or exchange any Security as may be provided pursuant to Section 3.01; or </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) reduce the percentage in principal amount of the Outstanding Securities of any series, the consent of whose Holders is required for any supplemental indenture, or the consent of whose Holders is </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">50</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">required for any waiver of compliance with certain provisions of this Indenture or certain Defaults hereunder and their consequences provided for in this Indenture; or </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii) modify any of the provisions of this Section, Section 6.06 or Section 7.06, except to increase any such percentage or to provide that certain other provisions of this Indenture cannot be modified or waived without the consent of the Holder of each Outstanding Security affected thereby; provided, however, that this clause shall not be deemed to require the consent of any Holder with respect to changes in the references to the &#8220;Trustee&#8221; and concomitant changes in this Section and Section 6.06, or the deletion of this proviso, in accordance with the requirements of Sections 11.06 and 14.01(f); or </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv) modify, without the written consent of the Trustee, the rights, duties or immunities of the Trustee. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) A supplemental indenture that changes or eliminates any provision of this Indenture which has expressly been included solely for the benefit of one or more particular series of Securities or which modifies the rights of the Holders of Securities of such series with respect to such covenant or other provision, shall be deemed not to affect the rights under this Indenture of the Holders of Securities of any other series. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) It shall not be necessary for the consent of the Securityholders under this Section 14.02 to approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) The Company may set a record date for purposes of determining the identity of the Holders of each series of Securities entitled to give a written consent or waive compliance by the Company as authorized or permitted by this Section. Such record date shall not be more than 30 days prior to the first solicitation of such consent or waiver or the date of the most recent list of Holders furnished to the Trustee prior to such solicitation pursuant to Section 312 of the Trust Indenture Act. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section 14.02, the Company shall mail a notice, setting forth in general terms the substance of such supplemental indenture, to the Holders of Securities at their addresses as the same shall then appear in the Register of the Company. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s1d7b67479d454e779028c3e8b65729d6"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Trustee Protected</font><font style="font-family:inherit;font-size:12pt;">. Upon the request of the Company, accompanied by the Officer&#8217;s Certificate and Opinion of Counsel required by Section 16.01 stating that the execution of such supplemental indenture is authorized or permitted by this Indenture, and evidence reasonably satisfactory to the Trustee of consent of the Holders if the supplemental indenture is to be executed pursuant to Section 14.02, the Trustee shall join with the Company in the execution of said supplemental indenture unless said supplemental indenture affects the Trustee&#8217;s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into said supplemental indenture. The Trustee shall be fully protected in relying upon such Officer&#8217;s Certificate and an Opinion of Counsel. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">51</font></div></div><hr style="page-break-after:always"><div><a name="s2e1511ac1b984674b3fe8b9971ac1c64"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Effect of Execution of Supplemental Indenture</font><font style="font-family:inherit;font-size:12pt;">. Upon the execution of any supplemental indenture pursuant to the provisions of this Article XIV, this Indenture shall be deemed to be modified and amended in accordance therewith and, except as herein otherwise expressly provided, the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the Holders of all of the Securities or of the Securities of any series affected, as the case may be, shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s15c77126834a45eaaa5f2a17118fcc60"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notation on or Exchange of Securities</font><font style="font-family:inherit;font-size:12pt;">. Securities of any series authenticated and delivered after the execution of any supplemental indenture pursuant to the provisions of this Article may bear a notation in the form approved by the Trustee as to any matter provided for in such supplemental indenture. If the Company or the Trustee shall so determine, new Securities so modified as to conform, in the opinion of the Trustee and the Board of Directors of the Company, to any modification of this Indenture contained in any such supplemental indenture may be prepared and executed by the Company and authenticated and delivered by the Trustee in exchange for the Securities then Outstanding in equal aggregate principal amounts, and such exchange shall be made without cost to the Holders of the Securities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s050be75b99b244b7a1aaf3d3d97c1b72"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Conformity with TIA</font><font style="font-family:inherit;font-size:12pt;">. Every supplemental indenture executed pursuant to the provisions of this Article shall conform to the requirements of the Trust Indenture Act as then in effect. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sfb804a7e9fe243a28e4df6871ea54890"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE XV</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SUBORDINATION OF SECURITIES</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s9b5ec22c775444f88d8526fbc97049f4"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agreement to Subordinate</font><font style="font-family:inherit;font-size:12pt;">. In the event a series of Securities is designated as subordinated pursuant to Section 3.01, and except as otherwise provided in a Company Order or in one or more indentures supplemental hereto, the Company, for itself, its successors and assigns, covenants and agrees, and each Holder of Securities of such series by his, her or its acceptance thereof, likewise covenants and agrees, that the payment of the principal of (and premium, if any) and interest, if any, on each and all of the Securities of such series is hereby expressly subordinated, to the extent and in the manner hereinafter set forth, in right of payment to the prior payment in full of all Senior Indebtedness. In the event a series of Securities is not designated as subordinated pursuant to Section 3.01(c), this Article XV shall have no effect upon the Securities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sfce6b0fc7e8d4fc99b7d0a4b97d07624"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Distribution on Dissolution, Liquidation and Reorganization; Subrogation of Securities</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 15.01, upon any distribution of assets of the Company upon any dissolution, winding up, liquidation or reorganization of the Company, whether in bankruptcy, insolvency, reorganization or receivership proceedings or upon an assignment for the benefit of creditors or any other marshalling of the assets and liabilities of the Company or otherwise (subject to the power of a court of competent jurisdiction to make other equitable provision reflecting the rights conferred in this Indenture upon the Senior Indebtedness and the holders thereof with respect to the Securities and the holders thereof by a lawful plan of reorganization under applicable bankruptcy law): </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) the holders of all Senior Indebtedness shall be entitled to receive payment in full of the principal thereof (and premium, if any) and interest due thereon before the Holders of the Securities are entitled to receive any payment upon the principal (or premium, if any) or interest, if any, on Indebtedness evidenced by the Securities; and </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">52</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) any payment or distribution of assets of the Company of any kind or character, whether in cash, property or securities, to which the Holders of the Securities or the Trustee would be entitled except for the provisions of this Article XV shall be paid by the liquidation trustee or agent or other Person making such payment or distribution, whether a trustee in bankruptcy, a receiver or liquidating trustee or otherwise, directly to the holders of Senior Indebtedness or their representative or representatives or to the trustee or trustees under any indenture under which any instruments evidencing any of such Senior Indebtedness may have been issued, ratably according to the aggregate amounts remaining unpaid on account of the principal of (and premium, if any) and interest on the Senior Indebtedness held or represented by each, to the extent necessary to make payment in full of all Senior Indebtedness remaining unpaid, after giving effect to any concurrent payment or distribution to the holders of such Senior Indebtedness; and </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) in the event that, notwithstanding the foregoing, any payment or distribution of assets of the Company of any kind or character, whether in cash, property or securities prohibited by the foregoing, shall be received by the Trustee or the Holders of the Securities before all Senior Indebtedness is paid in full, such payment or distribution shall be paid over, upon written notice to a Responsible Officer of the Trustee, to the holder of such Senior Indebtedness or his, her or its representative or representatives or to the trustee or trustees under any indenture under which any instrument evidencing any of such Senior Indebtedness may have been issued, ratably as aforesaid, as calculated by the Company, for application to payment of all Senior Indebtedness remaining unpaid until all such Senior Indebtedness shall have been paid in full, after giving effect to any concurrent payment or distribution to the holders of such Senior Indebtedness. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) Subject to the payment in full of all Senior Indebtedness, the Holders of the Securities shall be subrogated to the rights of the holders of Senior Indebtedness (to the extent that distributions otherwise payable to such holder have been applied to the payment of Senior Indebtedness) to receive payments or distributions of cash, property or securities of the Company applicable to Senior Indebtedness until the principal of (and premium, if any) and interest, if any, on the Securities shall be paid in full and no such payments or distributions to the Holders of the Securities of cash, property or securities otherwise distributable to the holders of Senior Indebtedness shall, as between the Company, its creditors other than the holders of Senior Indebtedness, and the Holders of the Securities be deemed to be a payment by the Company to or on account of the Securities. It is understood that the provisions of this Article XV are and are intended solely for the purpose of defining the relative rights of the Holders of the Securities, on the one hand, and the holders of the Senior Indebtedness, on the other hand. Nothing contained in this Article XV or elsewhere in this Indenture or in the Securities is intended to or shall impair, as between the Company, its creditors other than the holders of Senior Indebtedness, and the Holders of the Securities, the obligation of the Company, which is unconditional and absolute, to pay to the Holders of the Securities the principal of (and premium, if any) and interest, if any, on the Securities as and when the same shall become due and payable in accordance with their terms, or to affect the relative rights of the Holders of the Securities and creditors of the Company other than the holders of Senior Indebtedness, nor shall anything herein or in the Securities prevent the Trustee or the Holder of any Security from exercising all remedies otherwise permitted by applicable law upon default under this Indenture, subject to the rights, if any, under this Article XV of the holders of Senior Indebtedness in respect of cash, property or securities of the Company received upon the exercise of any such remedy. Upon any payment or distribution of assets of the Company referred to in this Article XV, the Trustee, subject to the provisions of Section 15.05, shall be entitled to conclusively rely upon a certificate of the liquidating trustee or agent or other person making any distribution to the Trustee for the purpose of ascertaining the Persons entitled to participate in such distribution, the holders of Senior Indebtedness and other indebtedness of the Company, the amount thereof or payable thereon, the amount or amounts paid or distributed thereof and all other facts pertinent thereto or to this Article XV. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">53</font></div></div><hr style="page-break-after:always"><div><a name="s3df8cf03c59e455fa473dea8ac227241"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Payment on Securities in Event of Default on Senior Indebtedness</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 15.01, no payment by the Company on account of principal (or premium, if any), sinking funds or interest, if any, on the Securities shall be made at anytime if: (i) a default on Senior Indebtedness exists that permits the holders of such Senior Indebtedness to accelerate its maturity and (ii) the default is the subject of judicial proceedings or the Company has received notice of such default. The Company may resume payments on the Securities when full payment of amounts then due for principal (premium, if any), sinking funds and interest on Senior Indebtedness has been made or duly provided for in money or money&#8217;s worth. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event that, notwithstanding the foregoing, any payment shall be received by the Trustee when such payment is prohibited by the preceding paragraph of this Section 15.03, such payment shall be held in trust for the benefit of, and shall be paid over or delivered to, the holders of such Senior Indebtedness or their respective representatives, or to the trustee or trustees under any indenture pursuant to which any of such Senior Indebtedness may have been issued, as their respective interests may appear, as calculated by the Company, but only to the extent that the holders of such Senior Indebtedness (or their representative or representatives or a trustee) notify the Trustee in writing within 90 days of such payment of the amounts then due and owing on such Senior Indebtedness and only the amounts specified in such notice to the Trustee shall be paid to the holders of such Senior Indebtedness. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s216c52307ff548e59f8e45501583c113"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Payments on Securities Permitted</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 15.01, nothing contained in this Indenture or in any of the Securities shall (a) affect the obligation of the Company to make, or prevent the Company from making, at any time except as provided in Sections 15.02 and 15.03, payments of principal of (or premium, if any) or interest, if any, on the Securities or (b) prevent the application by the Trustee of any moneys or assets deposited with it hereunder to the payment of or on account of the principal of (or premium, if any) or interest, if any, on the Securities, unless a Responsible Officer of the Trustee shall have received at its Corporate Trust Office written notice of any fact prohibiting the making of such payment from the Company or from the holder of any Senior Indebtedness or from the trustee for any such holder, together with proof satisfactory to the Trustee of such holding of Senior Indebtedness or of the authority of such trustee more than two Business Days prior to the date fixed for such payment. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s2b7502e593374c4fa665d9e5adcd1452"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Authorization of Securityholders to Trustee to Effect Subordination</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 15.01, each Holder of Securities by his acceptance thereof authorizes and directs the Trustee on his, her or its behalf to take such action as may be necessary or appropriate to effectuate the subordination as provided in this Article XV and appoints the Trustee his attorney-in-fact for any and all such purposes. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sfe9e6bd28a41478381a7903e86fa8e9a"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notices to Trustee</font><font style="font-family:inherit;font-size:12pt;">. The Company shall give prompt written notice to a Responsible Officer of the Trustee of any fact known to the Company that would prohibit the making of any payment of monies or assets to or by the Trustee in respect of the Securities of any series pursuant to the provisions of this Article XV. Subject to Section 15.01, notwithstanding the provisions of this Article XV or any other provisions of this Indenture, neither the Trustee nor any Paying Agent (other than the Company) shall be charged with knowledge of the existence of any Senior Indebtedness or of any fact which would prohibit the making of any payment of moneys or assets to or by the Trustee or such Paying Agent, unless and until a Responsible Officer of the Trustee or such Paying Agent shall have received (in the case of a Responsible Officer of the Trustee, at the Corporate Trust Office of the Trustee) written notice thereof from the Company or from the holder of any Senior Indebtedness from the trustee for any such holder, together with proof satisfactory to the Trustee of such holding of Senior Indebtedness or of the authority of such trustee and, prior to the receipt of any such written notice, the Trustee shall be entitled in all respects conclusively to presume that no such facts exist; provided, however, that if at least two Business Days prior to the date upon which by the terms hereof any such moneys or assets may become payable for any purpose (including, without limitation, the payment of either the principal (or premium, if any) or interest, if any, on any Security) a Responsible Officer of the Trustee shall not have received with respect to such moneys or assets the notice </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">54</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">provided for in this Section 15.06, then, anything herein contained to the contrary notwithstanding, the Trustee shall have full power and authority to receive such moneys or assets and to apply the same to the purpose for which they were received, and shall not be affected by any notice to the contrary which may be received by it within two Business Days prior to such date. The Trustee shall be entitled to rely on the delivery to it of a written notice by a Person representing himself to be a holder of Senior Indebtedness (or a trustee on behalf of such holder) to establish that such a notice has been given by a holder of Senior Indebtedness or a trustee on behalf of any such holder. In the event that the Trustee determines in good faith that further evidence is required with respect to the right of any Person as a holder of Senior Indebtedness to participate in any payment or distribution pursuant to this Article XV, the Trustee may request such Person to furnish evidence to the reasonable satisfaction of the Trustee as to the amount of Senior Indebtedness held by such Person, the extent to which such Person is entitled to participate in such payment or distribution and any other facts pertinent to the rights of such Person under this Article XV and, if such evidence is not furnished, the Trustee may defer any payment to such Person pending judicial determination as to the right of such Person to receive such payment. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sd9833ddb52614e728e85a77bc13abc0b"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.07. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Trustee as Holder of Senior Indebtedness</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 15.01, the Trustee in its individual capacity shall be entitled to all the rights set forth in this Article XV in respect of any Senior Indebtedness at any time held by it to the same extent as any other holder of Senior Indebtedness and nothing in this Indenture shall be construed to deprive the Trustee of any of its rights as such holder. Nothing in this Article XV shall apply to claims of, or payments to, the Trustee under or pursuant to Sections 7.05 or 11.01. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sa0236b2afa894a7c8181488e5d1140d5"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.08. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Modifications of Terms of Senior Indebtedness</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 15.01, any renewal or extension of the time of payment of any Senior Indebtedness or the exercise by the holders of Senior Indebtedness of any of their rights under any instrument creating or evidencing Senior Indebtedness, including, without limitation, the waiver of default thereunder, may be made or done all without notice to or assent from the Holders of the Securities or the Trustee. No compromise, alteration, amendment, modification, extension, renewal or other change of, or waiver, consent or other action in respect of, any liability or obligation under or in respect of, or of any of the terms, covenants or conditions of any indenture or other instrument under which any Senior Indebtedness is outstanding or of such Senior Indebtedness, whether or not such release is in accordance with the provisions of any applicable document, shall in any way alter or affect any of the provisions of this Article XV or of the Securities relating to the subordination thereof. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s9e598d3515f64686883c95767c856a6d"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.09. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reliance on Judicial Order or Certificate of Liquidating Agent</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 15.01, upon any payment or distribution of assets of the Company referred to in this Article XV, the Trustee and the Holders of the Securities shall be entitled to conclusively rely upon any order or decree entered by any court of competent jurisdiction in which such insolvency, bankruptcy, receivership, liquidation, reorganization, dissolution, winding up or similar case or proceeding is pending, or a certificate of the trustee in bankruptcy, liquidating trustee, custodian, receiver, assignee for the benefit of creditors, agent or other person making such payment or distribution, delivered to the Trustee or to the Holders of Securities, for the purpose of ascertaining the Persons entitled to participate in such payment or distribution, the holders of Senior Indebtedness and other indebtedness of the Company, the amount thereof or payable thereon, the amount or amounts paid or distributed thereon and all other facts pertinent thereto or to this Article XV. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s5b17a6ff57f94a83a39b8e76c37ed4f3"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.10. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Satisfaction and Discharge; Defeasance and Covenant Defeasance</font><font style="font-family:inherit;font-size:12pt;">. Subject to Section 15.01, amounts and U.S. Government Obligations deposited in trust with the Trustee pursuant to and in accordance with Article XII and not, at the time of such deposit, prohibited to be deposited under Sections 15.02 or 15.03 shall not be subject to this Article XV. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">55</font></div></div><hr style="page-break-after:always"><div><a name="s6aa41d75023b4268ba9f9101b7d3c04d"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.11. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 15.11 Trustee Not Fiduciary for Holders of Senior Indebtedness</font><font style="font-family:inherit;font-size:12pt;">. With respect to the holders of Senior Indebtedness, the Trustee undertakes to perform or observe only such of its covenants and obligations as are specifically set forth in this Article XV, and no implied covenants or obligations with respect to the holders of Senior Indebtedness shall be read into this Indenture against the Trustee. The Trustee shall not be deemed to owe any fiduciary duty to the holders of Senior Indebtedness. The Trustee shall not be liable to any such holder if it shall pay over or distribute to or on behalf of Holders of Securities or the Company, or any other Person, moneys or assets to which any holder of Senior Indebtedness shall be entitled by virtue of this Article XV or otherwise. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sa6ac74b3bed64f94933821ce7dacb7c7"></a></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ARTICLE XVI</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">MISCELLANEOUS PROVISIONS</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s2a39450d0e704c3bb8d77cccb37df31c"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.01. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Certificates and Opinions as to Conditions Precedent.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) Upon any request or application by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall furnish to the Trustee an Officer&#8217;s Certificate stating that all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been complied with, except that in the case of any such application or demand as to which the furnishing of such document is specifically required by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) Each certificate or opinion provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant provided for in this Indenture (other than the certificates provided pursuant to Section 6.05 of this Indenture) shall include (i) a statement that the Person giving such certificate or opinion has read such covenant or condition; (ii) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (iii) a statement that, in the view or opinion of such Person, he or she has made such examination or investigation as is necessary to enable such Person to express an informed view or opinion as to whether or not such covenant or condition has been complied with; and (iv) a statement as to whether or not, in the view or opinion of such Person, such condition or covenant has been complied with. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Any certificate, statement or opinion of an officer of the Company may be based, insofar as it relates to legal matters, upon a certificate or opinion of, or representations by, counsel, unless such officer knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to the matters upon which his or her certificate, statement or opinion is based are erroneous. Any certificate, statement or opinion of counsel may be based, insofar as it relates to factual matters, upon a certificate, statement or opinion of, or representations by, an officer or officers of the Company stating that the information with respect to such factual matters is in the possession of the Company, unless such counsel knows, or in the exercise of reasonable care should know, that the certificate, statement or opinion or representations with respect to such matters are erroneous. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) Any certificate, statement or opinion of an officer of the Company or of counsel to the Company may be based, insofar as it relates to accounting matters, upon a certificate or opinion of, or representations by, an accountant or firm of accountants, unless such officer or counsel, as the case may be, knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to the accounting matters upon which his or her certificate, statement or opinion may be based are erroneous. Any certificate or opinion of any firm of independent registered public accountants filed with the Trustee shall contain a statement that such firm is independent. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">56</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e) In any case where several matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several documents. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f) Where any Person is required to make, give or execute two or more applications, requests, consents, certificates, statements, opinions or other instruments under this Indenture, they may, but need not, be consolidated and form one instrument. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sefe67758c3a04ee996627d258cf4c434"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.02. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Trust Indenture Act Controls</font><font style="font-family:inherit;font-size:12pt;">. If and to the extent that any provision of this Indenture limits, qualifies or conflicts with the duties imposed by, or another provision included in this Indenture which is required to be included in this Indenture by any of the provisions of Sections 310 to 318, inclusive, of the Trust Indenture Act, such imposed duties or incorporated provision shall control. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sa606543b65c94241a5284586166025dd"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.03. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notices to the Company and Trustee</font><font style="font-family:inherit;font-size:12pt;">. Any notice or demand authorized by this Indenture to be made upon, given or furnished to, or filed with, the Company or the Trustee shall be sufficiently made, given, furnished or filed for all purposes if it shall be mailed, delivered or telefaxed to: </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) the Company, at 5115 Ulmerton Road, Clearwater, Florida 33760 Attention: Chief Executive Officer, or at such other address as may have been furnished in writing to the Trustee by the Company. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) the Trustee, at the Corporate Trust Office of the Trustee, Attention: Trust Administrator. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any such notice, demand or other document shall be in the English language. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4adcf57b9ab849b7985d98496f189cb7"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.04. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notices to Securityholders; Waiver</font><font style="font-family:inherit;font-size:12pt;">. Any notice required or permitted to be given to Securityholders shall be sufficiently given (unless otherwise herein expressly provided), </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a) if to Holders, if given in writing by first class mail, postage prepaid, to such Holders at their addresses as the same shall appear on the Register of the Company. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b) In the event of suspension of regular mail service or by reason of any other cause it shall be impracticable to give notice by mail, then such notification as shall be given with the approval of the Trustee shall constitute sufficient notice for every purpose hereunder. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c) Where this Indenture provides for notice in any manner, such notice may be waived in writing by the Person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the validity of any action taken in reliance on such waiver. In any case where notice to Holders is given by mail; neither the failure to mail such notice nor any defect in any notice so mailed to any particular </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Holder shall affect the sufficiency of such notice with respect to other Holders, and any notice that is mailed in the manner herein provided shall be conclusively presumed to have been duly given. In any case where notice to Holders is given by publication, any defect in any notice so published as to any particular Holder shall not affect the sufficiency of such notice with respect to other Holders, and any notice that is published in the manner herein provided shall be conclusively presumed to have been duly given. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">57</font></div></div><hr style="page-break-after:always"><div><a name="s02898f70ec984ac79b88953bedd5fd9b"></a></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.05. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Legal Holiday</font><font style="font-family:inherit;font-size:12pt;">. Unless otherwise specified pursuant to Section 3.01, in any case where any Interest Payment Date, Redemption Date or Maturity of any Security of any series shall not be a Business Day at any Place of Payment for the Securities of that series, then payment of principal and premium, if any, or interest need not be made at such Place of Payment on such date, but may be made on the next succeeding Business Day at such Place of Payment with the same force and effect as if made on such Interest Payment Date, Redemption Date or Maturity and no interest shall accrue on such payment for the period from and after such Interest Payment Date, Redemption Date or Maturity, as the case may be, to such Business Day if such payment is made or duly provided for on such Business Day. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sada595b2c1be420e8511ba61d2a33c31"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.06. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Effects of Headings and Table of Contents</font><font style="font-family:inherit;font-size:12pt;">. The Article and Section headings herein and the Table of Contents are for convenience only and shall not affect the construction hereof. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s1372a6faaa194298bbf7b9b05b8b37ec"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.07. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Successors and Assigns</font><font style="font-family:inherit;font-size:12pt;">. All covenants and agreements in this Indenture by the parties hereto shall bind their respective successors and assigns and inure to the benefit of their permitted successors and assigns, whether so expressed or not. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s7930f09734064478a2aecc1e0e303aba"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.08. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Severability Clause</font><font style="font-family:inherit;font-size:12pt;">. In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sc4d7a01e8dca4798be06e0c2833a76ef"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.09. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Benefits of Indenture</font><font style="font-family:inherit;font-size:12pt;">. Nothing in this Indenture expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or to give to, any Person or corporation other than the parties hereto and their successors and the Holders of the Securities any benefit or any right, remedy or claim under or by reason of this Indenture or any covenant, condition, stipulation, promise or agreement hereof, and all covenants, conditions, stipulations, promises and agreements in this Indenture contained shall be for the sole and exclusive benefit of the parties hereto and their successors and of the Holders of the Securities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s27de0da8b3bf41349b4d21dec42657c1"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.10. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Counterparts Originals</font><font style="font-family:inherit;font-size:12pt;">. This Indenture may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sa20b4ed3af67452aa9717ed1b5ef9eb0"></a></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.11. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Law; Waiver of Trial by Jury</font><font style="font-family:inherit;font-size:12pt;">. This Indenture and the Securities shall be deemed to be contracts made under the law of the State of Florida and for all purposes shall be governed by and construed in accordance with the law of said State. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">EACH PARTY HERETO, AND EACH HOLDER OF A SECURITY BY ACCEPTANCE THEREOF, HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS INDENTURE. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[Signature page follows.]</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">58</font></div></div><hr style="page-break-after:always"><div><a name="s46cb0e48b6e943aba4a311e846d30c7d"></a></div><div><br></div><div style="line-height:120%;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed as of the date first written above. </font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:48%;"></td><td style="width:8%;"></td><td style="width:34%;"></td><td style="width:2%;"></td><td style="width:8%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Bovie Medical Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">as Issuer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">as Trustee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">59</font></div></div><hr style="page-break-after:always"><div><a name="s7e8ab3ae6f5f4baf91e6ad9a1c0054cd"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CROSS-REFERENCE TABLE (1)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section of Trust Indenture Act of 1939, as Amended Section of Indenture </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:34%;"></td><td style="width:66%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.04(a)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.04(b)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inapplicable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.01(f)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.01(f)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inapplicable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">312(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.03(a)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.03(b)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">312(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.10</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">312(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.10</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.01(a)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.01(a)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.01(a)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313(d)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.01(b)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.05</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.02</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inapplicable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.01(a)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.01(d)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314(d)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inapplicable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314(e)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.01(b)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314(f)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inapplicable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.02(b)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.03</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.02(a)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315(d)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.02(b)(i)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.02(b)(ii)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315(e)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.08</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.06</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.07</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.02(e)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.03</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.03</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.02</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(1) This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">60</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>bvx_201805xex51opinionofrmf.htm
<DESCRIPTION>BVX_2018.05_EXHIBIT 5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s1c9e18c4324a4f8aa51f4ad346226c48"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 5.1</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Writer's Direct Dial:&#160;&#160;516-663-6600</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Writer's Direct Fax:&#160;&#160;&#160;516-663-6601</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">May 3, 2018</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Bovie Medical Corporation</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5115 Ulmerton Road </font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Clearwater, Florida 33760</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Re:&#160;&#160;&#160;&#160;Registration Statement on Form S-3 Filed by Bovie Medical Corporation</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Ladies and Gentlemen:</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We have acted as counsel to Bovie Medical Corporation, a Delaware corporation (the &#8220;Company&#8221;), in connection with the Registration Statement on Form S-3 (the &#8220;Registration Statement&#8221;) to be filed by the Company with the Securities and Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).&#160;Under the Registration Statement, the Company may offer and sell from time to time, on a delayed or continuous basis pursuant to the provisions of Rule 415 under the Securities Act as set forth in the prospectus contained in the Registration Statement (the &#8220;Prospectus&#8221;) and as may be set forth in one or more supplements to the Prospectus (each, a &#8220;Prospectus Supplement&#8221;): (i) the Company&#8217;s debt securities, in one or more series, consisting of notes, debentures, bonds and other evidences of indebtedness (the &#8220;Debt Securities&#8221;), (ii) shares of common stock of the Company, $.001 par value per share (the &#8220;Common Stock&#8221;), (iii) shares of preferred stock of the Company, in one or more series (the &#8220;Preferred Stock&#8221;) (iv) warrants (the &#8220;Warrants&#8221;) to purchase Debt Securities, Preferred Stock or Common Stock and (v) units comprised of any of the foregoing securities, in any combination (the &#8220;Units&#8221;).&#160;The Debt Securities, Preferred Stock, Common Stock, Warrants and the Units are collectively referred to as the &#8220;Securities.&#8221;&#160;The maximum public offering price of the Securities being registered is $25,000,000.&#160;The Securities may be offered separately or as part of units with other Securities, in separate series, in amounts, at prices, and on terms to be set forth in the Prospectus Supplements.&#160;With your permission, all assumptions herein have been made without any independent investigation or verification on our part except to the extent otherwise expressly stated, and we express no opinion with respect to the accuracy of such assumptions or items relied upon.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In rendering this opinion, we have: (i) investigated such questions of law, (ii) examined originals or certified, conformed or reproduction copies of such agreements, instruments, documents and records of the Company, such certificates of public officials and such other documents and (iii) received such information from officers and representatives of the Company and others, in each case, as we have deemed necessary or appropriate for purposes of this opinion. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">760654</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Bovie Medical Corporation</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">May 3, 2018</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Page </font><font style="font-family:inherit;font-size:12pt;">2</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In all such investigations and examinations, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of original and certified documents and the conformity to original or certified documents of all copies submitted to us as conformed or reproduction copies.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Based on the foregoing and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that:</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">1.</font><font style="font-family:inherit;font-size:12pt;">Each series of Debt Securities (including any such Debt Securities comprising a Unit) will constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with their terms, when (i) the Board of Directors of the Company (or a duly authorized committee thereof) has taken all necessary corporate action to approve the issuance of such Debt Securities and to establish the terms and conditions thereof in accordance with the indenture pursuant to which the Debt Securities are to be issued, which is substantially in the form of the indenture filed as Exhibit 4.5 to the Registration Statement (the &#8220;Indenture&#8221;), and so as not to violate any applicable law, rule or regulation or result in a default under or breach of any agreement or instrument binding upon the Company and so as to comply with any applicable requirement or restriction imposed by any court or governmental body having jurisdiction over the Company, which corporate action shall remain in full force and effect, without amendment or modification, at all times at which the Debt Securities of such series are offered and sold by the Company; (ii) the Indenture and any necessary supplemental indenture to the Indenture (each, a &#8220;Supplemental Indenture&#8221;) shall have been duly authorized, executed and delivered by the Company and the trustee to be named in the Prospectus Supplement relating to the offering of the Debt Securities (the &#8220;Trustee&#8221;); (iii) the Trustee is eligible under the Trust Indenture Act of 1939, as amended, to act in such capacity under the Indenture and has been duly appointed and a Statement of Eligibility of Trustee on Form T-1 has been filed in compliance with the Securities Act and the rules and regulations promulgated thereunder; (iv) the Debt Securities of such series shall have been issued in the form and containing the terms described in the Registration Statement, any applicable Prospectus Supplements, the Indenture, any applicable Supplemental Indenture and the corporate action; and (v) the Debt Securities of such series shall have been duly authenticated, executed, sold and delivered in accordance with the Indenture and any applicable Supplemental Indenture against payment of the agreed consideration therefor in accordance with the applicable underwriting, purchase or similar agreement or upon exchange in accordance with the terms of any other Security, or upon exercise of any other Security in accordance with the terms thereof, that has been duly authorized, issued, paid for and delivered.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">2.</font><font style="font-family:inherit;font-size:12pt;">The Common Stock (including any such shares of Common Stock comprising a Unit) will be duly authorized, validly issued, fully paid and non-assessable when: (i) the Board of Directors (or a duly authorized committee thereof) has taken all necessary corporate action to approve the issuance of the Common Stock in accordance with the Company&#8217;s certificate of incorporation, as amended (the &#8220;Certificate of Incorporation&#8221;) and applicable law, which corporate action shall remain in full force and </font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Bovie Medical Corporation</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">May 3, 2018</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Page </font><font style="font-family:inherit;font-size:12pt;">3</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-left:48px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">effect, without amendment or modification, at all times at which such Common Stock is offered and sold by the Company; and (ii) certificates representing the Common Stock shall have been duly executed, countersigned, registered and duly delivered to the purchasers thereof against payment of the agreed consideration therefor in accordance with the applicable underwriting, purchase or similar agreement or upon exchange in accordance with the terms of any other Security, or upon exercise or conversion of any other Security in accordance with the terms thereof, that has been duly authorized, issued, paid for and delivered.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">3.</font><font style="font-family:inherit;font-size:12pt;">Each series of Preferred Stock (including any such shares of Preferred Stock comprising a Unit) will be duly authorized, validly issued, fully paid and non-assessable when: (i) the Board of Directors of the Company (or a duly authorized committee thereof) has taken all necessary corporate action to approve the issuance of such Preferred Stock and to establish the terms and conditions thereof in accordance with the Certificate of Incorporation and so as not to violate any applicable law, rule or regulation or result in a default under or breach of any agreement or instrument binding upon the Company and so as to comply with any applicable requirement or restriction imposed by any court or governmental body having jurisdiction over the Company, which corporate action shall remain in full force and effect, without amendment or modification, at all times at which such Preferred Stock is offered and sold by the Company; (ii) certificate of designations to the Certificate of Incorporation establishing the designations, preferences and rights of the series of Preferred Stock being issued and delivered have been duly filed with the Delaware Secretary of State; and (iii) the certificates representing such series of Preferred Stock shall have been duly executed, countersigned, registered and duly sold and delivered to the purchasers thereof against payment of the agreed consideration thereof in accordance with the applicable underwriting, purchase or similar agreement or upon exchange or conversion in accordance with the terms of any other Security, or upon exercise of any other Security in accordance with the terms thereof, that has been duly authorized, issued, paid for and delivered.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">4.</font><font style="font-family:inherit;font-size:12pt;">Each series of Warrants (including any Warrants comprising a Unit) will constitute the valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, when: (i) such Warrants shall have been duly authorized, executed and delivered by the Company; (ii) the Board of Directors of the Company (or a duly authorized committee thereof) shall have taken all necessary corporate action to approve the issuance of such Warrants and to establish the terms and conditions thereof in accordance with the Certificate of Incorporation and so as not to violate any applicable law, rule or regulation or result in a default under or breach of any agreement or instrument binding upon the Company and so as to comply with any applicable requirement or restriction imposed by any court or governmental body having jurisdiction over the Company, which action shall remain in full force and effect, without amendment or modification, at all times at which such Warrants are offered and sold by the Company; (ii) any and all actions required under the Indenture, and the applicable Supplemental Indenture and the General Corporation Law of the State of Delaware (the &#8220;GCL&#8221;) to validly issue the </font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Bovie Medical Corporation</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">May 3, 2018</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Page </font><font style="font-family:inherit;font-size:12pt;">4</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-left:48px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">Securities issuable upon exercise of the Warrants shall have been taken; and (iii) such Warrants shall have been duly executed and authenticated or countersigned as provided in the Warrant Agreement relating thereto and duly sold and delivered to the purchasers thereof against payment of the agreed consideration therefor in accordance with the applicable underwriting, purchase or similar agreement.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The foregoing opinions are limited to the applicable (i) federal law of the United States, (ii) the law or the State of New York, and (iii) the Delaware General Corporation Law, each as in effect on the date on which the Commission declares the Registration Statement effective (the &#8220;Effective Date&#8221;), and no opinion is expressed with respect to such laws as subsequently amended, or any other laws, or any effect that such amended or other laws may have on the opinions expressed herein.&#160;The foregoing opinions are limited to matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated herein.&#160;The foregoing opinions are given as of the Effective Date, and we undertake no obligation to advise you of any changes in applicable laws after the Effective Date or of any facts that might change the opinions expressed herein that we may become aware of after the Effective Date.&#160;Our opinions are also subject to the following exceptions, limitations and qualifications: (i) the effect of applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer or similar laws relating to or affecting creditors&#8217; rights and remedies; and (ii) the effect of general principles of equity, whether raised in an action at law or in equity (including the possible unavailability of specific performance or injunctive relief), concepts of materiality, reasonableness, good faith and fair dealing, and the discretion of the court before which any proceeding therefor may be brought.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The foregoing opinions assume that, at or prior to the time of delivery of any such Security: (i) the Registration Statement shall have been declared effective and such effectiveness shall not have been terminated or rescinded; (ii) any necessary Prospectus Supplement with respect to such Security shall have been timely filed with the Commission and any required exhibits shall have been timely filed with the Commission in an amendment to the Registration Statement; (iii) the Indenture (and any Supplemental Indenture) has been duly authorized, executed and delivered by the Trustee and is a valid and binding obligation of the Trustee; (iv) the Indenture has become duly qualified under the Trust Indenture Act of 1939, as amended; (v) none of the terms of any Security to be established subsequent to the date hereof, nor the issuance and delivery of such Security, nor the compliance by the Company with the terms of such Security will violate any applicable law or will result in a violation of any provision of any instrument or agreement then binding upon the Company or any restriction imposed by any court or governmental body having jurisdiction over the Company; and (vi) a sufficient number of shares of Common Stock or Preferred Stock, as the case may be, will be authorized and available for issuance and the consideration thereof will not be less than the par value of the shares of Common Stock or Preferred Stock, as the case may be.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Bovie Medical Corporation</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">May 3, 2018</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Page </font><font style="font-family:inherit;font-size:12pt;">5</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Our opinion is intended solely for the benefit of the Company, and may not be relied upon for any other purpose or by any other person or entity without our prior written consent, except that we consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to us under the heading &#8220;Legal Matters&#8221; in the Prospectus and each related Prospectus Supplement.&#160;In giving this consent, we do not admit that we are experts within the meaning of Section 11 of the Securities Act, or within the category of persons whose consent is required under Section 7 of said Act.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:336px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Very truly yours,</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:336px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"></font><font style="font-family:inherit;font-size:12pt;font-style:italic;text-decoration:underline;">/s/ Ruskin Moscou Faltischek, P.C.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:336px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">RUSKIN MOSCOU FALTISCHEK, P.C. </font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>bovies3consentexecuted.htm
<DESCRIPTION>BVX_2018.05_EXHIBIT 23.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>bovies3consentexecuted</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:791;"><!-- bovies3consentexecuted001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="bovies3consentexecuted001.jpg" title="slide1" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white">    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM   To the Board of Directors and Stockholders of Bovie Medical Corporation Clearwater, Florida  We hereby consent to the reference to our firm under the caption &quot;Experts&quot; in this Registration Statement on Form S-3 and to the incorporation by reference on this Registration Statement on Form S-3 of our report dated March 13, 2018 on the consolidated financial statements as of December 31, 2017 and 2016 and for each of the three years in the period December 31, 2017, of Bovie Medical Corporation in its Annual Report for the year ended December 31, 2017, as filed on Form 10-K with the Securities and Exchange Commission.  Frazier &amp; Deeter, LLC Tampa, Florida May 4, 2018 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>a2017bvxlogoa01.jpg
<DESCRIPTION>BVX LOGO
<TEXT>
begin 644 a2017bvxlogoa01.jpg
M_]C_X1"J17AI9@  34T *@    @ # $   ,    ! LP   $!  ,    ! -(
M  $"  ,    $    G@$&  ,    !  4   $2  ,    !  $   $5  ,    !
M  0   $:  4    !    I@$;  4    !    K@$H  ,    !  (   $Q  (
M   D    M@$R  (    4    VH=I  0    !    \    2@ "  (  @ "  M
MQL   "<0 "W&P   )Q!!9&]B92!0:&]T;W-H;W @0T,@,C Q-2 H36%C:6YT
M;W-H*0 R,#$U.C Y.C(Y(#$R.C,P.C,Q      20   '    !# R,C&@ 0 #
M     ?__  "@ @ $     0   LR@ P $     0   -(         !@$#  ,
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MQ?\ P]7_ .>LE<]]0_KGT?ZN],R<7/%SK;L@VM])FX;?3JKU=O;[MU;UT/\
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M#P   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
M  !);G1E96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET
M8F]O;      +<')I;G1E<DYA;65415A4    %@!% %  4P!/ $X ( !3 '0
M>0!L '4 <P @ %  <@!O "  ,P X #  ,       #W!R:6YT4')O;V93971U
M<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T
M=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--
M64L .$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO
M;G,    7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
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M;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M   08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N
M9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H
M=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0
M 2P    !  $!+     $  3A"24T$)@      #@             _@   .$))
M300-       $    'CA"24T$&0      !    !XX0DE- _,       D
M      $ .$))32<0       *  $          3A"24T#]0      2  O9F8
M 0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M     0 U     0 M    !@       3A"24T#^       <   ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H   X0DE-! @      !     !   "0    D      .$))300>
M       $     #A"24T$&@     #:0    8              -(   +,
M&@!" $\ 5@!) $4 7P!# &\ ; !O '( 7P!( &D 9P!H %( 90!S &\ ; !U
M '0 :0!O &X    !                          $              LP
M  #2                      $                         $     $
M      !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $
M     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<
M  #2     %)G:'1L;VYG   "S     9S;&EC97-6;$QS     4]B:F,    !
M       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$
M;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T
M;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG    T@    !29VAT;&]N
M9P   LP    #=7)L5$585     $       !N=6QL5$585     $       !-
M<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q497AT
M27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG
M;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L
M:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O
M;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET
M;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T
M=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-
M!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M!     $X0DE-! P     #S@    !    H    "\   '@  !8(   #QP &  !
M_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)
M"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,
M# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( "\ H ,!(@ "
M$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!
M  $% 0$! 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@% PPS
M 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S
M-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U
M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!  (1
M R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,'
M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6
MIK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ +0_QQO/'2&G_P!"O_?5
M/_X\5G_E./\ V*_]]59_QH]+Z9A= QK,/$HQK'9C&N?36QCBWTL@[2ZMK?;[
M4+_%=T?I/4.C9EF?@X^78S++6OOJ98X-]*AVQKK6N]FXJU6+@X^#K56P7DX^
M#B&U[,!_CB=.O1Q'>,F3_P"VS5U/U:^NO1_K$33CE^/F,;N=BW !Q C<^IS2
MYEU>[_KG^DK8CY7U-^JN52:K.E8K ?SJ:VU/']6W'%=C?\Y>.Y3<CZL?69XH
M>76]+RIJ?,%S =S19MV_S^._T[OZ[TV,,60$1!C(>*3*<"#(B42:VI]TSLVC
M Q;,O();54 7$"3J=C6@?RGNVKG'?6WJ6:XLZ1T]U@!CU'@OY_?;5MKJ_P"W
MUT]E5=K#7:QME;M',< 0?BURDUK6-#6@-:- !H %'"<(CU0XY=+/I_Q49L>:
M<@(9?:A6O#&\DC_?E\KS Q/KMF ^MDUX;"?H M! _DFAECO_  9&K^JV<_\
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M &\ <    !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# $,
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MJ+7]EL'9-)Y-/D^VVK@J?R:-6C7XJ!->G4;7^ES[1/N^[24\3<[AJ<*R.?\
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M7N_7BF[A7 ^' JIS7WM+U/S-^2]65:7M"L0J"!]MMS9M&"#_ *I:/;L"N?\
M$@GVM3V^Y/2M-F7\Y)3_ (9#T"[W^\/^^1?LCS^]5PI44'AV&TPC\Q%8(&/S
M()\N'7O:>F^4_P AIUE5^V=VJ)0P8PU4%,RZKW\34U/$T)YXT%;?BWM4O)?*
MJD$;'!CU!/\ A.?SZ"=S]]S[V-TDT<OOMOP$E:Z)4C(KQTF.-2GRT%:>5.O>
MVO\ V9#OO_G[_8'_ *$N2_Z_>W_ZI<L?]&&U_P"<:_YNB7_@OOO1_P#A?>:_
M^YC<?]!]>]M7^G?O#_G\O:W_ *,/=W_UX]O?U:Y<_P"F?LO^<$7_ $#T1_\
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M_8Q[]_PRQ_+!_P"\3=J?^AGVK_\ 9Y[]_P &;]YK_P *M=_]D]C_ -LO7O\
M6-]J?^F/A_YRW'_6WKW_  XG\S_^?Z9S_P!![9'_ -C'OW_#+'\L'_O$W:G_
M *&?:O\ ]GGOW_!F_>:_\*M=_P#9/8_]LO7O]8WVI_Z8^'_G+<?];>O?\.)_
M,_\ Y_IG/_0>V1_]C'OW_#+'\L'_ +Q-VI_Z&?:O_P!GGOW_  9OWFO_  JU
MW_V3V/\ VR]>_P!8WVI_Z8^'_G+<?];>O?\ #B?S/_Y_IG/_ $'MD?\ V,>_
M?\,L?RP?^\3=J?\ H9]J_P#V>>_?\&;]YK_PJUW_ -D]C_VR]>_UC?:G_ICX
M?^<MQ_UMZ]_PXG\S_P#G^F<_]![9'_V,>_?\,L?RP?\ O$W:G_H9]J__ &>>
M_?\ !F_>:_\ "K7?_9/8_P#;+U[_ %C?:G_ICX?^<MQ_UMZ]_P .)_,__G^F
M<_\ 0>V1_P#8Q[]_PRQ_+!_[Q-VI_P"AGVK_ /9Y[]_P9OWFO_"K7?\ V3V/
M_;+U[_6-]J?^F/A_YRW'_6WKW_#B?S/_ .?Z9S_T'MD?_8Q[]_PRQ_+!_P"\
M3=J?^AGVK_\ 9Y[]_P &;]YK_P *M=_]D]C_ -LO7O\ 6-]J?^F/A_YRW'_6
MWKW_  XG\S_^?Z9S_P!![9'_ -C'OW_#+'\L'_O$W:G_ *&?:O\ ]GGOW_!F
M_>:_\*M=_P#9/8_]LO7O]8WVI_Z8^'_G+<?];>O?\.)_,_\ Y_IG/_0>V1_]
MC'O#4?R4OY7]33STTGQ/VRD=1#) [4^^NVZ6=4E0QL8:JF[ BJ::4*WIDC=9
M$/*D$ ^[Q_?0^\W%(DB^ZMR64@BMM8,,9RK6I!'J""#P((ZJWL7[4.K*>3XJ
M$4Q+< _D1-4'YC(XCK)%_,7^:$,L<R=Y9AFBD211+MG8<\19&# 20S;5>&:,
MD<JZLK#@@@V]I2;^1#_*MD0HGQAFIV)!\L/=OR%9P ;D 5':\\=F_-U]FJ??
MH^](K5;W,5AZ';=II_*Q!_GTC;[OOM&10<J$?9=7G^6X/3['_,W^;:.&;N:*
M8"_HDZXZI"&_Y)AV/$]Q_K^P2W[_ ,)S?Y=6[B[;;I>[.K&,)C2/9/9JY2G6
M3[DU G9>R=O[^G=Q%^Q;RA3$+V\G[GL:[%_>(_>&VD*-QDV3=!6I-Q9E"1II
M3_$YK4#/=7375_1[>B+</NS^VEY4VJW]IC_0I]0XUK^LDI^7'A\\]"/MG^;=
M\LL&$7+OUOO,*X9WW!LZ2BF=?"(BFK:67VS$H+_N7T7UFWZ/1[KJ[J_X2^YN
MFH*ZO^/'R>QV7R"2U<F/VOW%M"?!P24UE:CII]Z[-J,V?NTTE7D&"6.4L"%B
M"G5D/R9_><6,L\,'N#[920VY"AIMOG$I!_$PM[@1=OF!]22*$5:N(SWS[J-P
MD;R<M<UH\M31+F,H*>0\6,OGU/A4/H*9-KUW_.@Q4]5!2]K],UN.I&2G2?,[
M!ST65E2;414S+M_/Q8O_ "<@AE3^(LZ:2"7)N*%_E!_+=^9OP^^ZKN[>D]Q8
MO:<$T<,?8>VWI=Y=?U(ECJ)8G;<^W)J^EQ;21TLA\->*.I0+=XU#+JSM]L?O
M&>SGN[X4/)7.EO+NK DVDVJWNEH0#^C,$9\L!JBUH:X8T-,>^:_;'GCDO4^_
M;%*EF#_;)22$UJ?C0L%X'#Z2/,"O5GG3'RY^/??OBINM^Q\17YN2-Y'VMEEG
MP&Z(A')#$_\ N%R\5)4U:"2H0!Z?S1-J]+DAK$9]S=T NC)^_>_=>Z][][]U
M[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>S ]4_&+N/N%(*W:^V'HMOSDZ=U
M;CD?#;?=0Q4R4M1)#+696-9%*L:*"ITL"&M8^POO?..P;"6CO+P-=#_0X^]_
MS& O^W9>LJ?8[[F'W@_O 1VNY<E<EM;<JRUIN>X,;2Q(!(+1NR-+<J&!5C:0
M7&E@0U"#U[W8!L+^6_L['K!5=C;VS&XZH>N7%;;@AP.*#6(,$M=5#(Y.NB_.
MN,43W_%AS%VY^[5_+J3:=NCBC\FD.MOM &E0?D=0ZZJ>UW]T'[?;4EM>^[ON
M/N&[WHRUMMZ)96P/\#32">XF7SUH+1J^5 :^]G,V/T%TWUSXGVCUWMO'5<%O
M%E:BB&7S:E1:ZYO,M7Y6/5]2%F"D_CV -RYGW_=M0OMUF>,\5!TI_O"47^77
M0_VU^ZU]WOVB\"3D'VFV>TW".FFYDA^JO 1YB\NS/<K7B0LH4G-.%/>Q?]D'
M4^=>]^]^Z]U[W[W[KW7O?%W6)7DD=4C16=W=@JHJ@EF9B0%50+DGZ>]@%B !
M4GJLDB1(\LKA8E!))-  ,DDG  &23@"N:=>]@UNOY$]';+\HW#VAM&GFI[^:
MBH,FF>R414D%7Q>!7)Y%7!'T\6H_T]B"RY4YDW'3]+LTY4\"5T+_ +T^E?Y]
M8\<\?>V^[5[<BX7FSWIV&*YBKKA@N!>W"TP0;:R%S< X^'P]1]#U[V6[=/\
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M:+):50'[V3(_Q"/R%26=_P"'5]/RUFTV'T ]XU>YT<B<UW#/\+PQE?LTZ?\
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M_P">>P?_ )Z:#_ZG]^_OYOG_ )[/=?\ Z$67_P#JSW[]Q;)_T9K3_G#'_P!
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M'I ;IZ#Z/WNTTF[^G^LMR5%28C/69C9&VZVOD,*TZ1WR$V-:M&F.EC3B071
MI]/'NVCXP_\ "B#YL=/Y7&T'=TFV_DGL.-**CKJ7<N,QNT-_TM'3SSM-4X;>
MVUL=24]3DIZ><)(V6Q^3\H@CLT;F623%'W-_N^/9;F^UN;CDI;CEO?B696A=
MY[5F(%!);3NQ5 14""6&FIL, JK,/*GWDN>MDEBBWTQ;IMXH") (Y@ 34K*@
M%6(-*R(]:#@:DD6[F_E0?'+L"CK:OKN/+=0;HD-544TV$K*K-[6FJ988UBAK
M]MYFJG:"BBGCU!:"IH]/D;AET*FXO\-_FWT)\Y^L3V9T;N;[],95+C-X[.RP
M@H=Z;%R\CU2TM)N7"K/-+2TV7BHY)\?5J6IZV!6*-Y(YHXN/_O%[*\^>Q_,P
MY:YWVW094UV]Q'5K>YC&G4T,E "T98++&:/&Q%1I9&;-?DGGOE[G[:OWIL%U
MJT'3)&U!+$V:!U\@U"4;@PX9# :_GR$^.'9_QHWH-G=DXC[?[V UNWMPT/DJ
M-O;FH%6$S3XC(&-$DJ*!ZA(ZNG-I::4C4"CQNYN?<2]#+H!O?O?NO=>]^]^Z
M]U[W\[3^=G\/:'XC?-?<\6TL5!B^K^Z<;_I:V#34,5#38[$?Q?)5U'NK:='0
M8[%XNCQE/MO<%+(M/3J)V&/GI9))FDD=4^A;[EON]/[M>RVV/NUTTO,^S2?0
M73,6+R>&BM!.SN[LYFB8%V[1XJR*J!54GFK[Z\EQ\F\]W:V<03:KY/J(0* +
MJ8B2, *H4(X.D9["I+$D@;9G\N;OVI[X^.>%ESM;+6[SZ]K/[B[IGJ7J9JJO
M;'4=+48;-SU575U<U9+E\5.C2R'QK]U',BQJB*6J#]Y;]0ST?3W[W[KW7O?O
M?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W
M[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>
M]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW
M7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z
M]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?
MNO=>]^]^Z]U[V?/X-?(#&=7;KR.Q-WUT>/V?OFHI9:7*5,GCHL#NB!/MZ>HK
M'9UBIL?F:8K!/,01%)% S%8A(PC/W(Y7FWFQAW.PC+W]L""HXO&<D#S+(>X#
MS!:E6H.NH']VA]ZG9O9/GG=O;'G_ ')+7V_YFEC:.YE;3#8[BB^'')*20L<%
MW'I@FF((CDCM6=DA661?>[N%964,I#*P#*RD%64BX((X((]XZ_(\>OI&5E=5
M=&#(P!!!J"#P(/IU[WW[UU;KWM);YWSMCKC;&4WAO#*08G!XF RSSRD&6>4@
M^"AH8+^2LR%9)Z(84NTC&P_)"_;=MO-VO(;"PA+W+F@ X >9)\E'$D\.@)[E
M^Y?)?M#R7O?/_/\ O<=ARU81EG=CW.WX(84^*6>5NR*)*L[$ "E2/>]<SN#L
MK)=N=C;HW]DT:G;.5P-!0M)Y%QF'HXHZ+$X]2/06IJ"",2,H DF+R6NQ]Y8;
M#M$.Q;39[7":B->YN&IR:LWYDFGH*#RZ^1;[P'O%O'OW[O<Z>Z>\QF)]RN?T
M(2=0M[6)5AM8!Y5C@1!(R@"24R24JYZ][#/V<=0WU[W[W[KW7O?O?NO=>]^]
M^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?
MO?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[
MW[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]__]7Y_P#[]U[K?X]^]^Z]
MU[V>3^69_P!O"?AE_P"+'=5?^]9CO<(?>5_\1^]Y/_%=OO\ JP_0^]K/^GD<
MC_\ 2SM_^K@Z+7\Q_P#LE/Y"_P#B(][_ /NCJ_?TX_?S0]=4NM-/W[W[KW7O
M?O?NO=>]_.8_GB_]O3/E7_VLNJ/_ 'Q/5_OZ(_N2?^(O>UG_ #3OO^[G>]<S
MO?K_ *>US=_I[?\ [18.MMW^6W_V11T?_P!06]O_ 'Y>\_=3_O*KJ(.CQ^_>
M_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWL]O\NGYK[N^"7R:V9V_AIZNJ
MV76U='M?MS:\4U8:?<W7&2R-)_'D6AIZJFIZK/86G0UN*:8.D-="EU*LX,&_
M>&]E]H]\O;3>>4+Q%7>41IK"<A:PWB(WA'402L4A_3G"D%HV.:@=#_VTYZO/
M;_FJQWJ!B;%B$N(ZFDD+$:\ @%E'='4$!P.BS_++XZX'Y,]-[AV!D8X(-P0P
M3YG8V9>*G:;#;NHZ6;^%R?<30RRP8ZOE/V]:(RC24TC"X(!'TPMN[@PN[=OX
M/=6VLG29K;FYL/C-P8#,T$HGH,MA<S109'%9.BG7TS4E?0U,<L;CAD<'W\V&
MX[?>[3N%]M6Y6SP[C;3/%+&PHT<D;%'1AY,K J1Y$==2K:Y@O+:WO+64/;2H
MKHPX,K ,K#Y$$$=:=&7Q.2P.6R>#S%'/CLOA<C6XG*X^I7144.2QU3+1UU'4
M)<Z)Z:JA9''X93[>/:/I_IN]^]^Z]U[WKJ_\*4>DUWQ\,MB=R45'439;H[MG
M%#(U44L:T])LKLJCEVOE'JX9*JG\I?>$& CB=$GEC,C (J/*Z]#?[M_G0[)[
MQ[[R=-*HM=[VE] (-6N+-A,FDA33_%S=%@2H- :EE53C3]Z'8OK^2-OWN-"9
MK"\6I\A%./#:HJ/]$$0!R14XH21;5_)][%.W/D'NCKZHFA2A[(V+6/21.'\T
MNX=GU"9BC2G=8I H_@,^3:16:-6"*2Q9%4Z,7ON!U@+ULK>_>_=>Z][][]U[
MKWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=
M>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWO
MW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][]
M[]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>
M_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[K
MWOWOW7NO>_>_=>Z][,]U3\N^Z>I*&GPN*S=)N3;=(BQ4FW]WT\^6HZ")0$6'
M'5D%70YBAIXT%HX$J?MT^HC^MP=O?(O+V^R-<3V[0W;<7B(4GYL"&1CZDKJ/
MKPZS1]C/O\?>,]A]MM>7=BYD@W?E"!0L5CNL;W4,*@4"6\J2PW<**!1(4N!;
MIQ$7&OO8]UW\R3L^6C$6.V)L:BKC&%:KJ7SM= '*@-)%1IDJ)DLURH:5P.+Z
MK&X8C]H]F635+N=RT5> T _F=)_P#_-E%N?]\%[T3[>(=I]L>6;;<RM#+(;V
M9 : %EB%Q"1FI4-*X& VH U][)OV=W+V1W!DHLEO_<U7F?M#)_#L<J0T.&Q:
MR?J&/Q-%'!10RLH"O,4:>55'DD:P]C_9^7]HV&%HMKLUC+?$V2[?Z9C4GY"N
MD>0'7/7WG^\-[O\ O_O$&\>Z?.5QN/@5\"W 2&TM@W'P+6%4A1B**\I5II%5
M1+*^D'KWL+O9SU"W7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[
MKW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]
M^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?
MO?NO=>]^]^Z]U[W[W[KW7O?_UOG_ /OW7NM_CW[W[KW7O9Y/Y9G_ &\)^&7_
M (L=U5_[UF.]PA]Y7_Q'[WD_\5V^_P"K#]#[VL_Z>1R/_P!+.W_ZN#HM?S'_
M .R4_D+_ .(CWO\ ^Z.K]_3C]_-#UU2ZTT_?O?NO=>]^]^Z]U[W\YC^>+_V]
M,^5?_:RZH_\ ?$]7>_HB^Y)_XB][6?\ -.^_[N=[US.]^O\ I[7-W^GM_P#M
M$@ZVW?Y;?_9%'1__ %!;V_\ ?E[S]U/^\J^H@Z/'[][]U[KWOWOW7NO>_>_=
M>Z][][]U[KWOWOW7NO>_>_=>Z][^BO\ R.^ZY^Z_Y</2E1D\G7Y;<76=3NKJ
M/<55DI:FIJA/M#-SU&WH&K*FFIQ5QQ;'S.)",AE6-;1M(TB/;YY?ON<EQ\E_
M>+YSCMK:.+;]R6"_B5 JK2>,+*=()TDW,<]:Z23W!0K#KI9[";ZV^^V6Q-+*
MSW-J9+=RQ)-8V)3) K^DT=.-!BI(/6IA_,GZZCZZ^7/8D='24E%BMY4^"WWB
MH***&" 1YS'1T^4<4\,LGA=]Q8VM+:@A=CK"A67W;A[Q,ZF3HAWOWOW7NO>Z
MWOYO>S8=]?RUOEWAII:>!:#J]MY))54:UT?FZ]W%@M^PPI"\D0CJ*F3;8BBF
M!O3R.LH#%-)R-^Z-N[[)]Y'VDO$5F,FY_3T5M)I=0RVI)-#4 359?Q %:BM1
M&'O/9+?^UW.4+$ +:^)D5S"Z2C'J=% ?(FOET;_X#9Z3;OS"Z'KXUE<U.\7P
M++#.:=O'N?"Y7;<CLZJY:*)<J7=+6D12AL&O[^:S[^D#KE]UN ^_>_=>Z][]
M[]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>
M_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[K
MWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>
MZ][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW
M7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][
M]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_
M>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KW
MOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z
M][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWO_]?Y
M_P#[]U[K?X]^]^Z]U[V>3^69_P!O"?AE_P"+'=5?^]9CO<(?>5_\1^]Y/_%=
MOO\ JP_0^]K/^GD<C_\ 2SM_^K@Z+7\Q_P#LE/Y"_P#B(][_ /NCJ_?TX_?S
M0]=4NM-/W[W[KW7O?O?NO=>]_.8_GB_]O3/E7_VLNJ/_ 'Q/5WOZ(ON2?^(O
M>UG_ #3OO^[G>]<SO?K_ *>US=_I[?\ [1(.MMW^6W_V11T?_P!06]O_ 'Y>
M\_=3_O*OJ(.CQ^_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>
M]Z;_ (3.???[(3V9]W]W]O\ [-;O[^%_<>;P_8_Z*NDO)]AY?1]I_$ON-7C]
M'G\E_5J]\.O[RCP/]??EKPM'B?U5M==*5U?7;E353.K1HI7.G3Y4ZS]^ZUXG
M^M[NFO5I_>\NFO"GT]KP^6K5P\Z^=>M:'^<;]M_LS^SO!X/+_H/VO][X?'Y/
MN?[[]C:/NM'J\_V?BMK]7BT?V;>]B'WSWZR3ZJ=]^]^Z]U[V0;^:9DL?BOY=
M?S'JLE6TU!3R]#[WQL<]7-'!$^0S./\ X1B:-'D(5JG(Y2NAIX$_5)-*J+RP
M]SU]URWGNOO#^S\=M"SR#?+=R%!)"QMXCM0>2(K.QX!5).!U'7NY+'%[9\[/
M*X53M\BU)IEAI4?:6( 'F2!T:?X0TE36_+;X_P -)!+4RIV3@JMXX4:1UIJ!
MY*ZMG*J"1%2T=-)+(WT6-"QX'OYF/OZ4^N6G6XS[][]U[KWOWOW7NO>_>_=>
MZ][][]U[KWOWOW7NO>_>_=>Z][][]U[KWM7['V!OGLO<6/VAUULW=&^]U9>?
M[7&;<VA@LGN/-U\_AGJ3%2XS$TM75S,E-2RRMI0A8HG<V5&(*=ZW[9.7-ON-
MVY@WBUL=KB74\L\B11J*@59Y"JC) %3DD 9(Z5V.WW^YW,5GMUG+/=N:*D:,
M[$\:!5!)P"?L!/ETQ[AW-MW:6*J\YNK.X?;F&H86J*W*YO(TF+Q]+ C1HTDU
M76RPP1H))56Y879@!R1[MPZ0_D(_S&>Y:3&Y;)];[9Z4P63I(*Z&O[GW9#M[
M)1PSL/\ )ZS9VWZ/=.]\7D4@8.8*W'4I7]#E9 RKB=SM]^[[NW)TMU:VW,EQ
MO-]$Q4IMT!F0D>:W$K0VSK7&J.9_4 J03,>P_=[]S-\6&:3:H[&W<5U7,@1A
M]L2AY5-/)D'I@UZ(IV1_,[^)'7LU=14N]<GV%E**1HFHNO,+-FJ2=PO#4VX:
MZ7%;8JH-8TZX:V3^H!!!-F&Q/^$N.<FI*2?LWY?XK'5S+2/7XO8G4=9FJ2-@
MUZZEI,]N#?& FF5DXBJ'QL>DB[0D>GWC9OO]Y[M\<LB<L>T<TL'=I>ZOEB8_
MPDQ16TP&?B42FO ../4I[=]TZY9%;=N<XTDQ58;<N/F SRI^1T?ET3G=/\ZC
M#0SO'LGH;*9"F!F6.KW3O:DP\[ @?;ROCL3@,Y&MFOKC%4;CZ./K[,YC_P#A
M,-\3XJ95ROR!^0];6:F+3X\];8RF*$^A5I*G966E5E'U)F(;^@]QI<?WFGNB
MTA-I[?; D-.#F[=O]Z$\8_XST*(_NI\J!0)N9MQ9_51"H_84;_#T$%7_ #GN
MXWF+4/476=-3Z5 BJZW=-;,''ZF,\.2H$*L?H/'Q_4^^LC_PF&^*$E/HQ/R"
M^0M%5^13Y\C_ *-\I3^(!M:?:TVR\1)Y&)%F\UA;])OQNW_O-/=!9*W?M[L#
MQ4X(;M#7UU-/(*?+3^?7I?NI\J%:0\S;BKUXL(6'[ B_X?RZ[H_YSW<23:J_
MJ'K2I@T,/'1UVZ:&;7<:6\TV1R": +W7QW/]1^2L[[_X2X[JIJ.MGZR^7^W\
MSD%IJEL?BM]]1Y';5'/6*LC4D%;N#;^^-US4M-(VE))4QDS1@%UC>XC$G;%_
M>>[1++$G,_M'<PP:AJ>UODF8+^(K%+;VX)&2 9E!X%A\704W#[IUZB.VT\YQ
M224-%FMVC%?*KI+*0/(G0:<:'AT,NUOYT^W)YHX][=#9K&4YEB$M7M;>M!G9
MA"2!,\>.RV!VZCR)RR*:I0Q.DLMM1K3[S_D+_P QGI:FK,IC.LMO]VX*AAJ*
MF?(]*;H@W)D5AA,A58=G9ZEVOOC)UDL4898:#&UCDL%%VX]Y)<C_ 'Z_N[<Y
MR0VMSS//LM](0 FXPF%*FG&XC,ULB@FFJ29!@G ZBW?_ +OON;L2R31[0E];
MK7NM9!(:9X1,$E)/HJ-QIT<3K7^9M\2.Q9::CJ=\UW7F4J= 6B[%Q$V#I4D8
M)J67<%')E-L4Z([D:IJV($*3]/=2F]-A[VZWW!D=I=@[0W-L?=&)J&I,GM[=
MF#R6W\S05"QPSF*JQV5IZ6JA8P5$<@NEFCD1A=6!.5^S[YLW,-A;[KL.[6U[
MMDJZDE@D26-E)(JKH64Y!''B".(/4/7UA?;;<26FX6<L%TAHR2*48'T*L ?,
M'[#7SZ/1@=R;?W5C*7-;9SF(W!AZZ!*FCR>&R-)DZ&I@D+JLL-31RS0NA:-A
M<-PRD?4'VDO9KTDZ>O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]FD^-7PM^3OS
M"EWE#\;NJ<GVA)U_'@)=XKCLYM+"_P $3=#9E<"9FW5G\$M0<BVWZS2(#*5\
M!UZ;K>,O<?WD]M/:--G?W%YKBVM;\RBWUQS/XAA\/Q:>#%)31XL==5*ZA2N:
M"KECDGFKG,WJ\L[.]V;?1XFED73KU:*ZV6NK0W"O#/0-]N?(+IWH>/ 2]M[Y
MQNRH]SODH\"V0I<K5?Q%\.M"V2$*XO'U[)]H,E!J+A0?*+7Y]FI_X91_F@_]
MXG;E_P#0\ZB_^V#[B[_@S/NR_P#A5[3_ +)[W_MEZ%O^L?[J_P#3'3_\Y(/^
MMO0+?\.%?#3_ )_MMS_SS[N_^QWW[_AE'^:#_P!XG;E_]#SJ+_[8/OW_  9O
MW9?_  J]I_V3WW_;+U[_ %CO=7_ICI_^<D'_ %MZ]_PX5\-/^?[;<_\ //N[
M_P"QWW[_ (91_F@_]XG;E_\ 0\ZB_P#M@^_?\&;]V7_PJ]I_V3WW_;+U[_6.
M]U?^F.G_ .<D'_6WKW_#A7PT_P"?[;<_\\^[O_L=]^_X91_F@_\ >)VY?_0\
MZB_^V#[]_P &9]V7_P *O:?]D][_ -LO7O\ 6/\ =7_ICI_^<D'_ %MZ]_PX
M5\-/^?[;<_\ //N[_P"QWW[_ (91_F@_]XG;E_\ 0\ZB_P#M@^_?\&9]V7_P
MJ]I_V3WO_;+U[_6/]U?^F.G_ .<D'_6WKW_#A7PT_P"?[;<_\\^[O_L=]^_X
M91_F@_\ >)VY?_0\ZB_^V#[]_P &9]V7_P *O:?]D][_ -LO7O\ 6/\ =7_I
MCI_^<D'_ %MZ]_PX5\-/^?[;<_\ //N[_P"QWW[_ (91_FA?]XG;E_\ 0\ZB
M_P#M@^_?\&;]V7_PJ]I_V3WW_;+U[_6.]U?^F.G_ .<D'_6WKW_#A7PT_P"?
M[;<_\\^[O_L=]U<5%/+2U$]+4)XYZ::6GF34K:)87:.1-2%D;2ZD7!(/X]Y-
MQR)+&DL9JC $'U!%1QZBIE*,R,.X&A_+HY,4J3Q1S1-JBFC26-K%=22*'1K,
M PNI^A /O#[OU7K)[][]U[KWLR?QN^(7R.^7F:W+M[XY]89/LW,;/Q='FMRT
M>.S&V,-_"L;7U;T-%4S5&Z,W@Z67[BJ1D5(W>3TDZ;"_N.O<7W9]N_::RV[<
M?</F:+;+.[E:.%G29];JNIE ACD(HN22 . K7H3<L\G<R\XW%U:\M;2]W/"@
M9PK(NE2: G6RC)QC/03=L]Y]4=&8S%9CMC>>/V9C<Y7RXS%55?2Y2J6MKH*<
MU4M/&F+H:Z5&2 :B655M^;^S=?\ #*/\T'_O$[<O_H>=1?\ VP?<3?\ !F_=
ME_\ "KVG_9/??]LO0Q_UCO=7_ICI_P#G)!_UMZ O_APKX:?\_P!MN?\ GGW=
M_P#8[[]_PRC_ #0?^\3MR_\ H>=1?_;!]^_X,S[LO_A5[3_LGO?^V7KW^L?[
MJ_\ 3'3_ /.2#_K;U[_APKX:?\_VVY_YY]W?_8[[]_PRC_-!_P"\3MR_^AYU
M%_\ ;!]^_P"#,^[+_P"%7M/^R>]_[9>O?ZQ_NK_TQT__ #D@_P"MO7O^'"OA
MI_S_ &VY_P">?=W_ -COOW_#*/\ -!_[Q.W+_P"AYU%_]L'W[_@S?NR_^%7M
M/^R>^_[9>O?ZQWNK_P!,=/\ \Y(/^MO7O^'"OAI_S_;;G_GGW=_]COOW_#*/
M\T'_ +Q.W+_Z'G47_P!L'W[_ (,W[LO_ (5>T_[)[[_MEZ]_K'>ZO_3'3_\
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M'3_\Y(/^MO1=_P#APKX:?\_VVY_YY]W?_8[[]_PRC_-!_P"\3MR_^AYU%_\
M;!]^_P"#,^[+_P"%7M/^R>]_[9>O?ZQ_NK_TQT__ #D@_P"MO7O^'"OAI_S_
M &VY_P">?=W_ -COOW_#*/\ -!_[Q.W+_P"AYU%_]L'W[_@S/NR_^%7M/^R>
M]_[9>O?ZQ_NK_P!,=/\ \Y(/^MO7O^'"OAI_S_;;G_GGW=_]COOW_#*/\T'_
M +Q.W+_Z'G47_P!L'W[_ (,W[LO_ (5>T_[)[[_MEZ]_K'>ZO_3'3_\ .2#_
M *V]>_X<*^&G_/\ ;;G_ )Y]W?\ V.^_?\,H_P T'_O$[<O_ *'G47_VP??O
M^#-^[+_X5>T_[)[[_MEZ]_K'>ZO_ $QT_P#SD@_ZV]>_X<*^&G_/]MN?^>?=
MW_V.^P9[Z_EK?-_XP]>U7:O>O0F;Z_Z_HLIB\+5;DK-S[!S%/!D\S,U/C*:2
MDVWNS,Y%?NIT*A_#XPU@6%Q[&/(GWC?97W,W^/E?D;GRWW#?WB>00K%<H2D8
M!=@98(U[00::JTX ]$?,'MESURKMS;MS!R[+;;<'5"[/$P#-72*(['-/3H0>
MLOEK\=>Y-T)LOK/M'#[LW/)0U>33$46/S]-.U#0"-JNH$N2Q%%3:8!(MQKU&
M_ /LC'N;>@)T8SW[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[
MW[W[KW7O?O?NO=>]G)^//\OKYE?*AH9>D/C]O_=6%F:LC7=];CH]J;%6:@EC
MIZFE;>^[)L)M;[Q*B41^$59E)5SITQ2E(?\ <'W]]GO:Y7'.W/UA:7@"GP%?
MQKDA@2&%M ))BM!75HID9JR@C7EOVZYUYN(.P\NW,T))'B%=$0(P099"L=?*
MFJO'T- ![6^470'2:2?Z2>T=K8&N2**88.*M_B^Y98)@S1SP;<PZU^:GA*(3
MK6 CZ?EU!N+ZH_X3*_*O<\5#6=N=U].]4TU32":IQ^"I]Q]F[DQU4ZJZT=31
M04^T-N3>,-IDD@R\JB0,$UKI=L0>:O[ROVJVMYX>4^3MXW616HKR&&SA<?Q!
MF,TPKQ :W!I2M#4":=G^ZSSC=K')O&]V-FI&577.ZGT( 1#\Z2'\^)(%OC^<
M;T3@Y:NFV-L'L#?4T,H6GK:L8K:.&K8P2K2QU%9/E,U#>UU$F/4E2+V-U!X=
MF?\ "7GI6B3_ (R%\J.T=R2&=WMLW8NT]DHE.:8+'3ZLYD.P#+/'6W<S617B
MLGB5OW/<([O_ 'G7.$Q(V'VLVVW%/^)%U/<9KDTCCM: KC34D'.HCMZ'UE]T
M_94_Y*'-]U)G_0X8X_+AW-+Y^=,C%!QZ+;G?YTV^Y]0VUT9M+%^@!7SF[LQG
M;N);M(8Z#%;=TH\' 342K^K4P]/L0O\ H&*^'W_/]_DI_P"?#J__ .UQ[(/^
M3F7NS_TP7+O[+S_MJZ,?^!4Y/_Z:/<O^J'_6KI+_ /#S?=__ #ZGJK_DK=W_
M -?_ &#>]_\ A+EL*K9Y.M_EWN_ H(6$=)O?JG#;L9ZCS.Z%\C@=X[+$4)I]
M*$"E=M=Y+V/C]C#9?[SW>XM*\Q>T=K-G+6U])#04S1);>>IK4CO IV_TNB6^
M^Z=8MJ.V<Z2IC EMU?/S9)8Z"F/A/K\NE]M[^=3GHVB3=?06'K4\B^6HV]OR
MLQC)%H56,5'DMM9<22"2["\Z@K9>#Z_=>7<__"<+YU]>Q5.0ZTS'4W>N.CJ7
M2&BVWN:?9NZVH0NI:VIQ&^Z3#X-)%"MK@I\M5R\J(Q*20N07)W]XK[%\P.EO
MS':[ML=P5%6GA%Q#J_A$EJTDE.%&>&->.HJ!F-M\^[+[@[:K2;9+9[A'7A')
MX;T]2LH1?R5V/"E>C7=>_P W#XQ;LD2EW93;XZTJF2(>;/82/-8AZEV"M!%7
M[8J<K5K&I86EGI:>.URQ0"YI0[<Z+[EZ$W+-L_NGJ[?75VY8?5_"M[;:RN F
MJH3)-$E9C9:^FBILKCYWIY!%4TKRT\N@E'8 GWFCRGSMR?SWMJ;OR;S-8[IM
MK?Z);3)* <55PA)1A455PK"HJ!U!>\;#O7+]TUEOFU7%I=#\,J,A(SD:@ P-
M,,*@^1ZL4V/V/L+LS#Q9_K[>6VMY8>;4$R&W,Q0Y:!'33Y(9_M)I'IJB(N-<
M<@5TN+@7]A1[%'13TM??O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W
M[KW7O?O?NO=>]__0^?\ ^_=>ZW^/?O?NO=>]GD_EF?\ ;PGX9?\ BQW57_O6
M8[W"'WE?_$?O>3_Q7;[_ *L/T/O:S_IY'(__ $L[?_JX.BU_,?\ [)3^0O\
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M@_6L)[][]U[KWOWOW7NO>_>_=>Z][][]U[KWNCW_ (4,_P#;M7>__B4.IO\
MWI?>;W]WO_XD=M7_ $JK[_JVO4!?>4_Z=A=?\]EO_P >/5F/\IC_ +*[QO\
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M5 55  %O>%TDDDTDDTTC/*[$LQ))))J22<DDY).2>IU1$C1410J*   *  <
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MC=XW1W*#[EOH&]#O[][]U[KWO;6_X2R_\7+YP_\ 4%\<O^M_>?OD_P#WH?\
MN-[)?\U-W_P;;UF)]TO^UY]_TME_ANNJ*OYV'_ 'XW_]1?;/_6GKCWMX^^27
M69G5"GOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOY)^X/\
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M]P]\_P#/&;K_ /0=R_\ ]1^\I?W[LG_1YM/^<T?_ $%U$?[NW#_E!F_WAO\
M-T=S^\^VO^>AP?\ Y]J#_P"J/?O[A[Y_YXS=?_H.Y?\ ^H_?OW[LG_1YM/\
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M+-,WDJ:AM(9FTK87L/?TB[#L>U\L[)M/+NR6B0;18V\<$,:@!4CB4(B@* ,
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M$!A'">#4&5ZQLW[[UF\2NT?+7+5O!#D![AFE<\:'1&8U4\#0LX\OGU;'UO\
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MK6%/-5U=0UR5CB6."FIX4"QPP1(D,$*+'&BQJJA9>R;I=TG/?O?NO=>]E?\
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M0/M'_P!-9_V:WO\ VS]+W_ALOYN_\^4'_HR.I/\ [//?O^'V_P"55_WE*?\
MT2'R,_\ M1>_?\ S]Z7_ ,)?_P!U+:/^V_KW_! ^T?\ TUG_ &:WO_;/U[_A
MLOYN_P#/E!_Z,CJ3_P"SSW[_ (?;_E5?]Y2G_P!$A\C/_M1>_?\  ,_>E_\
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MT4L%705&WMHQ9+(0U".C)4TT2JP=T]Y.?=!]L3[H^^W*&VW,(;9=ND_>%U4
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M<\8=EAK:*9E055#5!"8Y .>58*ZLH%/V%NC?I#>_>_=>Z][)[\[/B#LGYO\
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M=C[,AIC3X&NRAW?M$B(0T[[:W2SY.D@HT\L[?:XBLDJ,>I9BQ-&;\^S_ 'N
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MO#SWSLDI;;KF]9+7CBT@I#;<>&J)%=A_$S==5?;;E<<G<D<O;"R4NHX TO\
MS6D[Y?V.Q4?(#K3.^67<#=Z_(3L[L:*H:?#Y+<-1CMKGR-(B[4P(7#[?>+6
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M[?\ [/O?O^@:;X _\]U\H?\ T8?77_VH/?O^3D?OW_T8^6/^R2[_ .V_KW_
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M!M*K>G:*')_&OKVHAGL"E4U/O;L^BE(8$CR0FG"LILP4*;692>Z7]W%<I-[
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MG3>7#]0X)ZNA,C!(WW;NB*KQ.**JP/W(H<4E=,0/\U+X6)!*AM$3WW-ZY_\
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M%LUONL_=/VC[QFP<U;K=<\S[5>;9>1Q&-+9+@.DL>M7J9XF4ZE=::2#3!J&
M@;W=]XK[VQW+:+.#8([N"Z@9]32M&59'TE<(P(H5/$$5R.'5DWP@^".W/EUL
M_>NX<CV5EME9#9^Y*/#-CZ#;U!FXJNCR&+CKJ6L9Y\OCYZ>0SQSI8J48(+&X
M8"J?_H*4WC_WACMK_P!'EE/_ +5OO*;_ )-@;'_X6&[_ .Y='_VV=1'_ ,%E
MN7_3%0?]E+?]:>CN_P##*VT?^?\ NX__ $ L9_\ 9-[]_P!!2F\/^\,=M?\
MH\LI_P#:M]^_Y-@;'_X6&[_[ET?_ &V=>_X++<?^F*@_[*6_ZT]>_P"&5MH_
M\_\ =Q_^@%C/_LF]^_Z"E-X?]X8[:_\ 1Y93_P"U;[]_R; V/_PL-W_W+H_^
MVSKW_!9;C_TQ4'_92W_6GKW_  RMM'_G_NX__0"QG_V3>_?]!2F\/^\,=M?^
MCRRG_P!JWW[_ )-@;'_X6&[_ .Y='_VV=>_X++<?^F*@_P"REO\ K3U[_AE;
M:/\ S_W<?_H!8S_[)O?O^@I3>/\ WACMK_T>64_^U;[]_P FP-C_ /"PW?\
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MC_\ 0"QG_P!DWOW_ $%*;P_[PQVU_P"CRRG_ -JWW[_DV!L?_A8;O_N71_\
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MO=CW:Y'Y%6-FM+R]4W!&--K"#-<G51@I\&-U4E2-944-:$%^X?,Z<G<F;_S
M6 GA@(BKYS/V18J*@.RD@$'2#D<>A^^+G4$_>W??6O6:PR38[-[A@JMQE-:B
M+:V%1\SN-FG6*84SS8FAEABD96432("#>Q^7YD*^LRU?6Y3)5,M;D<E5U-?7
MUE0YDGJZVLF>HJJF>0\O-//(S,?RQ]_39!!#:P0VUO&$MXT"JHX*JBB@?(
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MO3/E7_VLNJ/_ 'Q/5_OZ(_N2?^(O>UG_ #3OO^[G>]<SO?K_ *>US=_I[?\
M[18.MMW^6W_V11T?_P!06]O_ 'Y>\_=3_O*KJ(.CQ^_>_=>Z][][]U[KWOWO
MW7NO>_>_=>Z][][]U[KWOWOW7NO>S2?"[XT;C^7OR8ZHZ!VT/%+O;<D"9S(F
M."=,)M'&*V3W7GI:27+X.:MI\/@:6>>2&GJ$J7C1O$&>P]QA[R^Y.W>TGMKS
M5S[N64LK8^$E2#)._9!$&$<@4R2LJJSH4!(U4%3T+.1^5KKG/FG:.7;7C/*-
M9QVQKW2/34I(5 20#JH,"O0*_(?N'#]"].[X[1S)UQ[<Q$K8VE#/$V1SM811
MX3&1SK0Y".":OR4T<2/+$T(=AK(6Y]_4'VSMO";.VWM_:&VL?3XC;FU<'B=M
M[?Q5(@CI<9A,'04^,Q6/IHQPE/14%+'&@_"J/?S';GN5[O&Y;AN^Y7#2[C=3
MR32NWQ/)*Q=W/S9F)/S/75VTM8+&UMK*UC"6L,:HBC@JH J@?(  #K2\S68R
M6XLSEMP9FJDKLOG,G7YC*ULQO+69+)U4M;754I%@9*BJG9V_Q/M\]HNG^FSW
M[W[KW7O>L#_PIW[EIL'T'\>>AJ:>$Y3L/L_,]DY&)6BDGAP76FW)L%3I-$T$
MCP19++]AH\4@DB9C02* Z^33TV_NS>3I+WGOW!Y[EC;Z;;]LCLT.0#+>2B5J
M&HJ4CM"&%& $JDT.FN*7WJ]\6#E[EOEY&'BW-TT[#S"0)H%<8#--@U%=! KF
MET'\F;KV;(]F]K]H3PRBBVKL['[/HI2KK!+D]WY5,I4>-UD59I:*@VK9T*N%
M%4C'22E]+;WV7ZP<ZV(/?O?NO=>]["__  G2^5-'TS\M=P]$[ER,5#M3Y+;?
MH\+BC-]G!!'V;LQLCE=FF>LGD2H8Y3&5^4QL%/&KF:LKH/TA3JY_?WAOM9-S
MG[36'/&VVQ?=N6IVE>FHDV5QI2X 48&AUAF9S33'$XR2*9'?=JYN38N<[C8+
MJ739[I&$6M /'CJT53Q[@7C '%G!\CU59_-EZ/G[&Z'Q_9.&HVJ<]TYDJC+U
M7C6>6=]FYI:>CW+''$A\$:4<U/25\LS_ *(*-U%RPMO8>^&?70+K62]^]^Z]
MU[W[W[KW7O>@M_//_EUUOQ-[_K>\NN<&\7Q][[SE=EZ!<;0+#BNNNQJF/[[<
M>R*AX)&BI:/-5 J,IB08X(_MY)J:,-]FS'O1]R#[PT/NQR##R5S%? ^X&Q0+
M&^MB7N[0'3#<BN6:,:89\L=861M(F4=<[O?SVT?DWF.3?=MMR.6]PD++I';#
M,<O$:< QJ\> -)*BN@];27\MCY9T_?'5=-UYNS*(_:W6..IL?D15U+-7;KVO
M"WV^(W/$)@6J)Z:$1TE>0[L*A5E<()XQ[HA]YR]0!U9=[][]U[KWOWOW7NO>
M_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWO8/_D)_P NVO\ DCWC1_)[
ML;$?\8-Z&W#3U>&@K8JR.+?W;..%+DL%B*6WAI:[!;4,D=?E0S30RM]O221/
M'42F/ +[]OWA8/;?DB;VUY=N_P#D<;[;E7*E:VMB^I)93Q999J&* C2P[YE<
M-& V1GW>_;63FG?TYHW.#_D/[?("H(-)K@49$'D53#R<0>U"M'J*L?YG7RRI
MNF^M)^H=I9 #LSL[%S4U1)33Q>?:NR:KST>3R\@374TN2RNAZ:@8>)T;R3QO
M>#2V]Q[X7]=!.M8WW[W[KW7O?O?NO=>]Z%G_  H8^5]-WM\RJ?IG;&6&1V3\
M8,+5[*G%+/3SX^;L_<,M%E.QIH7AU.U5A_L\?A:E)&O!5XJ= JG67[N_W?GM
M5)R+[.-SAN5IX>]\S3+<BH(<6409+0&OX9 TMPE!W).I).*<]/O(<X+S!SP-
MEM9M5AM2&+!P9VHTQ^U2%B/HT9%.-=H/^51T=+UA\>?[_9BA%+N3N:OAW.&E
MBT5<>SJ".:CVA"SZC>FK89JC(Q6 O'7*3?@"@OWGAUCUU9[[][]U[KWOWOW7
MNO>_>_=>Z][][]U[KWM1[1W7N#8FZ=M[VVGE*O"[GVEG,7N/;^7H9I*>LQN9
MPU;#D,=6T\T+QRQRT]53JP*D'CV7[KM=AOFV;CLVZVR3;;=0O%+&P!5XY%*N
MI!J""I(R.E-G=W%A=VU]:2E+J%U=&!H592""",X('35F\-C=QX;*8#,TD&0Q
M&:Q]7B\E15,<<T%70UT#TU3#+%*K1.DD,K @@CW]2?XL]\8'Y._';IWOS;;4
MO\/[/V+AMQU%+1S-44^*SS0FBW5@%F=8WDDV[N>CK*"0LJMY*9M2@W ^8#W2
MY$OO;+W$YPY#W -X^V7TD2LP +Q5UP2D# \6!HY10D4?!(ZZR<H<PP<U\L[)
MS%;4T7=NKD#@K_#(G^TD#+^76E5WEU?D>E^W>PNKLF)O/LW<M?C*::H"">LQ
M#LM;@<E(([QJV3P=53U%EX'EX]C[[ /0CZ"GW[W[KW7O?SJOYW7QIC^-O\P/
MM9,52"EVAW4(>]MJKYH&M_?VNR+;N@6F@IZ=:&FI.P,?EHJ>.SC[98SK)+*O
MT-_<J]R6]R/8+E5[J;7N^S5VR?!_XBJ@@)8DZF:U:!G..\L* 4)YH^^W*PY7
M]QMX6&/397M+J/A_HQ)D   H!,) !GM _+;6_ES]QMW#\6MBSUU3]SN#8*/U
MMGS^^[^7:\%+%A9IYYWD:IJJW;%113RN"+22,+6 )VEOY OQBDZ"^".!WUG<
M4<=OCY&9^L[1R_W-*(,C#M&'7@>NL?/(P\TE)+@:-\M I.E/XP]@"6+<O_O[
M^YB\^>^5[L-C=>)LG+MNMDE&JAN&I+=N*8J)&6!O,FW&:4IEG]W3E0\O<@0[
ME<0Z;_<Y#.U10B,52$&N::09!_S4ZI3_ )I_<R]G?)>MVIC*W[K;G4>)@VC1
M^*5):63<-8(LKNJJ@,;,H=:N6&BDOSJH?Z6M=_[PDZGOJM7W[W[KW7O>I!_P
MIN^3R"+H[X@X&M4NQD[R[$@1(I/1_N6VEUW0FH2J\E-*A7-5,\#P$R(]+(KJ
M 0_6;^[1]LC_ ,C;W<OX,&FVVA-1_!/=L 5HP/\ BZ*P;!652"<C#?[U'-8)
MV'DRWDR/\:F&#_%'".-01^HQ!&04-?6^3^39TNR1]D=]Y2E(\Q3K?:4L@GB/
MBC-%FMUU<:M$(:JGGE-! DBOZ)()D()/IU%_?6?K#?J]SW[W[KW7O?O?NO=>
M]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>][IG_"7[_LG;Y,
M_P#B:=N_^\-1^^-7]YQ_ROOME_TJ)_\ M(ZSA^ZC_P J]S9_SVQ_]6NM>C^=
M)_S,CI+_ ,,C<O\ [OJ7WL]^^8_65_5*WOWOW7NO>Z/?^%#/_;M7>_\ XE#J
M;_WI?>;W]WO_ .)';5_TJK[_ *MKU 7WE/\ IV%U_P ]EO\ \>/5F/\ *8_[
M*[QO_B/M[?\ 6B@]_/Z]][^N=G6T?[][]U[KWOWOW7NO>_>_=>Z][OD_X3W_
M "FBZ*^;,'5&XLK]ELKY,8)NOM%97Q4F+I^Q<7))FNO*UHY86^XRF4JXZK!T
MD:R1^2;,*MI'\8&"_P!__P!KVYY]E9>:=NM=>\\M3_5]JZG-HX\.[6H.$12E
MRYH:"WKVC4>L@?NX\VKR_P ^)M%S+IL=TC\')HHF'=":4RS$&)<C,GF:=5F?
MS4NE7[.^-]5O/%47W&XNGLB-WJT-,):R;:TT?\/W73^8R*T5#1T4J9&;TL;4
M%^!J)WX_?!KKH?UJY>_>_=>Z][][]U[KWO0Z_GW?R_*[XV?(*K^26P\4_P#H
M4^0V?KLI6"DI<A)3;)[8JTFR>Z,!6U+O545'0[GD$V3Q,>JEC$9J*6GA\=$7
M/=;[B'O]![D<@0^W6^W8_KKR_ J#4RZKFQ6B0S*,,S0C3#.>\ZA'+(X:<#KG
MQ]X3VYDY6YC?F;;H3^X=RD+8!I%<&K2(3D /EXQVBFI%6D9/6SU_+$^55+W+
MU53=3[GR$9[*ZKQM/0@5%1#]UN395/XJ3#9R&-UCJ:JJQJE:.O>\[^41SS.I
MJ47WK^^\]^L=NK1O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW
M7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z
M]U[W_]3Y_P#[]U[K?X]^]^Z]U[V>3^69_P!O"?AE_P"+'=5?^]9CO<(?>5_\
M1^]Y/_%=OO\ JP_0^]K/^GD<C_\ 2SM_^K@Z+7\Q_P#LE/Y"_P#B(][_ /NC
MJ_?TX_?S0]=4NM-/W[W[KW7O?O?NO=>]_.8_GB_]O3/E7_VLNJ/_ 'Q/5WOZ
M(ON2?^(O>UG_ #3OO^[G>]<SO?K_ *>US=_I[?\ [1(.MMW^6W_V11T?_P!0
M6]O_ 'Y>\_=3_O*OJ(.CQ^_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KW
MM1;3VGN??FY\!LK96 RVZMW;JRU#@=N;<P-#49/,YO,Y.HCI:#&8R@I8Y*BJ
MJZJHD5415))/LOW;=MLV+;+_ 'K>K^*UVFUB:6::5@D<<: L[N[$!54 DDGI
M39V=WN-W;6-C;/->S.$1$!9G9C0*H&22> Z:<[G<-M?#93<6XLI0X3 X2AJ<
MGE\ODZF*CQ^-Q]'$T]565E5.R10001(69F(  ][^G\FS^5PGP,ZWRW8G:#09
M/Y']MXG%P[JA@>"HQG6VUZ=VKZ78F&J8E8U>3J*R59LS5B1H9IX((85"4YEJ
M."OWQ/O/M[[<QVG+O+ ,?MSM,KF D$/>3D:6N9 ?A0*"MO'0,JL[N2T@6/HC
M[)>TP]O=LFW/=J-S/>(HD H5@C&1$I\V)S(U:$A0  M6U</Y@WS4?Y.;NH=H
M;+#TG46Q:^LEPTDB/%6;OSDJBEGW+7QN1X*&&!3'00:0R))))(6:15BNQ]X6
M=3MU7)[][]U[KWOWOW7NO>_G4?SL/E=3_*GYV]AU.WZRDKNO>F8(>F-AUM'-
MC*R'*TFUJJLGW/G8LCC)JN"MH\QO3(9"2D;S-:A$.I(Y3*@^AO[EWM7)[6^Q
MG+T6X0O'S!O+'<;I6#J4:=5$,11PI5H[=(ED[1^IKH672>N:7OKS>O-WN!N3
M6SAMML0+:$@J0PC)+N&4D$-*7*Y^'3@&HZVT_P"71T?+TC\9=IP96FGI=U]@
M22=@[IIZB.LII:.IS4,,>'QLM)6I$]/48[;U+21S@(MZCR6+(%8U'^\LNH<Z
M/;[][]U[KWM2;0W9N'86ZMM[WVEE*S![HVCG,5N3;V9Q\\M-6XS,X6MAR.-K
MJ:>!XY8IJ:KIT8%6!N/K[+]VVJPWS:]QV7=;5)]LNX'AEC<!E>.12CJP(((*
MDC(_+I39W=Q87=M?6<K1W<,BNC D%64@@@C@01TU9S"XS<F&RVWLW109'#YO
M'5F*RE!5PQSTU905\#TM5330S+)%)'-#(P(92"#[^F-_+U^9&U?G+\7]A=UX
M2:"#=#4B[8[1V\D:TTNV^R,'!!!N.E6C6HJ_M\5EI&3(X[]V2^/JX@S>59%7
MYK_O!^SNZ>R'N=OW)EXC':M?C64M=0FLY23$=5!5XQ6&7"_JQL0-)4GJ3[:\
M[VG/W*>W[Y"P%X!X=PG I,H ?&:*WQID]K 5J#33J^6?QZS7QJ[IW/U]70RO
MM^2=\UL?*LYFBRNTLC+))C;U)5#+7XL7HZO4J,:B!G"A'0L=WW"70^Z+3[][
M]U[KWL)^\>DNM_D7U7O+IKMG;U+N78V^,148G+4,\<#5%*[J6HLQB9ZB"H6@
MSF&JPE31U(1C#41JUB 019R/SMS'[=<T[/SCRGN#6V]V4H=&!.EA^*.0 C7%
M(M4D2HU*2*@T()N8-@VOF?:+W8]YMA+83H588J#Y,I(-'4Y4TP1P(J.E]UAV
M9O'I_?. [#V'E9<3N3;M;'5TLJM+]M5PAA]UC,E#%+"U7B\C#>*>+4I9&]+*
MP5A\^/\ F5?RL>Y?Y?\ OIZUJ3([^Z"W-7U";%[8QF,F-'3R".2K_NOO6"!J
MI=M;EIJ6-WC69_!70Q/)3R2>*=8N_P#]W#[T/)OOYL8B6:.PY[MHP;FQ=QJ.
M0OC6Y.GQH2Q )4:HV95D5=2:N</N?[2[Y[=;@6=&N.7Y6/A7"J:<*Z) *^&X
M .":, 2I-&IM6_$+YJ]=?*7;4<4%52;9[,Q-)$^YMB5U9']XH\D=,<K@I)%I
M_P",X>6HD13)$@:%Y$65(V=0:K/>4743='5]^]^Z]U[W[W[KW7O?O?NO=>]^
M]^Z]U[W[W[KW7O=M_P#++_E-]Q_/G>E!N',T>7ZZ^-F%JA+O#M6JH@KYYZ=[
MML[KVFJ6C7-[DK=($]18TF*IW$\Y:1Z:GJ<3_O*_>LY.]AMFGL+66+<?<:=:
M6]BK?V8/_$BZ85\*%?PK\<S@H@ 65XIB]K/9_>_<2^CN)4>VY8C/ZEP1\5/]
M#A!IK<^9^&-3J;)56(M\Q?G)U[\7-O3XVEFHMV=M9. C;^QJ:JLU%&_H_CVY
MIXDE_A>'@.H1*1YJR9#'$+)-)#] [I_J'KGH7K7:'474VUL;LWK_ &-B8<-M
M[ 8N()#3P1EI:BKJIFO/D,KDZR62IK*N9GJ*NJEDFE=I'9CP&YOYNYBY\YDW
M?F[FO<Y+S?[Z4R2RN:DDX"J."1HH"1HM%1%5% 4 ==&=DV7;.7=JLMEV>T6'
M;K= J*O\R3YLQJS,<LQ))J>M5KL'L#=W:6\L_O[?69JL]NC<M?)7Y3(U3EBS
ML D--31W*4M!14Z+#3P):.&%%10%4#V)7L-]&O2-]^]^Z]U[V0G^9'\U=O\
MP4^+6^.WZF:CJ-_5]+4;3Z?V[51M4KG>QLO1U"X6:LI([.^ V\4-?D68QQF"
M#P"19IX0T\_=P]E[_P!\O=#9.4T1UY?C83[A*N/#M(V'B*K'A+-_91 58,QD
MTE8WI'?NCSU;^W_*5_O!93N3@QVR'.J9@=)(_@3XW\J +4%AT:;X>?'+*?)G
MNO;FQUAJ8]HT$\.=[ RL.J-:#:M%.CUE)%4ZXQ'E,W;[6E"L9 SM*%9(9+?-
M(W%N#,[LSV:W/N+)5N8SVX,G6YC,93)5E5D*_(9+(5$E55U=975TU3654\TT
MI9I)9'D8FY8FY]_21M]A9[78V>VV%ND5C!&L<:(JJJH@"JJJH"@ #   'H.N
M7-S<37=Q-=7$C/<2,69B22234DDDDU]22?7K<+Q>,H<-CJ'$XRF@H\?C:2GH
MJ.EIH(J>G@IJ>-8H8HH*>.*"%$1;!455']/;+[6=,]3_ '[W[KW7O?O?NO=>
M]^]^Z]U[W[W[KW7O?O?NO=>][H'_  F?^4)W9U%V]\4MQ98U&:ZNS<79NP*2
MJK)9JH["W:]/B]S4%#32W$.,VYNZ&"=O&Q42YRQ5;@OQN_O*/;$;5S5RA[J[
M?:Z;/<X3973*H"_4P:I(&8CB\T!=<YTVV"<@9O\ W6N:S=[1O7*%S-6:U<3P
M@DD^%)19 *\%20*<><O#UUZOYQO3"X;>G7W>6)HO%0;NH)-D;HFBBACA_O%A
MA49+!U,QC"R2UF4PLE1&S/SHQZV)Y VA_?,/K+'JE3W[W[KW7O>N?_PH4^*&
M0[_V?\.]Q[5@E;=W^S&8+H(2QT[/ F+[X:FI*'(9*IAHJR>CI,1N/:M,BR$K
M /OGUAW,2^^B?]WW[J6_(>[>[^V;K(!M/]7I-TR?Q[94NJ@LH9I(IV-,L?#%
M*#4>L9/O)<H2<PV?)5Y9I6]_>2VG#RNJ:230T"O&,\.\UJ:=6[?RG^[Z3K3-
M]_8'.5'CP*]6U_::B24+'%4]<>4Y%(86G@6:HK\7FKD"[D4H TC4?>P7LS:6
M!V!L_:FQ-K4,6+VQLK;6"VEMS&0"T&.P.V\72X;$4,()-HJ3'T4<:C^B^^?V
M];O?\P;QNV_;I,9-SO;F6XF<\7EF=I)&/S9V)_/K)"PLK?;;&RVZT33:6\21
MH/1$4*H_( #JJ3<NX,GNW<>?W5FYS59G<V;RNX,O5$ &IR>9KI\C7SD#@&:J
MJ7;_ &/M2^RWI7TR>XU;64N.HZO(5T\=+14--/65E5,P2&FI:6)YZB>5SPL<
M,*%F/X ]NP037,\-M;QEYY'"JHR69C0 #U)( ZI)(D,<DLKA8E4DD\  *DGY
M =2*2DJ:^KI:&B@DJ:RMJ(:2DIH5+S5%34R+#!!$@Y>265PJC\D^_F!_/GY(
MU'RU^7O>?>YGFFPN[]Z5M-LN.>%()J38.W4BV[LBCFCCFJ4^XBVSBZ8S.&M)
M,SN @(1?IL]B/;F/VH]I>2.11&HO+.R4W!!)#74M9;EA4#!F=Z"F%H*FE3RE
M]P>9WYQYRW_F$L3#/.?#!I41)V1#%<A%6I\S4_+K= ^,G4<'1?1/6W621Q)6
M[=VY3'/20&0Q56Y<D7RFXZQ/,JR(E5F:N9U4CT+87-KDGON7.@9T/'OWOW7N
MO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z][W3/^
M$OW_ &3M\F?_ !-.W?\ WAJ/WQJ_O./^5]]LO^E1/_VD=9P_=1_Y5[FS_GMC
M_P"K76O1_.D_YF1TE_X9&Y?_ '?4OO9[]\Q^LK^J5O?O?NO=>]T>_P#"AG_M
MVKO?_P 2AU-_[TOO-[^[W_\ $CMJ_P"E5??]6UZ@+[RG_3L+K_GLM_\ CQZL
MQ_E,?]E=XW_Q'V]O^M%![^?U[[W]<[.MH_W[W[KW7O?O?NO=>]^]^Z]U[V];
M=W!F=IY["[GV[DJW#Y[;^3HLQA\IC:RJQ]?C\ECZB.JI*NCKJ&:FK*6>&:(,
MLD4B2*1<,#8^T>X6%GNEC>;;?VZ2V,\;1R(ZJRLC@JRLK J00<@@@^AZ>MKB
M:TN(;JWD9+B-@RL"000:@@@@BGJ"#Z=0,IC*',XZNQ.3IH*S'Y*DJ**LI:F"
M*HIYZ:HC:*:*6"HCE@F1T:Q5U93_ $]_3._EX?,3;OSA^*_77=F.J*--V24"
M[8[4P=-''2-M_LO;\45)N6%<<M77-C\7F9=&3QT;32L,=6PAG+A[?-9]X7V?
MW#V2]TN8>3+B)_W1K\>QD)+>+9RDM"==%U/$*PRG2M98W(4*5KU,]M.=K;GW
ME';=\C<?6Z?#N%&-$Z !\9HKXD05-%8"I(/6G+\MOC[E?C9W=NOKVH@G_NZ]
M2V<V-D96:9,EM'*2//BU^[94-368D%J*J8JC-44[/H576YW_ '"/0^Z+1[][
M]U[KWL+NZ.F.M_D'UCN[I[MO;-%N[8.]\8^+SN&K01J4.D])74-2EIJ#*XNM
MBCJ*6IB*R03QJZFX]BCDOG/F3V^YGVGF_E/<GM-^LI-<<B_91D9>#(ZDJZ'#
M*2.BC?MBVOF7:;W9-YM1-MTZZ64_M# ^3*:%2.!'2YZV[(WAU)O7 ]@[#R\V
M$W/MVK%505D7JCD5E:*IHJR D)54%=3NT4T3<.C'Z&Q'SW?YEG\K#N3^7_OM
MZW[7)[_Z!W+6S)L;MC'8N84E/*(7K'VMO2"GDK%VWN2DIXY&B$TGAKX(7EIW
M<QSI%] ?W;_O0\F^_FQ+"LL=ASY;1@W-B[C4173XUN2%\:%B0"5&J-F59%74
MA;G![H>TN^>W6X%VC:XY>E;]*X533A71(*GPW K0$T8 E2:&FUC\0OFMUW\I
M=LI%#4TFV>S<331ON78E96QFL"^5:?\ BV#DE2F.9Q$TTB!GB35 \B+(B%D!
MJK]Y1=1+T=;W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]NF&PV6W%EL
M;@<#C:W,9O,5M/CL7B\=3RU=?D*^KE6&FI*2FA5Y9JB:5PJJHN3[37EY:[?:
MW%]?7"16<2%W=R%5545+,3@ #IR&&6XEC@@C9YG8!5 J23P '42NKJ/%T=3D
M,A4P45#1025-75U,BQ04\$2EI)99&(5451[V>_Y;/_"?/>&_:C#=O?.K&Y'8
MNQ!_"LM@>BH:JHQV_MUPO''D#'V%/3/!6; Q;,8X)\>&&:D4SQN,?(L4S<S?
MO'_?^V;88KSE'V.N8[_?:.DFYE0]K :E:VH-5NI *LLO^XX.A@9UUQ]95^U_
MW<K_ '%X-YY^B:VV[M9;6I6:0<?U:4,*\ 5_M2-0I&=+=4S_ "__ )J6V]J0
M9'8?QJK:/=6ZF2KHLAV28H:S:F D+/3:]M+(LE/NJO1 TL50+XY&,3ZJD"2'
MV0_^=I\ :;X5_)M]R==8"/#_ !_[QAJMT==TM%'308O:>X:5D3>G7='3PK$T
M-)@JF:&LHE$>A,=D((M;R12-[G3[EOOW)[T>V8V_F&_,W/VR$079:I>>(YM[
MMB2:F50R2&HK-%(P5591U'WOK[=)R+S4;C;;?1RY?@R0 4TQN/[6$<,(:,O&
MB.H))!Z,[_+J^4DWR,Z93'[KR?WW:?74D6#WC),6-7FL?*&?;^ZYB9);R9>G
M1X9V] :LI9F5%0J/=,'O,?J$>K!O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]_
M_]73C_X;,_F$_P#>&7R._P#15;L_^MWN$/\ @E?N_?\ A9.7?^RZ#_H/H??Z
MUGN1_P!,/N?_ &3R?YNMV3_9Q_BG_P!Y"]1_^AO@_P#ZK]^_X;,_F$_]X9?(
M[_T56[/_ *W>_?\ !*_=^_\ "R<N_P#9=!_T'U[_ %K/<C_IA]S_ .R>3_-U
M[_9Q_BG_ -Y"]1_^AO@__JOV;[X ? #YO==?-[XH;ZWU\4.^]K;.VMWWUCF-
MR;DS'6.ZJ3$8+$4FZL<U9E<K6-CO%18ZBBO)//(5BAB4NY5%9A$?OY[^>RG,
M7LI[J['L?NKL-UO%UL-['##'>P-)+(T#Z41==6=CA5&6-%4$D C3VZ]NN?-L
MY\Y0W#<.4-QALH=Q@9W:"0*BB1:LQTX XDG %232IZ 3Y3?*;XW[M^-_>.V=
ML]X]7YO<&;ZOWGC\1B,?O/"3U^3KY\)5K3T-#3K5ZZFLJ7]$427>1R%4%B ?
MH2^_G]ZZ/=:IWOWOW7NO>_>_=>Z][TT_YHW\GWYY?)SYW]]]Y=/=6[>W!UQO
MNMV#-MK+UW9G7V!JJR/ ]5;%VMDVEQ.9W#19*C\6:P=3&HEB0NJ!Q=6!/8K[
ML/WO/8GVT]B^0^2.;^:+BWYCL4NA-&MG=RJIEOKF=*21Q,C5CD0G2QH30Y!'
M6$?NQ[+>X/-7N!S#O^R[3')MEPT11C/"A.B"*-NUG##N5AD>5>MA#X6_/OXP
M]-?&7J_K7?\ O7*XK=VV:7<T>8H*;9VZLG!3OD]Z[ES5($K\?B:BCJ->/R4+
M'0[!22IY!]D!_P"& _YGW_/E=J?^CCZJ_P#LL]SW_P 'M]V7_IM+O_N7WW_6
MCJ._^!U]UO\ HQP_]E-O_P!;.C2?\.E?##_GXN<_]%_O?_ZQ^_?\,!_S/O\
MGRNU/_1Q]5?_ &6>_?\ ![?=E_Z;2[_[E]]_UHZ]_P #K[K?]&.'_LIM_P#K
M9U[_ (=*^&'_ #\7.?\ HO\ >_\ ]8_?O^& _P"9]_SY7:G_ *./JK_[+/?O
M^#V^[+_TVEW_ -R^^_ZT=>_X'7W6_P"C'#_V4V__ %LZ]_PZ5\,/^?BYS_T7
M^]__ *Q^_?\ # ?\S[_GRNU/_1Q]5?\ V6>_?\'M]V7_ *;2[_[E]]_UHZ]_
MP.ONM_T8X?\ LIM_^MG7O^'2OAA_S\7.?^B_WO\ _6/V+M!_PF[_ )AE8:85
M&6^.^*$Z(TK5_96Y)!1ETU-'4_POK[),[QMZ6\(E6_T)'/L)W']XQ]WR$2F.
MWY@E*DTT6<0U?-==TG'CW:<<:''1Q']V/W)D*:Y-M2OK.^/MTQ-_*O2(J_YN
MGQ.IUF,,':=>8BP1:39N.1JD*U@T'W^Y*-560<CR&,V^MCQ[-7U%_P )?>T:
MZL@J.^/D[L/;..C^TDJ,5U-M//[UR%:KPDUU)'G-W-L.EQ#PSV6*<T%>)%NS
M1(?3[BOFW^\WY7@A>/D7VSO[FX.H![Z>*V1<]K&.#ZII*C)7Q8J' 8\>A?LW
MW4=VD=6Y@YKMXHQ2JV\;RDXR-4GA!:'@=+5]!T!F_/YT&R*:GDBZRZ9W3F:M
MC.D59OC.8K;=)3@2 4\[8_!#=$U=Y(KEH_N*?0W =OK[V+/AQ_+6^)GP<HWG
MZ7V!]QO:JIWI<EVCO2HAW'V!6TK5&5G6D@RK4M)18.DCAS,U,5Q]-2/44JQI
M4M.8T8<\O>'[R/NO[W2B/G+?M.R*VI+*V!AM5-$&HIJ9I6)C5ZRNX1]31B/4
M1UDMR3[7<G<A(6V/;JWY%&GE(>8BK8#4 448KV*I*T#%J#JI;Y _,/O7Y)SK
M#V%NGP[;AD66EV7MR.3$;6AE6.A4SST0GGJ,G.\N/CF!JIIDBGU/"L6M@3[>
MX'ZD/HKWOWOW7NO>_>_=>Z][IL_G0?S"<3\+/C;E=G;0S=&/D'W;B<EMKK_$
MPU]=397;FVJJV,W7V(\F(D@R.+.*HJF2#%SB>D=\FP>&1C2RJ,Q/N:?=^N_>
M;W'M=XW>R?\ J!LDJ374A13'-,O?!:#Q 4?6P#3KID A&EU E4]0C[X^Y$/(
MW+$MC93K_6._1DA4$ADC/;)-V]RZ02$-5J^5-4(ZL)_EW_%.M^1';U'N+/XZ
MH/5?6]=1Y?<];)2034.8S4/^683:BBN5Z2K%7/$LU;'XYU6D71(@$Z-[^>A4
M5$]5/-554TM34U,LE145%1(\T\\\SF2::::0M)+++(Q9F8DL3<\^_H&CC2)$
MBB0+&H   H !@  8  P .'7-YF9V9W8ER:DG))/$D];6D444$4<,,<<,,,:1
M111(L<444:A(XXXT 5(T4     #WB]WZUUS]^]^Z]U[W[W[KW7O=I?\ *?\
MYA^=_E__ "%AS&46HRW2':,N%VOW-MV&63RPXJGJYUQ&^,-"TJTS[@V7+DII
ME5U/W-%+44P:,S++'C!]ZK[OEA[^^WSV5L4BYUVP23;=,1@N5&NVD(!;PK@(
MJFGP2".2C:-)ECVA]R;GVZYD6XDU/L5T52Y0'\()TRJ.&N(L2*\5++4:J@EW
MS?\ BCBOE-U3/BJ4TU!V+M!*_-=>YJ6$%5R$D,9K-OU\T<;52XC<4=*D4FDL
M(IEBGT.8@A^BKLK>FU>QMH[;WYL?.4&YMG[OPV/W#MO/XR0RT.6P^4IHZJBK
M*=F5)$$L,@U(ZI)&UT=5=2H^>7>]EW7ES=]RV'?+&2VWBSF:*:)Q1DD0T932
MH.1@@E6%"I((/72W;[^SW2RM=QV^X66QG0.CKP96%0?4?,$ @X(!!'6I;N;;
M.>V9N',[4W1BZK";AV_D*G%YC%5JJM115U)(8YH7*,\4BW%TD1FCD0AT9E8$
MJ?V5]*^F+W[W[KW7O:?W5M3;&^=N9G:&]-O8;=>U=Q4$^+SVW-Q8VDS&$S&.
MJ5TST62QE?%/1UE-(/JCHPN ?J![,-JW;=-BW&SWC9=PFM-UMW#Q31.T<D;C
M@R.I#*?F#PQPZ37EE:;C:SV-_;1S6<JZ71U#*P/D5-01T[X'/YS:V9QVX=M9
M?)8'.XFI2LQF8Q%9/C\C05* A9J6LIGCGA?2Q4Z2+J2#<$CWK.?-#_A-UUGO
MNHR.]/AGO:#J7.5,HGDZIW_/E,OUTY8X^&1-N;JIH,INK;<4%)33RK35D.7%
M365'-32PJ%'2KV:_O&^8]DCMMF]Y-D;=;)107UJ$CN_Q$&: E()26*@O&T&A
M%Q%(Y).+'//W8=LOVEON1[\6<Y-?IYBS0^7P2 -(E #16$E6.748ZN1^/'\W
MK=>W8:3;OR&VW+O2@A3Q)OK:D5'0[F^DI5\U@99*/$9)Y9Y1Y)Z62C\4,8"T
MTKDL=<?O3^51\_OCU63P[Y^-'8N9Q<$-15'='6N)E[0VL:2"=H?N)\QL49R+
M%F6-1,L5:*:H$)+/&NB0)T4Y&^])["^X,4;;%[D[=%=,P7P+N064^HBM!'<^
M$7H>W5'J4M@,:J3C+S![2^X?+3L-QY6N6B KXD*^/'2OF\6L+ZT:AIQ S2W'
MK+YK?%_MF&%MJ=P;2IZZ>9:>/";IKTVAGFF**YCCQ.Y/X95U*J[%/)")(F<6
M5C=;D"R6+R6&JY<?E\=78NO@9XYZ+(TE115<+Q2O!*DM-51Q31O'-$Z,"H(9
M2/J#[GBWN;:[B6>UN$E@/!D8,IJ 10@D&H((SP->H]DBEA8QS1LCCB&!!_8:
M'CT9ZDK*2NA6HHJJFK('"E)Z6>.HA8,H=2LL3,C:D8$<_0@^^>*Q&6SM=3XO
M"8O(YG)U<L4%)CL515.0KJJ>>:.F@AIZ2CCFJ)Y9ZB9(T55)9V"CDCWJYNK6
MR@DN;VYCAMU!+.[!%4 $DEF(   )-3@ DXZ]%%+.ZQ01,\A. H))K@4 _P!5
M:==5E;1X^GDJJ^KIJ&EB5GEJ:N>*F@C5$:1V>:9TC14C0L23P 3^/=@O0_\
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M(.G,48U0VYPPU$S,5; C< ]9.\C?=CV?;6AO^=;T7MR*'P(ZK #G#N:/(.&
M$%1Q8&G51'R(_F[;VW7#7;<^/^WI-@XJ=7@;>NXEI:[=TL;>/]S$XN)JG$82
M16C;3+*]8[1R?HB<!O>REMW;FWMH8'$;6VG@L/MC;.W\?2XC [=V_C:/#8/"
MXJAB6GHL;B<5CH:>AQ]!20($CABC2-%   'OFYN.Y;AO%_=[INU]-=;G<2%Y
M9I7:261V-6=W<EG9CDLQ))XGK*.UM;:QMX;.RMTAM(U"HB*%15' *J@  >0
MIU3MF,SE]PY2OSF?RF1S>:RM3+6Y/+Y:MJ<CD\C63-JFJJVNK))JFJJ)6Y9W
M9F)^I]O7M'T_TV^_>_=>Z][1_8&_]F]6;*W-V+V%N'';4V5L[$5>=W'N#*RF
M*BQN-HDURR-I5YJB>5BL<$$2O/43ND42/(ZJ3CE_8-YYIWK;.7>7MODN]ZO)
MEBAB059W;@/(  59F8A44%W*JI(0[EN5CL]A=[GN=RL-A A=W;@H'\R3P %2
MQ(5020.E%M+:>X]];EPNS]HXBKSNY-PU\.-Q&*H4#U%753$V%V*Q000QJTDT
MTC)%!"C22,J*S#YS/\TC^87N3^8-\@)]WT\.2P/3NPER&V^F]GUM3)Y:/;\E
M2C5>Z<S11R?8P[IW?+3)45>A7>"%8:0S31TT;^_HB^[#]W[;?8#D&/:':.?F
M^^T3;A<*!1I:=L,;$:C! "4CK0,VN70K2,.N9WNO[D77N/S&]\ T>RV]4MHR
M>"5R[#AXDE S<2!1*D*.MMWX7_%3"_%;JN#;Q:CR6_=Q_:Y?L'<-/$"*S+K"
M1'BJ"I=14OA,(DC0TZG0CG7-XTDFDO6=[R3ZB[HX/OWOW7NO>_>_=>Z][][]
MU[KWOWOW7NO>_>_=>Z][][]U[KWNP_\ E8?*)_B1\X.DNR\AD_X=L;+[BBZ^
M[-,U944F/_N+ODC Y3*5X@IZH5$>UJFKARR1M'9Y:%5UQ:C*F/WWH?;%?=CV
M3YUY:M[;Q-[CMC=6=%!;ZFV_5C1:D:?&"M 2#A9":-329']I^;#R=SYL.[22
MZ;!I1%/DT\*7L8FE:Z*B0"G%1PX@JWS1Z77O7XX]D[*I:/[O<<&&DW'L\)'
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M_7+L]W$6V78E.Y3?$*O RBU4,.#&Z:)\D52-Z&M 85]_.:_ZL>W>YQ0O2_W
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M_P#5_OW^RW?(G_GPG=/_ **W?/\ ]8O?O]<'D+_IM]H_[++?_K9U[^KG,/\
MT8KW_G!+_P! ]>_TF=;_ //P=D?^A7@?_J_WN'_\)J]A;YV#T%\C\?OO9F[-
ME5U=W!MZLHJ'=NW<QMRKK*0;+IH6JJ6FS-'1S5%,)D*:T4KJ4B]Q[Y"_WDF]
M[+OG/'MM/LN[VMY"FTSJS02QRJK?45HQC9@#3-":TZS2^ZW87UAL/-4=]9RP
MNUY&0)$9"1X9%0& J*^G5 _\XS<. W#V'TO/@,YB,Y!3[,W)#/-A\E19.*"5
MLY2.(Y9**:9(Y&0WTD@V][)_OFWUE+U3=[][]U[KWNES^?GM7=&\_P"77O+
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M!NG:NV-\;=S&T-Y[>PN[-J[AH9L9GMN;CQE'F<'F,=4#3/19/%Y"&HHJVFE
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MWALK=\Z[JZM(0HK0ZD\9IAZT\+41D CH*[C[^^U>WJ].9/'D7\,,,SDXKAM
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@YFK_ ,7[??\ S+'_ *;_ /KGY/>E)[ZT=8G=6S>__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>bovies3consentexecuted001.jpg
<DESCRIPTION>F&D GRAPHIC
<TEXT>
begin 644 bovies3consentexecuted001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKA_CGJ5WHWP6\>W]A<
MRV5]:Z%?307-NY22*18'*LK#D$$ @BKA'GDHKJ3.7)%R['<45^+_ /PT-\4O
M^BC>*?\ P<7'_P 70?VA_BD/^:C>*?\ P<7'_P 77U?^KE;_ )^+\3YW^VZ?
M\C/V@HK\7A^T/\4C_P U&\4_^#BX_P#BZ=_PT-\4?^BB^*?_  <7'_Q='^KE
M;_GXOQ#^VZ?\C/V?HK\8/^&AOBC_ -%%\4_^#BX_^+H_X:'^*/\ T47Q3_X.
M+C_XNC_5RM_S\7XA_;=/^1G[/T5^,'_#0_Q1_P"BB^*?_!Q<?_%T']H?XI?]
M%%\4_P#@XG_^+H_U<K?\_%^(?VW3_D9^S]%>5?LM:YJ/B3X >"]2U6^N-2U&
MXM"\UW=RM)+(?,<99F)). .M>J#I7RM6#I5)4WT;7W'T%.:J04^ZN+112#KU
MK,T%HI*3!H =112-2 6BD%!.*8"T4W=2@YH 6BD -+2N 4444P"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBDQ0 M%(3BB@!:*0G%'7O0 M%)CWI!0
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MVTUE<RV]Q%);SQ,8Y(I5*NC X((/((/&#45>J<!^OW['_P#R;7X#_P"O)O\
MT:]>Q=*\=_9 ./V;/ ?_ %Y-_P"C7KF?VF+'2M<^*OP<TCQ#=O:^';VZU07H
M%_)9HX6T#)ND1U(PX7'(].]?D]6E[;&5(-VUD^^UW^A^APJ>SPT)6Z1_&R/H
M<=:!UKY]_P"%(? ?_H)1_P#A97G_ ,E5T-_^T%9:;XIUKP3X>\+:SXD\1Z(\
M4 L+,H%>,PJ_FM,[;40!E7+G+,> >2,7A^;2E=][I+]6:*MRZU++T=_T1[%2
M=,YKRG4_CAJ"ZG#H6C>!=6U_Q1'8P7NJ:;;W$$<6EF5<K%-.[!#(<-@+G(4G
MI5_P1\89/$/BZ3PIK_AC4O"'B/[&;^"UO9(IXKJ ,$9HY8F9259ERIP?F!Y%
M9O#U%'F:_%7MWMO;S-%7@W:_X/\ /8]('K0>:\SU7XJ^)]-U&\MX?A5XDOK>
M"5XTO(;JP6.902 ZAK@,%(&1D \\@5Y_J/QZT#XP?!;XE7>H^&_$6E>'M'@>
MVO)XI( ]PP)$BVTJ.R,RX&3G'S#FKAA:DK/IILT]_*Y$L1".G77HUM\CZ+QS
M0U>:>*OC#8>"WT#0-*TC4O%'B74;19[71=.V&9(  /.F=F"1)GC<QY/ !YQ7
MT3XY31^)]+T#QEX1U/P1?:LYATV>[EAN;2ZE SY0FB8A9" 2%8#..,GBH6'J
M-<R7^?K;<KV\$[-_UZ['J6*<!7CEW^T;#=^(-?\ #OAOPEK/B?Q'H]^]G/8V
MC11JJJJMYSRNP5$)?:H/S,5; P"1ZQI5U/?:99W%S:/87,T*22VDC!FA<J"R
M$C@D'(R..*F=*=-)S5KEPJPJ-J++E%-QBG5B:A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% "$XI,FE(YI,YH I:QK>G^'K(WFIWL&GV@=(S-<R!%W.P5%R
M>Y8@ =R16=;?$#PW>>*)O#<&N6,NNP@E]/2=3*N &88]0&4D=0""1@UY=^T9
M\*?%OQ&^Q7&C3Z9>6>G>3+;:5>PL66Z\]"UP'#JN5C!4 C@-)CE@1G:7\.O$
MTOCO3;"[T-XM-T_Q9J7B*;7#/$8;F"X@F5(D0,9-^;C80R@!8R=QR!79&C3=
M/F<M=?E_G_78Y)5)\_+RZ:'N&B^(=,\217,NEW\&H1VUP]K,]NX=4E3&]"1W
M&1D5B>&OBMX3\87L5GHVM0:C/*&9!"KD,!G.&QCL>]8OP2\#3?#_ $SQ/I[:
M;#I5E-X@O+JPMK<((Q;-M\LJJ\*,#IQC'2N#^ ^A^*/AYH&F:?JV@^-99[*S
ME1[9[O37T[<-SA8@)A)EL!5W8&6^; Y"5*FU.SVVU6NXW4FG'3??0][O[V#3
M;*XO+J58+6WC:665S@(BC+,?8 &DLKR#4K*"[M95GMIXUEBE3HZ,,@CV((KA
MOBUJ/B.7P9<66B>$[C6VU;3[JUECCNX8IK21X2(MRNP5E+$JQ5\KP0'!./"=
M<^&OQ7'B2QCT:PFT^6T6UM8=4@N08TB73UA+&1KK(43$DPK;X^7?EF/+I4(U
M(WE-+?\  *E:4'91;/JJZUFRL+^PLKBYCAN[YG2VA8_-*54NP7Z*"?PJ[FOD
MK4_A#XYU^#0QH6B:OX0O+&'=>W>H:RMP;VX^QR)*%"RL8A*Q6-IU8.=^[ *@
MUI:WX#^(]_XQU/4-!TG4M&>^T^X2)[Z^0I8L^G%(EBFBN ?EG"+Y;PNJMND#
M]*MX6F]JBV\O\S/V\_Y'_7R/J.LSQ#XCTSPGI4NI:O>Q6%C$55II3P68@*H'
M4L20 !DDD 5\^:5\*_$6M^,=.)T+5O#_ (!-[:M/H-]J^]\I9W:S2MY<S91Y
M)+5=NX[S&691R3U;^"O$#_ ;PIH^KZ3>:[K>G&U>[CCU(1ZA$8V.)H)RVTS(
M=I&YP&&X$\X,.A"+2Y[[=NOS^\T56;3?+;?N>E^'_'_AWQ1#;R:7K%K=&XED
M@CB#[93)&,R(8VPP91@D$ @$'N*Z#O7RIJ_PS\=:BT^H+HFISW ?5HM.NKF:
MSAU)/.TZ.*&:Z>!U1SYR,JM\SA!'NZ9K7U;X4>,-,\?V4>E+JHT>%M.;3;NU
MND=+$(X:[$QEF#Y9M[-B.7S X4D8&-)8:G?2HOZ_KMW,U6GU@?1>HZE::/92
MW=]<Q6EK'@O-.X1%R<#)/J2!]2*LFOD$?!_XB7^@:W;:O8:QJ-^;.070:^A$
M&ISB]BDC9#YY+MY:/M9UBVAMGICZXM"/LD.(GA&Q<12'+)QT/)Y'U-85J,:5
MN67,;4JDJF\;$W3O28R<T'I0M<IT#J***8!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5Y]^T-_R07XC?]B[J'_I.]>@UY]^T-_R
M07XC?]B[J'_I.];T/XT/5?F8UOX<O1GXOCI7T)^P7_R<YX;_ .N%Y_Z325\]
MU]"?L%_\G.>&O^N%Y_Z325^JX_\ W2K_ (7^1^?8/_>:?JOS/L']IOX1?&GQ
M]X[L-0^'/C ^']%CTY()K8:M-:[IQ+*S/L12#\K(,]>/:OAW]I;PS\3O GB#
M2O#_ ,2?$\WB*Y-K]OM0VH2W<<2N[(<%P,$F,YP.@%?2O[=/[0GQ"^$_Q9TG
M2/"?B271]/GT6*ZD@2WAD#2F>=2V71CT11C..*^,?B+\4_%/Q:U>WU7Q9J[Z
MS?V\ MHIGBCC*QAF8+A%4=78],\UXN44<0J=.I+EY+=O>^^QZ>95:+G.$>;F
MOWT/T5^-GB75O"7[#>EZIHFI76DZE#I&D".[LI6BE0$P X92",@D?C7D'["7
M[2?C+Q'\36\&>*-:N_$-AJ%K++;2WTGFRV\T8W'#GYBK*&!!)P0,8YS[I\1O
MAUK?Q6_8ST3PUX>@CN-6N](TEHHY91&I">2[98\#A37 _L=?L=>(OA#XUG\8
M^,I+.&[AMGM[&QM9O-9&? >1V VCY<@ $_>.<8&?&IU,*L#7C5MSN3MWZ6_$
M].<*[Q=*5._+97[=;GSS^W]X1LO"W[0U[-91+ NKV,.HRHHPOFL61VQ_M&/<
M?<D]Z^;QP.:]Y_;9^(]A\2?C[JUQI<JW.GZ7#'I<=PARLK1[B[ ]QO=P#W S
MWKP7^5?9X!2CA::GO9'S.+<7B)N.UV?K_P#L@?\ )MG@/_KR;_T:]87Q^\/:
M9XJ^.?P.TO6=/MM5TVXN]7\ZTO(EEBDQ9;AN5@0<, ?J!6[^Q_\ \FV> _\
MKR;_ -&O7I'B./1[&%-?U2SMYI-(22:"ZD@626WRN'\LD94LORG&,CBOS2M7
M6'Q56H^CG^-U^!]Q"G[3#0B^T7]UF<N?V>?A>1_R3SPS_P""J#_XFN6^#,,:
M_'#XX2! )&U'3D+ <D"R7 _4_G7HUIXMN1J%C;:GHUQI:WQ*6\KRQR N%+;&
M"GY6*JQ[CC&<UF_$CQ3H_P &_!?B;QN^CI(8$2YO?L4:1SW1!6-=S<;B 0 6
M/ &*YJ.)EB%*FFY.5DKWWNGU]"Y0IQM-:*.KT\G_ )GFHUG5/'7QE\>Z#)XT
M/@.ST5K6..UTN"UCO=05X%?SY)ID<E02R@(!C')KE?"NHZ#IO[6>AVEKXTU/
MQ5)%H=];SZAJ]XDT*SM) 1;PLJJF\#EE49^9<\\#H_%>M7'Q!:VN?$?[.-[K
M[PIB&6_DTV=T0\X4M)G'?%=?\,=6^'OQ-L8K"U\'VVCZEX4N%_XD&K:3%#<:
M/*>59$P53=C<KQG!X.:]1R]G!MQTM9VY7;2UVUKJ^]O4Y+<\TKZWNKWUUO;7
M3[CS_P =?%2P^-_BS4O NF>*[+PQX*TR5K;Q#K4MZEO<7[@X>RM=Q!"]0\N,
M8.!D'YMSXV7/A"V_9;\<Z)X/O-*DT[3=%>-+32[B.18$[9"DXR<\GDG)Y.:]
M+N?@Q\/[NXEGN/ OAJ>:5R\DLFD6[,[$Y))*9))[U<T[X8>#=(L[ZTL/">AV
M5K?1B*[@M]-AC2X09PLBA0'')X.>M<WUBC%PY$THM.VFKZM^9O[&I+FYFKRN
MKGSUJ=@=$_:#AGU;QCJG@>T\1>&[&#2M1LQ;"&XE@W>;;,\\4@5AN5P/ESN[
MG K4^('A[1]1U[PEX9O_ (D^*O&>I7NK6]Q;:79R::S6YA;S/M4C);JT<:;>
M2""<X .2*^@M=\*Z+XIT=M)UG2;+5=+;&;.]MTEA./N_(P(X[>E<=JMIX#_9
MU\':OXDL?#5EHFGPB,W7]BV,4<LNYU1<XV[L%QU/'-5'%*;C9>]LM%KT6N_]
M;HB6'Y4[OW=WO\]-OZV.;_9[MXT\9?&68(HE?Q=(K.!R0+>' )]!D_F:]I-5
M-/TBPTQ[J6RLK>TDO)?M%P\$2HTTA !=R!\S8 &3D\"K?2O/K5/:3YO3\%8[
M:4/9QY?7\P()HP:7-&:Q-0I:2EI@%%%% PHHHH **** "BBB@ HHHH ****
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M3J**DJX4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KS[]H7_D@OQ&_[%W4/_2=Z]!KS[]H;_D@OQ&_[%W4/_2=ZWP_\:'JO
MS,:W\.7HS\8*Z3X=_$37?A7XKM/$GARZ2SU:V5UBFDB64 .I5OE8$'@GM7-
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M9TGU&UO[[39KF*+RDN3;74L'FA<G&X1@D X!) X%=IG%<%;$SE-*:7NM]_\
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M*6NHO<****8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(0M(12T4#$QV%&.*6B@0W!HVTIH!S0 F#3J**!A1110@"BBBF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !28I:* $Q1BE
MHH 3%+110 4444 %%%% !1110 4E+10 F*6BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@!*6BB@ I,4M% !28I:* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@/6N<^$WC'Q%-^U[X#^'OC<S7'C3P1X7UZRN=4D0A-8LI)M.-G?J>F94C8.
M3MECD'I0!ZW8?MN?#[4]?GT2VTCQW)JUNL3W%F/!.J>; DA81O(OD916VMAF
MP#M;T->L_$SXCZ'\(_ ^J>+?$D\UMHFFJC7$D$#SN-\BQJ%1 68EG48 [UY-
M\.O^3UOC/_V+/AO_ -#U"F?M^+(_[(_CY89!%*5L@CLNX*WVZWP2,C/TS0!T
M.C_M6>!]0\0Z1HNH6OBKPK>:O=+8Z<_BCPKJ.EP75PV=L*33P+'O.#A2P)Z#
M)JIK'[7O@72?$VNZ%%IWC#6;W0[UM.OY-$\)ZC?P0W"JKM'YL,+(6"NAQGHP
M]:\=^*&D^/\ 0_BU\+=(^-'CFS\0?#2^UVVGL]1T'0ETM4UR!_-LK:\W33%8
M9&4%61OF=0K!003!\)H?%$GQ$^/)T3XN:-X"M/\ A85V&TW4=(@NY)'^PV.9
M@\DR$ C"XQC*$YYX /I+7_CWX/\ "?@'2?%VN7-_I&GZM(D%A97>F7*ZC<S/
MG; EGY9G:4[2=@3.!D@#FH/AY^T'X3^(_B6?PW;1ZSH/B6*V^VC1O$NCW.EW
M4MOD*9HDG1?,0,0"4)VDC.,BO)?'NKV_A']HGX%>*/&>O66I^&TT/5M'B\3,
M$@L4UF7[,5D8[BD1FBBN$0;CSN4')YNZG\4-67]J_P  >'+]_A[XBMM1DU4:
M?)IJ22:WI%JMJTGF.QD94$ACBC8A0&Z>E 'KUE\;?!EY\*YOB.VL+:>#H8YI
M9=1NHGC"+%*T3_(1N)WH5  )8XP#D5Q(_;#\!1R_9[RP\8:7J$T+7%AIVH>$
MM1@NM4C4J':TB:$-.4#AF5 65<L1M!(\C\"2^$4_X)YV<7CN74;3PK<7%S!>
M:AI8_?:>6UB4176?X1%)Y<A8@A0A)! (K2L/$?B;P#\5?A5IVN^/O"WQRTG7
M-4DM-+GDTFWBUW22;.9OML4L#F.2((C)(XC0XE')R00#T?P;^V/X#\>>*!X?
MTC3?&<NHK>QZ?<";PAJ44=G.X4JMP[0A8?E=6)<C"L">.:FUC]KWP+I/B;7=
M"BT[QAK-[H=ZVG7\FB>$]1OX(;A55VC\V&%D+!70XST8>M9G[-G_ "5[]HW_
M +'.#_TTV5>4_":'Q1)\1/CR=$^+FC> K3_A85V&TW4=(@NY)'^PV.9@\DR$
M C"XQC*$YYX />_%'[3WA#PE;>#WO;#Q3->>*[>YN=,TJR\,WUQ?M';^7YQD
MMDB,L>WSH\[U'6I?#?[3G@/Q-;>)BESJNDW_ (;TYM7U32==T6[TZ^@M &/G
M"">-'="$;E 1GCJ<5XW\:M,\7:_^T#^SC;>&/'6EVWB/^PO$HD\2RZ.M[;7)
M5-.$K+;K.@&X@])#MZ<UQD2ZV^N?M"P_%761?_%G2? -_9::+.T2TTVZT!TE
MD6YMH\L[,9@%EW,=C*J@D') /?/#7[8/@KQ=<:5'IFA>/)H=3:);6\;P5JB6
MSK(1LD,I@V!"&!WD[<<YQ4_B/]KKP'X9\7:_X<FM?%6H7V@SK;:E-H_A;4+^
MWM9#$LN&E@A=<['5CST->>_LYIXNM_AW\,IKCXY^'Y=(72=,9]!_L2V24P^3
M'_H_G?:-P;'R;]N<\X[5J_ KQAH/A;XN?M'-K.MZ=I 'C""4F_NXX,(-*LLM
M\Q''!YH ]\\%^--#^(GA;3O$GAO4X-8T/48O.M;VV;*2+D@]>00005(!!!!
M((KR6]_;-^'ECJNMV;6OBZXAT6_NM-O]1L?".IW5E!-;R-'.#/% R$(R,"02
M.*S/V)WCU'P5X_U[3H]GA;7_ !UK&J>'W"E8YK%Y$ FC4@8225)G7U# C@UY
MS\$?#WQG\0:7\4;3P=XK\&>'?#=UX_\ %$*S:CH5U>ZC QU.<.ZL+I(F()RH
M9,=,YH ^FO GQB\)?$S6-5T[PSJR:M+IMI8W\TL"-Y+07D;26SH^,.&1&/!X
M[XKG_$W[2_@7PII'B34;R\OYHO#^NP^&[V&RTV>XG.H2K$T4,<:*6E+>?$!L
M!R6QUKQG]FCPMX>_9U^/_P 1/A[-JT5G#%X5\,?V2^ISI'+?P6\-U!-,H)&<
M2#YMO"EQVKROQ-?#Q%X.^(NO:%K5M96.I_'S1?[,U_:L]LIBETV%K@ D+)&D
ML;_Q 'RV&>] 'U_\-_VC?!GQ0\2S>'=.;6-*\0QVQO5TKQ#HEWI=Q-;A@K2Q
MK<1IYBAF4$KG!(SC(KKOA]X]T;XG^#-*\4^'KA[O1=4B\^UFDB:-G3)&2K $
M<@]17S#HVK:WHO[7_P ,[?7_ ![HOQ9N-3TC6+*U.EV,5E-X>0)#/+<.L4L@
MD28P0PY?&UMNT_,P/:?L.^+M"B_9<^&>GOK6GI?FP$7V5KJ,2[S*X"[<YR<C
MC% 'L]K\0M$O/B'J'@B*Y=O$5AIL&K3VYB8*MM-))'&V_&TDM#(, Y&/<5PO
MBG]J?P)X6U[5M)!U[7IM%D\K6)_#F@7NIV^EMC<5N)8(F1&"\E<EE Y KG?#
MG_)]WCC_ +)_H_\ Z7W]8_['/C'0?"OP@\0Z)K^LV.F^*/#7B'6V\3I?7"12
MQ2OJ%Q,+B7<0=DD3QNLAX*]#Q0!]"^&?$VE>,_#^G:[H>H6^JZ/J$"W-I>VK
MAXYHV&592.U<S%\:_!\_Q@F^&":L/^$SATW^U6L#$X7R-R@@28VEP&1B@.X*
MP;&.:H_"3QOX+O?@IIWBSPYI2^$/ OV6?4+>":R2Q2&V#R.T_E)PJ. TH/\
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M"M(I(')XZ55UGX!_#'Q'=1W.K?#GPEJES'$D"37NAVLSK&@VH@+1DA5   Z
M=*[RB@#FM"^&7@[PO:V%MHWA/0])MM/N'O+.&QTV&%+:=T*/+&%4!'9&92PP
M2"03@UJ7'AS2;O7+/69]+LIM8LXWAMM0DMT:X@C?&]$D(W*K8&0#@X&:T:*
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M>)RB#<C%5RIX.!D<5VM% %?3M.M-(T^UL+"UALK&UB6"WMK>,1Q0QJ JHBC
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ML<G"CTJ'1O"^C>'-+;3-)TBQTO37:1VL[*V2&$L[%I"44 98DDG')))K3HH
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MNDV]GI,YNM.MXK&)8[*8[\R0J%Q&Y\R3++@_.WJ:W:* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/%OQ*U'X5Z8?"NLHFMZ9>Q6DLDINK B O)'("& 9L;<_(.>.?L8Q(9!(44R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMA90"Q9"Y?:<5]H_"1M13]EOP8VC@-JP\&V1LP<<S?84\OKQ]['6L>Y_8O\
M@U>PSV]QX-6XLI+DWD=A+J5XUI:S&02&2V@,WEVS%ADF%4R"1T)!]>T+1+'P
MSHFGZ/IENMIINGV\=I:VZDD111J%10223A0!R>U 'SU^R[HG@6^_8;\+1:K;
MV<WAN_\ #9G\3&^4;9KEHS_:+W!/)<3";<3R-OM7-?#N_N_C?>>,;/P5\2M9
M\#^!O!=AI5EX533T0,\,NF07<=[>&\C>69")50(Y4%8G+99B1ZOKO[(OPE\1
MZ[?:K?>$4>34+G[9?6,-_=0Z?>S9#&2>R25;>5B0"2\9+'KFM;QS^SC\//B-
MJ_\ :>N: SWKVJ6,[V%_<V*W=LA.R"X6WD19XQN.$E#* 2,8- 'QQX9^-OQ0
M^*_PA^+?Q/E\>:QX9N/"GA&SU?3M#TNWMDM&NI] 2>1Y?,B=W3S6\U%##!/)
M8$ >B_%+XD^._P!F;3M'\00^--0^),FO^%-:U&ZL]5C@-M%=V=A]KBN[=88T
M,<&X>6T>X@K)&<[AEO<?BA\ =*U_X2_%#PWX0L-/T+6?&>AR:6T[%TM]ZV?V
M6WW*H.Q$C"+A%Z+T)JW\.OV;_ ?PY"W-AH$;ZB^F_P!ER/>7<]['%;$+YEO
MD[NL$+%1F*-40X&5X% 'S9^T1XR^(O[.7PWTGQ'IGQ1U7Q9?>)]#U6*Z6_BM
M6CANXM)N;Z*^LECB7RD1[?:4.Y"DBYRPW'J_%EQXG\(P^"/#5S\3O'_BKQ!X
MDCN==O='\-:?8'4KA!%;J4@G=8XK.SCE?.')=C(JB3Y6SZWIO[)7PHTNUOK6
M/PJ;BUN].GTG[/>ZE=W4=M9S+ME@MEEE86R,O!6$(,<5O^//@1X(^)4VAW&N
MZ3,]YHB/%I][I^HW-A<P1N 'C$UO)&Y1@JY0L5.!D4 ?!_P4\7>,_$7QE^*N
MNZUXG\0_VQX3\&ZW8VT&J/8RS>7;7<R0Q71@C,<CQDAB4;#.F22,@_1&E>,O
M%7Q*U+X)^!E\5WOA:VUGP'_PE&KZGI:0QWNH2HMG&L$+LC+$-UP\C[5S@* 5
M&:]'TC]D7X1^']12^TOP;!IERL5U;DV=W<0J\5S&(YT=%D"NK*,[6! 8EAAB
M370^*?@/X&\8^'_#NC:EHK"T\.HL6CS6-[<6=U8((Q'MAN89$F0% %.'^8 9
MSB@#Y6\ >.?B5\1_C_/\);SXE:Q9Z-X?DU^QN=<TVWM$OM4BM6TM[=FD,+(D
MR?;6B=T0;A&W 9LCZ&_98\6:]XH^'6K6WB359->U/P_XFUGP]_:MQ&D<UY%9
MWTL$4DBHJKO*(N2H&2,]ZZCP;\#O OP^O-*N_#WAVWTRZTRUN;.VGC>1G$=Q
M*DMQO9F)D:22*-F=]S$KUZUT'A;P;HW@JVO[?1+%+"&^O[G5+E$9F\RYN)6E
MFD.XG!9V9L#CG@"@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_"36FK7#:+)##%92K(NV-I#G[4T14$@.JD,5S7I'C#]E?Q5X_P#%&@^*M?\
MBO=7OB#P[=1W.CVXT6'^QX6$<L;O+8L["65EF/[W>K)M79MQS;^'?[)K^"_C
M_>_%C4O'%_XEUN]M)[>X@N;&*%"\L=K&2GEX"HJV<2JF"0,Y9CR0#G-9_;2F
M\-VG@:#4O#D*ZOJ/BF[T#Q%!%<G9H]O;WZ6+W>2,E#+<V3#./EG]JU-:_:?U
MU_#%UKNGVGA/0/#[>)]1T2W\3^+=<2RTZ.VM"8C.P8AY7EN(YD1(^-J;F8=#
MI^*OV._#GBSQ9\5M=N-4NXI/'FD#3# D:[=,E*1J]S#S]]FMK1R.!N@![FDN
M?V38=.TKX4CPUXG?2M9^'ME<65I>:AIL=_#>"X2,7$TL+,N)F>,.)$8$%W!R
M&Q0!XG\'OVNO%GQ,_:"U.^O;S0QX*\+>&]8_M0Z-?3S6=X+:>U=KVW4J-S%)
M8PH8\ RX;INI^(O^"F9\+^"+/Q7*? .MQZK:336WAK0O$GVG5=,<6[SQ+>*%
MPP(C,;E /+D91\PYKUSP9^Q4WA#XE:OXMD\?W^NMKYU"/7K34].@(U"WO$M_
M.A#1[!%\]LK*57A6VXXS1XH_8XUWQA\,H_AQJ/Q<UL^";+39=,L+*WL8X9VB
M,30PB\F5A]J6)&^5=J!F56;<5% 'M_PSO/&NH>'I+CQUI^C:5JTLY>"TT6YE
MG2*W*J561Y$7,JL75MHVG (ZX'SC^V4NEWOQR^#&FZ]X<\5>+]$GTSQ%)-HO
MA*:=+F21#IWER,(9HB53<W5N-W3FOI+Q':^)IO&WA&;2;XV^@0O='6K9HHF6
MXC,)$(#-^\5UEVD;!@KOW$84-3\0_#*#Q!\5_!OCE[Z2&X\-6.I6,=FL8*3B
M\-MN8MG(*_91@ <[CZ4 ?-O@/1= \,?&[X,?\(GX9\6^!M/U23Q ;S2/%-W=
M/<3-%:0;'*33R_+\QQ@]<\5T\G[5'C$^!+CXLQ>%=&;X26VIR6K_ .GRG6)+
M%+HVK7ZIY?E !U+^26R8QG>#Q7M?BCX90>)_B9X'\8R7TD$_A9+](K58P5N/
MM421G<V<C;LR,=<UY9<_LBO-H,W@B+QS?0_"F?5FU23PJ+"$R[&N/M+6:W?W
MA;&8D[=A?:=GF8H X.;X]^,?B'\.=(\8^(?".BVO@J[\8:=I&G06>L74>H-<
MIKD=H+B38JKY0*NWE[CNV -E7('0?&SXO_$#Q=X:^-^G^!- TB7P_P"#K"ZT
MF^OK[4)8+V[NS8+/*+4(A5/)CGC(+GYWX&P?-7=6O[,EC:_!WP_\/QKMPUMI
M'B.'Q$EZ8%WR/'JIU$1%<X +'9G/3GVJMX[_ &:]1U^_\>#PUX\O/"&C^.HL
M:]I\.GQ7!:8P+;O/;R,087>%$1\AP=@(VMS0!Y)X@_:L\1?"/X<:0\EUX$TR
MWTOPIIU];6WBKQ#MU7Q$WV))9!;01;GC&<QAY%)9P3MVX8_6_@_Q%%XP\):)
MKT,300ZI8P7R1.<LBR1JX4GU ;%?/<'[%]QI.G>+='T7XAWNE:'XMT^"QUA5
MTJ"6^;R[)+,^3<MDQ1M'&N8RK[27V,F<CZ \$>&O^$,\%Z!X?%R;T:3I]O8?
M:6389?*C5-^W)QG;G&3C- &W1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6'XW
M\:Z/\.?".K^*/$-TUCH>DVSW=[=+!),88E&6?9&K,0!R< \"MRLGQ;X:L_&?
MA76?#^HIYFGZM936%RA&=T4J%''Y,: .>\:?&GP5\/-5\(:;X@UV+3[SQ;>+
M8:)'Y4D@O)FVA5#(I"@F1!N<JN749R16S#XXT2X\<77@^.]+^(K73XM5GLUA
MDQ';2R21QN9-NP%GBD 7=N^0G&.:^!=$T'6_VB/A_P"(!)F?Q-\)_ L.@6DC
M9++XEMKOSYF4#HV[2K+)ZXF(Z$BNAUWXO:QK/P1^*_QR\'S26+>,]?T;P_IV
MHK,D36.EQ/;VDLBS,"J$7$]_B0@A"P;G;0!][U@Z'XXT3Q)XA\2:'IU[]IU3
MP[<0VNJ0>4Z_9Y98$N(UW,H5LQ2QME20-V#@@@?/?P#3QCX4^/-WX9OUN])\
M/7'AHZA+H.N>-7\17RW2W*(EW&TQ:6.)U:57&[865"J@[L^>>-/AT^O_ !!_
M:Y\5Q>*_%.@ZAX>^R7FF)H.LSV$45S%X?M91-(D3 3$E47;*&4*#@#<30!]R
MT5^<FF?$/XE_%_1?B3XJO9]5M-0\.0V\=CJ5GXW.A66AK_9MO<+=360_=SB1
MY7D9IPZ,OR* %-2>'_%OCVQ_9/?XI77C3Q%J'BW7?$\GAJ\E&O.EAIEC)KS0
M2-;[\Q1,%!C2Y928UE&#M50 #[YUSQQHGAOQ#X;T/4;W[-JGB*XFM=+@\IV^
MT2Q0/<2+N52JXBBD;+$ [<#)(!WJ_-WQ3X3UR;]JOX1>"O$6L:WX(\/7EW+=
M#39_'LNKZG%.UA?(3#=.QG@CN5S$0'ZJ?+V,2:],G\5^)/A?JWC2[TOQ3K>M
M^!_AAXSTX3F_U&6\=M+N[.--0M9I7+-/]D:X6X4R%G39M+<4 ?:U%>/_ +-&
MNZMX]\,:_P"/M2O;N:Q\5ZQ/?:):3RL8[72DVP6GEH3A/-2+[0<=3.<UY!<1
MCQT_QG\9^+?BAXB\"7_@SQ/+86$VGZG/#9Z+9P1P/"TEBK".Y\\/O;SD?>)
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MDD ;/O9)'2@"+P]H?ASPY?ZO#HEEING7NH73ZEJ,=E&D<EQ<.%#3RA>6=@J
MLW)P.:CT_P"'WA?2O!Q\)6?AW2[;PL8I(#HL5G&MF8Y"QD0PXV;6+,2,8.XY
MZU\)'X;:=\'_  IX7C\9_"=? >L:/=V1M_C;X+N(-22:Z$B*+F_8F.[-O.S
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M:?Y<]M;BXC)$D>HQ$QO)E&)^9@N& /H;QM\&? ?Q)U;3-4\5^#]%\1:CIO\
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MVC3ZYIUK8^3ICZ'+;:G:2/I5A)':+=23.T< ,NQU$8,C[I?E!$0 /NF'X?\
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MK>^+'Q2TWX1>%4UG4+.]U2:YO+?3;#2]-17NK^[GD"10Q!F5=Q)R2S  !B2
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M$L"!6^''[5$/Q1U>PET3P'XDNO!VH:E/I5MXI@^S3P+-$75FG@CE:>WB+1L
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MZ)*JXY+(TB*RXR"W(KM?$/C70?"/AB?Q'K>L66D:#!$LTNHWLRQ0HC8VDLQ
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MQ]\=OA]\+;_[!XK\7:7H5_\ 9UNQ:7<V)FA8N ZH,LRYBDY .-AS4GC3XO\
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MN>(]6L]#T:T4-/?7\ZPPQ@D 99B!DD@ =22 .37@WQE_;7\%^#OAY8:UX/\
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MQEHG@KQMI^JZ-=>&=9U/X=^'M#LKZ]B*-%<QV5W'(H;J#$[Q[@.AQ7CGC7X
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M^&W]I_$G]HK5_B-_PCVM>'/#ECX8B\.V@\06+V5S>7#W37$[K"^'$:!85#,
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M+3=.L;.7[1;6UI9QQ1028(WHJ@!6PS#(YY/K6C#86MO=7%S%;0Q7-SM,TR(
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M/ME];>&- E_M;;/<W,6GP'[9DAU=V"_O.<,"<]C0!4^"/_)%_ /_ &+^G_\
MI-'7Q%\-_#?QBLOV+%\1>#/'5Q+HT-QJTMSX4T_1[87SV(U*Z%REK=.KGSRH
MD=-T;9/RC!P:_0Z"".U@CAAC2*&-0B1HH554#   Z "J'AN;1KC1;>7P^]C+
MI#[FA?32A@;+'<5*?*?FW9QWSWH _/9+C0O&'C:31]&D\)7WPLT3P1H\O@Z#
MQ?XIO-'BBL3%()[N'R8G$DZR((Y)&(>(QJ."QK@OA9JOAR^_90^(/C&\^(5U
MXB^,^CZR\?A_4SK-U]K^TGRC9+:P2E'*7#,=P,8,F]PX^7"_IIJ7PS\'ZSI]
MG8ZAX4T2^L;-VEMK:YTZ&2.!V.69%92%)/)(ZFN7^'/P!\,^ -:UW638V.K:
MSJ.N7NM0ZE<V$7VFR^T,&:&*3!8*.>A&<GB@#Y-\57WA_6? _P ?_%7Q#\27
M&C?%OPWK&HQZ$HU>6"ZTI(HU;2EL8 XRDV8V^52)FD<,6Z#F=2^&=MXW_93_
M &D/'WC6"^O_ !Y:7&O6JM/?S^58*B)(T$<*OY842[V^Z>3UP !^A>H>"?#N
MK:[::W?:#IEYK-F,6VHW%G')<0#G[DA7<O4]#WJ^FD6,5O=0)96Z073.]Q$L
M2A9F?[Y<8PQ;N3U[T <&N@>%]:^ TFE:7]GU#PO+HSI#]DNC+%(@0GY958DC
M(ZAJ^2?!FDZ)IOP0_9&\,ZY.^D?#3Q+IZW/B#=>206U[?_V:DEI!<2[AB.20
M2-Y>X*[1HN#TK[0UOQ7X%^$^D65CK&L>'O!NEN##:VU]=06,##NL:L54]>@]
M:U'T'P_XB\,1::^G:9J?AV:%!'9M!'+:/$ "@"8*%< $8&.F* /S]T[PUI?C
MS]J"Q^&ECJVHZK\$X_$-_#9VEKJT[6TCC1XY[JR2='W&&.X\MM@;:I9TZ96O
MH[]N?POI*_L?>+K*6 _8-+MK1X \SGRECGB4,6)R<)G)8GU/K7O.F>%=%T6V
ML+?3]'L+"WT\,MG%;6J1I;!AAA&% "9'!QC-7KRRM]1M)K6[@BNK69#'+#,@
M=)%(P593P01V- 'Q;#\$?A_\4OC?\:?M,4FJ:)I/A70%T;[#JDRP1 VUYLF1
MHY!O<!%VR$DKS@_,<^(^!O%'B+XI:7?ZA\0-2\-7G]F>"?#]WIU[XQ\5WND3
MVMO+I<<L^H6@@A</*UR9MTX.\-$J]AG]--+\-Z1H<+0Z=I5EI\31)"8[6W2-
M3&@(1,*!\J@D =!DXK%U[PCX&U&YT'3=:T7P]<W$6Y=(L[^U@=T\M0S"W1QD
M;5 )V#@ 4 >/:OH_C+QI^QAX?O[;66UCXA:9HUAK]CJ=LD]O_:-[:A+A-R2)
M'(!<!"C*Z*<3-E17@?Q,^)^N_%KP#>?%30KUK+P3XL\7Z/X7C:_U">PM$T*!
M9?/>:XB5F@2>_D>&251GRP@)QT^Z/'NB:YXB\*7VG>&_$/\ PBFL3!5AU;[$
MEWY W#=B)B 25R 2>"0><8K)\(^"?"GPI^''AKP$'M%T6&VCT6U@U)DS?L(V
M+*5;B220+([  D_.<=: /@#4-1ATCXU0_#YYO"U[HFH>3<)X)TCQS>V_ANVO
M(X+@L]Y=R6G22-HV%I#N+/"KN &R6?LF>$]/^+O[3GC3PMXAU!=4\(^&VO;G
M3-&T'7KR72;>1)-/>,P2;T>2-'FG*@_+ER0,!<?H>/A1X(&@#0AX.T :()OM
M(TW^RX/LPE_YZ>7MV[O]K&:U]/\ #&CZ1>/=V.DV-E=O&L+3V]LD<C1J %0L
M "5 50!T 4>E '@7[<^M:UI7P^\&6VG3V]KHVI^+;&PUV:]U&;3[7[$Z3$1W
M%S"K/##).MO&S <A]IX8FOG'P-X/3Q/^UEI'@._UG25\$?9KJ>Y\'^"_$.HW
M6G6]P+96='G>*%=L@$#FWC9@K)N<#S?G_1:_L+75+*>SO;:*\M)T,<MO.@>.
M13P593P0?0UFZ%X*\/>%[>VM]&T'3-(@MB[016-G'"L1?&\J%4!=V!G'7 S0
M!\#^!+32+OXVI\-/'6I30?![2]=\3VNBZ;J.IRK:3WL,EB\%I*[/\ZQ13W,D
M2.>N<9VC'#^!#_:7C/3O".CW>B:Y\+YM>\5W>F1^*_$-U9:=JMW'>Q+&'N(X
MY#<ND#,Z*_#!G?)*BOTPU7P5X>U[3KC3]3T'3-1L+F?[3/:W=G'+%++Q^\96
M!#-P/F//%,U+P'X9UC1GTB_\.Z3?:2\GG-87-C%) S_WC&5*EO?&: /S\^ A
M\&>-/$'Q+L?BOXZ@N-(\.6I;PC);^(KW['I]B9[L7$VGW$PB>X:&5/($X5B%
MAC56*D9^@/@O_P HW_#_ /V3EO\ TA:OH*Z\ ^&+V#28+CPYI,\.D,&TZ.6Q
MB9;(C !A!7]V1@?=QTK4@TJRMM-73H;.WBT]8_)6T2)1$(\8V! ,;<<8QB@#
MXQ\>_&CX>ZG^P/;>#+7Q'HOB3Q;KO@>VT'3/#>G7L-U?3ZA+9)%"BP(Q8,DI
M5B2/EV$G&*YCX@6.NZG\;/%^A>.)_"M[9^'/"^D?V9_PE_BJ\T=((C;M]KOK
M00PN'D,ZNK39WIY<8&,U]PZ1X!\,>'[P7FE^'-)TV[4%1/9V,44@!ZC<J@T_
MQ+X'\.>,_LO_  D'A_2]=^RMO@_M*RCN/);CE-ZG:>!R/04 ?G]\#+KP7XN^
M$&N>+OC!\0]6N?B5I.J6D-GX@L+VX@U6* 16WV!["UE0,5N58/M,!\XS2;E)
MR!QEUK'B2_\ A+<^,M3UKPKH7Q&FU^>VO-7F\3ZD_B 7(O'273CIZ6S*L9A!
MB$0(C2/;+E=NX?IM=^"_#U_KUIK=UH6F7.M6:[+;49K.-KB!>>$D(W*.3T/>
MHI? 7AF?Q"^O2^'=)DUQXS$VIO8Q&Y9"NTJ9=NX@KQC.,<4 ?%OA;X,Z#+XD
M_9KBFN]<G3QMX6NI?%*OK5V1K;1V-M/']H'F<A96) 7:,?)C9\M<-\(O#O@;
M5_V@H/"_CS5G3PWHL7B_2-'L-3U66*&2"WUXK#;O(7!E6.)6*H['_5AL?NQC
M]'4T>PC>S=;*V5K)#':L(E!@4@*53CY00 ,#' %9FI_#_P +ZW;SP:CX;TB_
M@G9FEBNK"*19"S[V+!E()+_,<]3SUH _.;PYK_B+QK\0?#_A74[C1O$?PQMK
M'6YO"!\<^(KO3[+5(8M6EABE\Z.*0W<D5JL(C\S_ )9N7&2=U=U^PEX-M?B)
M\3/'&L^)/$,GC4>%+FR;PU<6NK7\UE9QL]XH\MIEB-QMC2*$2R(0ZQ!E)#DM
M]QZYX(\.^)](ATK6= TO5M+@*F*QOK..:"/:,+M1E*C X&!Q5[3M$T[1]WV"
MPM;+<B1'[/"L>40;47@#A1P!V'2@#A_BAX]\.>'M;T/PWJFO/X2UWQ%;W<6C
MZ]Y,!$$D:HTB)).K1B0J0RHZD,$;@[:^<_AEX0T/Q!^S!\5(]4M=-\9#PQJO
MB1M(\6W$ F;596A:23459BR^<999H2\>%S"VP*/E'U_X@\-:1XLTU].US2K+
M6=/=@S6FH6Z3Q,1R"4<$9'TJ>#2K*UTQ=.AL[>'3UB\E;2.)5B$>,; @&-N.
M,8Q0!YS\"/$FD:;\&_A%I%YJEE:ZMJ?ABQ-C83W")/=B*SB:7RHR=S[%(+;0
M< @G%8G[2GQV\/?!"/P[))9Z3J/CW6))K+PY;ZK=164:G:K7$LMU)Q! BA"Y
M'+810&8BO2K_ ,!Z/J/B#PUK$ML%N/#JSKIT<0"1PF6,1,0 .T>Y0,XPQX)"
MD6]<\(:#XG>%M9T33M6:$$1-?6D<Q0'&=NX'&<#IZ4 ?'/PYT[PS\-?CW\.O
M$^H>/=&\6GQ+%XE&K>);2[B_L\:_<?V9+Y,9#LL0^S6NR-"VXI",Y)YT/ WA
M;0O'/P8_:%\676EV&LZ9/XI\2ZMX:OYH4F0*+&.V>YMV((&Z6&XPZ]020<&O
MJR3X=^%)="FT1_#&C/HT\GFRZ<UA$;>1\ ;FCV[2< #)&>!6M;Z38V>EQZ9!
M96\&FQQ"W2SCB585C P$" 8"XXQC&* /FGXF>(]6T[]C_P"'?AOP_=MI^O\
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MY]8E@NK^Z.J7SZA*+Z[DG6)V1$*0AR?+C C!$:X4$L<98UL4 %%%% !1110
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MJ(<;O497/L- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!;X6^,0 23HUX !_UP>@#R[X;_M+^*/B7:>%]4L?@CXPM?#?B!+6Y@UNXO\
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M[^#M"T/PYKGQ&TC]G^ZAOK;3_@S#:>'KO2I1,9;\7NK$,''#3-,VX_[3= *
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MI!=37UM#;3E1%-),JI)NY7:2<'/;'6OA[P)^TGX"?]AGPW\/](U-?%?Q O/
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M6ZU?Q1I=P)+#3GR@@M_, *RRR9<[%;**F3UH ]>HHHH **** "BBB@ HHHH
M**** "BBB@#X\_X*:WOASP/\"5\8W'A?1]5\5+JVFV>GW]YIT4]PNRY%R(@S
M#=L;R74J#@AV]37T)\ /AW%\)O@GX(\(QP+;R:3I-O!<*O\ %<; TSGW:0NQ
M]V->*?MA>!=;^+GQE_9X\&VVGWMSX8B\23>)-:NDM6>TA6RB#Q+-(!A3(9'1
M03R6KZJH 1F"*68@ <DGM7Y^?'O]N^_M/V@O ;>";7Q1J7PNT*[ODUS5O#VE
M/>0Z]=)$0;*#("N$;:"^X %R0?DR?8/'GB75?VJ/BGK_ ,)?#5[>Z/\ #GPX
M?LWC;Q#8N8I[VX8 KI5K(/N\$^>X&0IV KNR9/VL]=L_AM\)/#7PA\%&S\+W
M/B]CH-LR;88-(T>./=J%V6;"HL5ONY)SN=2,F@#H?V._VCO$'[4G@[7/&U[X
M27PIX4DO_LWA]99S)<W4*+B663@+CS,@;>.&'.W<WGW[8/[=$'P:UE/!/@9]
M/U/QG"JWNLWMYNDL="LU8%FN G+2R#Y$B!#%G3NR!O(OC/\ MB:A\._A=X2\
M&_ C3K7PGX-DQHNE^.?$W[N*:V@B_?7%E"PW2)&N&,[C#,=J+(S"O"_!5SX>
MMOCAX8\+W?P^\4:[%9>5XKMH+NS<:[\0-9D=O(O+MF.VWM$+2RJLK?(H8MN+
ML* /TMT+]I.QC^!UE\2/&GAW5/ J7I86OA^_3S=2N,N5@1(4&YI95"L(P,C=
MSP":\+^"OQ'\6_%K]K*^\3^,?%UOX7\+Z+ ^A:-X,BU$1)/JLB*\\#?,/MDT
M$17S"%VI*^U,B,NW:>(/A5\5?^$5U;Q_>K8^)?C9=Q_8/#UC%*!I7A.&X81R
M-!O*[W2-F:2?&^3;L4!?E/SQK7@#P=^S%\2OA#\/XKB7Q/XF\-V\GB[5;NXD
MS>Z]J3M)%8V<)=R(4-Q/<W!4G8BQ/(V3N>@#ZX_:E_:BTS]GGP_8V5C9MXE^
M(OB!_LGAOPM;9::^N&(568#E8E)&6XST'/3Y:_;,^/'CSXNW/AS]F;P5/I\7
MQ!UZUM+;QK<63,8+5YHPTUM'PS"(+ODD?G$>U"2SXKRSX%_%C5/&GQ0^(?QF
MT_0K_P"-WQD$$]MX=TO3XC_9^@V<:$-.7?'EB1RZPPJ3,R;LC=*6KT?]DSX
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M#+/;KJU[';>;''M#E=Y&<;UX'/-?G+^U?\=O G[7OQF\.>%&^)EIX.^#/A*
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M/3W$  8' I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0M3X<\3_  SM-8\'S/>Z5XLU*2\/B._5X6-Q#^\D598E\PN9#',RS#,6%)4
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M%&!R23Z7110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M12,=H).<#G@9J+[6G]V7_OTW^% $U%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #9)!%&SL&(4
M$D*I8_@!R?H*H?V[;?\ /*\_\ 9O_B*O2R"&)Y&#%5!8A5+'CT Y)]A6?_PD
M-K_SROO_  7S_P#Q% C3HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 -=Q&C,<D*,G:"3^0ZU5
M_M6#^Y<_^ LO_P 35B=#)#(JR-$S*0)$ ++QU ((R/<'Z5D?V7=?]![5/^_$
M'_QFFE?J2S;HHHI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% %?4+:2\L+FWANIK&66)D2ZMPADA8
M@@.H=64L.HW*PR.01Q7%_P#"N?$'_14_%O\ X"Z1_P#(%=U(I=&4,4)! 9<9
M'N,\53_L^?\ Z"=U_P!\Q?\ Q%:0FX[6^:3_ $,Y14M[_?;]2]11169H%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %)2TF:!"T444#"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DS2TF10(6BBB@84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4F14=S<):6TL[AV2)"["*-I'( R<*H)8^P!)[5S_ /PL#2_^
M?76__!#??_&:I1;V1+:6[.EHHHJ2@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""_O(].L;B[E65XH
M(VE=8(7FD(49(5$!9SQPJ@DG@ FN._X7%H/_ #X>*?\ PD=6_P#D:NQO[R/3
MK&XNY5E>*"-I76"%YI"%&2%1 6<\<*H))X )KCO^%QZ!_P ^'BK_ ,)'5O\
MY&K6$>;[+?I_PS,YRMU2]?\ ASN****R- HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"OJ%['IMA<W
M<RS/%;QM*ZV\+S2%5!)"QH"SMQPJ@DG@ FN+_P"%T>'_ /H'^+?_  CM7_\
MD6NTU"^CTRPN;R99GAMXFF=;>!YI"J@DA(T!9VXX5023P 2:XC_A=WAW_H'>
M+_\ PB]8_P#D2MJ<.9?"WZ?\,S*<N7[27K_PYW]%%%8FH4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!!>W::?97%U*LK101M*RP1/+(0!DA40%F/'"J"3T )KDO^%MZ'_SX^)__"4U
M3_Y&KM*2J7+U1+OT%HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,>YI)%+QLJNT9((#KC*^
MXR"/SJA_9ES_ -!>\_[XA_\ C=-(3-&BBBD,**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"MJ9*Z;=D33VY$3GSK:/S)4X/S(NUMS#J!M;)['I7
M?:I/^AN\;?\ A/)_\@5W^IG;IMV1-/;D1.?.MH_,E3@_,B;6W,.H&ULG P>E
M>?\ VN3_ *&[QO\ ^$ZG_P KZWIK3_@?\!F-3?\ K_-'I-%%%8&P4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!6U-MNFW9$T]N1$Y\ZVC\R5.#\R)M;<PZ@;6R<#!Z5Y_]L?\ Z&[Q
MM_X3J?\ ROKO]3;;IMVPFGM\0N?.M8_,E3Y3\R)M;<PZ@;6R<#!Z5Y_]N?\
MZ&[QQ_X3B_\ ROKHI+1_Y?\  9C4>O\ 7^:/2J***YS8**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MJZJ_EZ7>/YT]OMA<^;:Q>;,GRGYD3:VYAU"[6R<#!Z5YS_;'_4V>//\ PE__
M +W5Z7=0O<6LT4<\EL[H56>(*7C)& R[@5R.HR"/4&N<_P"$1U7_ *'?7O\
MOQ8?_(M;TVDM?Z_!F4TV]/Z_%'44445@:A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $5U"]Q:S11S
MR6KNA59X@I>,D8#*&!7(ZC((]0:YS_A$=5_Z'?7O^_%A_P#(M='=0O<6LT4<
M\EL[H56>(*7C)& RA@5R.HR"/4&N<_X1'5?^AVU[_OQ8?_(M:P=NJ^:_X#,Y
M>C_KYG44445D:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% $5U"]Q:S11SR6SNA59X@I>,D8#*&!7(
MZC((]0:YS_A$=5_Z';7O^_%A_P#(M='=0O<6LT4<\EJ[H56>(*7C)& RA@5R
M.HR"/4&N<_X1'5?^AWU[_OQ8?_(M:P=NJ7JO^ S.2\G_ %\SJ****R- HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,TM)0
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% "$X!-,\Y?1_^^#_ (4]CM!)S@<\#-1?:X_23_OT
MW^% $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !29%+29H 6BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,T
MM)FD M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I/SI:3'N: %HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-?5?>O1Q->K1K2ITWRQB[)+^M;^9PT*-.K24YJ[:O?\ K8_/OXE_#+2_B/\
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M3WH&<T"EKSF=H4444(84444P"BBB@ HHHH **** "BBB@ HHHH *3M2TG6D
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M4H$(5I;&P0$] 3&!7VG"G^_R_P +_-'DYG_!7JC[>_:/\3?LY7GP+\;0G4/
M5W=/I5P+.+2Y;1[HW/EMY/E",[]WF;<$=._&:_.;]GN:^B^"?[00A:1; ^'K
M+SBIPOF?;X@@/U4R_AFO>M+_ ."0WCV:_A74?&_AVVLBW[V6UCGFD4?[*,B
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=D/2EHH 2EHHH **** "BBB@ HHHH *3-+10!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
